1613 genotypes with 2201 annotations displayed
of selected term and subterms
|
Searched Term: abnormal response to infection
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/J)
|
sepsis
|
J:113232
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to Orthomyxoviridae infection
|
J:137452
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: FVB/N)
|
abnormal response to infection
|
J:189122
|
decreased susceptibility to bacterial infection
|
J:210086
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal susceptibility to infection
|
J:194800
|
increased susceptibility to bacterial infection
|
J:194800
|
A930024E05Rikem2Zfa/A930024E05Rikem2Zfa Satb1em1Zfa/Satb1em1Zfa Tg(Rorc-cre)1Litt/0
(involves: C57BL/6 * FVB)
|
increased susceptibility to bacterial infection
|
J:259392
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:259392
|
A930024E05Rikem2Zfa/A930024E05Rikem2Zfa Tg(Rorc-cre)1Litt/0
(involves: C57BL/6 * FVB)
|
increased susceptibility to bacterial infection
|
J:259392
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:259392
|
Abl1m1/Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
increased susceptibility to infection
|
J:14644
|
Abl1tm1Mlg/Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J * CBA)
|
increased susceptibility to infection
|
J:34643
|
Abl1tm1Mlg/Abl1tm1Mlg Tg(ACTB-Abl1*K290R)1Spg/0
(involves: 129S/SvEv * C57BL/6J * CBA)
|
increased susceptibility to infection
|
J:34643
|
Ace2em1(ACE2)Yowa/Ace2em1(ACE2)Yowa
(C57BL/6-Ace2em1(ACE2)Yowa)
|
increased susceptibility to Coronaviridae infection
|
J:288243
|
Ace2em2(ACE2)Gpt/Y
(C57BL/6JGpt-Ace2em2(ACE2)Gpt/Gpt)
|
increased susceptibility to Coronaviridae infection
|
J:302150
|
Ace2tm1a(KOMP)Wtsi/Y Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:282139
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282139
|
Ace2tm1a(KOMP)Wtsi/Ace2tm1a(KOMP)Wtsi Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:282139
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282139
|
Ace2tm1Pngr/Y
(B6.129P2-Ace2tm1Pngr/J)
|
decreased susceptibility to Coronaviridae infection
|
J:286299
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:282139
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282139
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:277074
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:277074
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:282139
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282139
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:277074
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:277074
|
Ace2tm1Pngr/Ace2tm1Pngr
(B6.129P2-Ace2tm1Pngr/J)
|
decreased susceptibility to Coronaviridae infection
|
J:286299
|
Acsns1A/J/Acsns1A/J
(involves: A/J * SM/J)
|
decreased susceptibility to parasitic infection
|
J:75549
|
Acsns2SM/J/Acsns2SM/J
(involves: A/J * SM/J)
|
increased susceptibility to parasitic infection
|
J:75549
|
Acsns2SM/J/Acsns2SM/J Acsns3SM/J/Acsns3SM/J
(involves: A/J * SM/J)
|
increased susceptibility to parasitic infection
|
J:75549
|
Acsns3SM/J/Acsns3SM/J
(involves: A/J * SM/J)
|
increased susceptibility to parasitic infection
|
J:75549
|
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen)
|
increased susceptibility to bacterial infection
|
J:301741
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:301741
|
Adamts13tm1Dgi/Adamts13tm1Dgi
(involves: 129X1/SvJ * C57BL/6J * CASA/Rk)
|
increased susceptibility to bacterial infection
|
J:101752
|
Adartm1Olds/Adartm1Olds
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:169014
|
increased susceptibility to Paramyxoviridae infection
|
J:169014
|
Adcyap1r1tm1Bbt/Adcyap1r1tm1Bbt
(involves: 129 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:73990
|
Adgre5tm1Kake/Adgre5tm1Kake
(B6.129S6-Adgre5tm1Kake)
|
decreased susceptibility to bacterial infection
|
J:118705
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:118705
|
Adh5tm1.1Llli/Adh5tm1.1Llli Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Adh5tm1.1Llli Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:173666
|
Adh5tm1Stam/Adh5tm1Stam
(B6.129-Adh5tm1Stam)
|
increased susceptibility to bacterial infection
|
J:88337
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:88337
|
Adm2em1Zhan/Adm2em1Zhan
(Not Specified)
|
increased susceptibility to infection
|
J:266495
|
Adprhtm1Jlms/Adprhtm1Jlms
(involves: 129X1/SvJ * C57BL/6J)
|
increased susceptibility to infection
|
J:123619
|
Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu/Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu
(involves: FVB/N)
|
increased susceptibility to Herpesvirales infection
|
J:231311
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:231311
|
increased susceptibility to Poxviridae infection
|
J:231311
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:231311
|
Agbl5em1Zfa/Agbl5em1Zfa
(Not Specified)
|
increased susceptibility to Herpesvirales infection
|
J:231311
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:231311
|
increased susceptibility to Poxviridae infection
|
J:231311
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:231311
|
Ahnaktm1Vtm/Ahnaktm1Vtm
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:131148
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J)
|
increased susceptibility to bacterial infection
|
J:118646
|
Aicdatm1Hon/Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:169227
|
Aicdatm2.1Hon/Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
increased susceptibility to bacterial infection
|
J:169227
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:169227
|
Aim2Gt(CSG445)Byg/Aim2Gt(CSG445)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:158969
|
increased susceptibility to Herpesvirales infection
|
J:158969
|
increased susceptibility to Poxviridae infection
|
J:158969
|
Aim2tm1.1Vmd/Aim2tm1.1Vmd
(C57BL/6-Aim2tm1.1Vmd)
|
increased susceptibility to bacterial infection
|
J:160545
|
Aim2tm1Ktak/Aim2tm1Ktak
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:188013
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:188013
|
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
|
decreased susceptibility to fungal infection
|
J:174653
|
increased susceptibility to fungal infection
|
J:174653
|
Akip1em1Cya/Akip1em1Cya
(C57BL/6N-Akip1em1Cya)
|
decreased susceptibility to viral infection
|
J:326919
|
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak)
|
increased susceptibility to fungal infection
|
J:233952
|
Aknatm2Mak/Aknatm2Mak
(B6.129-Aknatm2Mak)
|
increased susceptibility to fungal infection
|
J:233952
|
Alox8tm1a(KOMP)Wtsi/Alox8tm1a(KOMP)Wtsi
(C57BL/6N-Alox8tm1a(KOMP)Wtsi/MbpMmucd)
|
abnormal susceptibility to Orthomyxoviridae infection
|
J:277623
|
Ank1ity16/Ank1+
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:199427
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199427
|
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:199427
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199427
|
Ank1MRI23420/Ank1+
(SJL/J-Ank1MRI23420)
|
decreased susceptibility to parasitic infection
|
J:187820
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:187820
|
Ank1nb/Ank1+
(involves: C57BL/6J * WB/Re)
|
decreased susceptibility to parasitic infection
|
J:111131
|
Ank1nb/Ank1nb
(involves: C57BL/6J * WB/Re)
|
decreased susceptibility to parasitic infection
|
J:111131
|
Ank1Rbc2/Ank1+
(involves: 129S1/Sv * BALB/c)
|
decreased susceptibility to parasitic infection
|
J:148127
|
Anth2CBA/J/?
(involves: A/J * CBA/J)
|
decreased susceptibility to bacterial infection
|
J:9501
|
AnthC3H/HeNCrj/AnthC3H/HeNCrj
(involves: C3H/HeNCrj * C57BL/6NCrj)
|
decreased susceptibility to bacterial infection
|
J:11149
|
AnthC3H/HeNCrj/AnthC57BL/6NCrj
(involves: C3H/HeNCrj * C57BL/6NCrj)
|
decreased susceptibility to bacterial infection
|
J:11149
|
Antxr2tm1.2Lepp/Antxr2tm1.2Lepp
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:150952
|
Ap3b1m1Btlr/Ap3b1m1Btlr
(C57BL/6J-Ap3b1m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:132673
|
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe)
|
decreased susceptibility to bacterial infection
|
J:125473
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:125473
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:125473
|
Apcstm1Mpe/Apcstm1Mpe
(129.Cg-Apcstm1Mpe)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:125473
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:125473
|
Apobec3Gt(XN450)Byg/Apobec3Gt(XN450)Byg
(B6.Cg-Apobec3Gt(XN450)Byg)
|
increased susceptibility to Retroviridae infection
|
J:118597
|
Apobec3Gt(XN450)Byg/Apobec3Gt(XN450)Byg
(B6.129P2-Apobec3Gt(XN450)Byg)
|
increased susceptibility to Retroviridae infection
|
J:138778
|
Apobec3Gt(XN450)Byg/Apobec3Gt(XN450)Byg
(129P2/OlaHsd-Apobec3Gt(XN450)Byg)
|
increased susceptibility to Retroviridae infection
|
J:138778
|
Apobec3Gt(XN450)Byg/Apobec3Rfv3-s H2b/H2d
(involves: BALB/c * C57BL/6)
|
increased susceptibility to Retroviridae infection
|
J:138778
|
increased susceptibility to Retroviridae infection induced morbidity/mortality
|
J:138778
|
Apobec3Rfv3-r/Apobec3+
((B10.A x A)F1)
|
decreased susceptibility to Retroviridae infection
|
J:6147
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
increased susceptibility to parasitic infection
|
J:125366
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:138241
|
Aqp4tm1.1Lmno/Aqp4tm1.1Lmno
(B6.Cg-Aqp4tm1.1Lmno)
|
increased susceptibility to parasitic infection
|
J:193622
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:193622
|
Aqp9tm1Nlsn/Aqp9tm1Nlsn
(involves: 129S1/Sv)
|
decreased susceptibility to parasitic infection
|
J:123305
|
Aregtm2c(EUCOMM)Hmgu/Aregtm2c(EUCOMM)Hmgu Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
increased susceptibility to Orthomyxoviridae infection
|
J:224904
|
Aregtm2c(EUCOMM)Hmgu/Aregtm2c(EUCOMM)Hmgu Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
increased susceptibility to Orthomyxoviridae infection
|
J:224904
|
Arg1tm1Pmu/Arg1tm1Pmu Lyz2tm1(cre)Ifo/?
(B6.Cg-Arg1tm1Pmu Lyz2tm1(cre)Ifo)
|
decreased susceptibility to parasitic infection
|
J:143229
|
Arg1tm1Pmu/Arg1tm1Pmu Tg(Tek-cre)1Ywa/?
(B6.Cg-Tg(Tek-cre)1Ywa Arg1tm1Pmu)
|
decreased susceptibility to bacterial infection
|
J:143229
|
Arhgap15tm1Ehi/Arhgap15tm1Ehi
(B6.129-Arhgap15tm1Ehi)
|
decreased susceptibility to bacterial infection
|
J:174896
|
Arhgef2Gt(IST13976A8)Tigm/Arhgef2Gt(IST13976A8)Tigm
(involves: C57BL/6N)
|
increased susceptibility to Orthomyxoviridae infection
|
J:209086
|
Arih1em3Gpt/Arih1em3Gpt Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6JGpt)
|
increased susceptibility to Herpesvirales infection
|
J:330879
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:330879
|
Arih1em3Gpt/Arih1em3Gpt Lyz2em1(icre)Gpt/Lyz2+
(C57BL/6JGpt-Arih1em3Gpt Lyz2em1(icre)Gpt)
|
increased susceptibility to Herpesvirales infection
|
J:330879
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:330879
|
Asgr1tm1Sau/Asgr1tm1Sau
(B6.129S4-Asgr1tm1Sau)
|
increased susceptibility to bacterial infection
|
J:136946
|
Asgr2tm1Her/Asgr2tm1Her
(B6.129S7-Asgr2tm1Her)
|
increased susceptibility to bacterial infection
|
J:136946
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
|
increased susceptibility to bacterial infection
|
J:208213
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:208213
|
Atf2tm1Glm/Atf2tm1Glm
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:30611
|
Atf2tm1Glm/Atf2tm1Glm
(C.Cg-Atf2tm1Glm)
|
increased susceptibility to Herpesvirales infection
|
J:67176
|
increased susceptibility to Picornaviridae infection
|
J:67176
|
Atg16l1tm1.1Mvlc/Atg16l1tm1.1Mvlc
(C57BL/6-Atg16l1tm1.1Mvlc)
|
increased susceptibility to bacterial infection
|
J:206931
|
Atg16l1tm1c(EUCOMM)Wtsi/Atg16l1tm1c(EUCOMM)Wtsi Tg(Vil1-cre)997Gum/?
(involves: C57BL/6J * C57BL/6N * SJL)
|
increased susceptibility to bacterial infection
|
J:221019
|
Atp7aMo-3Btlr/Y
(C57BL/6J-Atp7aMo-3Btlr)
|
decreased susceptibility to prion infection
|
J:188598
|
AU040320em1Janc/AU040320em2Janc
(FVB/N-AU040320em1Janc AU040320em2Janc)
|
decreased susceptibility to Parvoviridae infection
|
J:229089
|
AW112010em2Flv/AW112010em2Flv
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:267975
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:267975
|
B2mtm1Jae/B2mtm1Jae
(B6.129S2-B2mtm1Jae)
|
decreased susceptibility to parasitic infection
|
J:64283
|
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
decreased susceptibility to bacterial infection
|
J:123934
|
increased susceptibility to infection induced morbidity/mortality
|
J:123934
|
Bahd1tm1.1Ics/Bahd1+
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:169470
|
Batf2tm1Kmm/Batf2tm1Kmm
(129S6/SvEvTac-Batf2tm1Kmm)
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:101977
|
Bbaa21C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:73060
|
Bcl2a1atm1Prys/Bcl2a1atm1Prys
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased susceptibility to parasitic infection
|
J:74478
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal response to infection
|
J:123409
|
Bcl3tm1Rsch/Bcl3tm1Rsch
(involves: 129P2/OlaHsd * CD-1)
|
increased susceptibility to bacterial infection
|
J:116724
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:39747
|
Bcl3tm1Ver/Bcl3tm1Ver
(involves: 129P2/OlaHsd * FVB/NJ)
|
increased susceptibility to bacterial infection
|
J:38092
|
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:40769
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:40769
|
Bcl6btm1Dtf/Bcl6btm1Dtf
(involves: 129P2/OlaHsd)
|
abnormal response to infection
|
J:99818
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal response to infection
|
J:67297
|
increased susceptibility to infection
|
J:67297
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:85147
|
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
|
sepsis
|
J:23804
|
Belr1BALB/cJ/Belr1BALB/cJ
(involves: BALB/cJ * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:133125
|
Belr1BALB/cJ/Belr1BALB/cJ
(B6.C-H2d/bByJ)
|
decreased susceptibility to parasitic infection
|
J:133125
|
Berr1WLA/Pas/?
(involves: C57BL/6JRj * WLA/Pas)
|
decreased susceptibility to parasitic infection
|
J:78027
|
Berr2WLA/Pas/?
(involves: C57BL/6JRj * WLA/Pas)
|
decreased susceptibility to parasitic infection
|
J:78027
|
Bpgmm1Pgrs/Bpgmm1Pgrs
(involves: C57BL/6 * C57BL/10J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:301620
|
Bpgmm1Pgrs/Bpgmm1Pgrs
(involves: A/J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:301620
|
Bpifa1m1Ingm/Bpifa1m1Ingm
(involves: C3HeB/FeJ)
|
increased susceptibility to bacterial infection
|
J:195535
|
Bpifa1tm1(KOMP)Vlcg/Bpifa1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:171589
|
Bpifa1tm1.1Jpst/Bpifa1tm1.1Jpst Scgb1a1tm1(cre/ERT)Blh/Scgb1a1tm1(cre/ERT)Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to Orthomyxoviridae infection
|
J:265391
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:265391
|
Bpifa1tm1.2Jpst/Bpifa1tm1.2Jpst
(involves: BALB/cJ * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to Orthomyxoviridae infection
|
J:265391
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:265391
|
Bptfem1Zfa/Bptfem1Zfa Tg(Rorc-cre)1Litt/0
(involves: C57BL/6 * FVB)
|
increased susceptibility to bacterial infection
|
J:259392
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:259392
|
Brca2tm1Hst/Brca2tm1Hst
(involves: 129S7/SvEvBrd * C57BL/6)
|
sepsis
|
J:82434
|
Bst2tm1.1Bsz/Bst2tm1.1Bsz
(involves: C57BL/6)
|
increased susceptibility to Retroviridae infection
|
J:180252
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:128518
|
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:83712
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:44240,
J:30152
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:205353
|
C3tm1Crr/C3tm1Crr
(B6;129S4-C3tm1Crr/J)
|
decreased susceptibility to Coronaviridae infection
|
J:286325
|
increased susceptibility to bacterial infection
|
J:136745
|
C3tm1Hrc/C3tm1Hrc
(either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
increased susceptibility to bacterial infection
|
J:56193
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:30152
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:30152
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae)
|
decreased susceptibility to Coronaviridae infection
|
J:286325
|
C5ar1tm1Cge/C5ar1tm1Cge
(involves: 129S4/SvJae)
|
increased susceptibility to bacterial infection
|
J:69177
|
Camptm1Rlg/Camp+
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:72924
|
Camptm1Rlg/Camptm1Rlg
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:72924
|
increased susceptibility to fungal infection
|
J:199719
|
Camptm1Rlg/Camptm1Rlg
(129X1(B6)-Camptm1Rlg/Kini)
|
increased susceptibility to bacterial infection
|
J:109553
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:109553
|
Cap2tm1a(EUCOMM)Wtsi/Cap2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
increased susceptibility to infection
|
J:234044
|
Capgtm1Djk/Capgtm1Djk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:86277
|
Car2tm1(KOMP)Vlcg/Car2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:216402
|
Card9tm1Jrld/Card9tm1Jrld
(involves: 129P2/OlaHsd)
|
increased susceptibility to fungal infection
|
J:111706
|
Card9tm1Tks/Card9tm1Tks
(B6.129-Card9tm1Tks)
|
increased susceptibility to bacterial infection
|
J:122394
|
Card9tm1Xlin/Card9tm1Xlin
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:117799
|
carmelo/carmelo
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:220661
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:117251
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del Slc11a1r/Slc11a1r
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:124378
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del Slc11a1s/Slc11a1s
(B6.129S2-Casp1tm1Flv)
|
increased susceptibility to bacterial infection
|
J:124378
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(C3N.129S2-Casp1tm1Sesh Casp4del)
|
abnormal response to infection
|
J:86761
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(B10.Cg-Casp1tm1Sesh Casp4del H2r H2-T18b)
|
decreased susceptibility to bacterial infection
|
J:63488
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:63488
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(C3.129S2-Casp1tm1Sesh Casp4del)
|
increased susceptibility to bacterial infection
|
J:136368
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:136368
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del Slc11a1r/Slc11a1s
(involves: 129/Sv * 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:112400
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del Slc11a1s/Slc11a1s
(B6.129S2-Casp1tm1Sesh Casp4del)
|
increased susceptibility to bacterial infection
|
J:112400
|
Casp12tm1Dwni/Casp12tm1Dwni
(involves: 129S1/SvImJ * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:144912
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:144912
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
increased susceptibility to bacterial infection
|
J:115914
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:115914
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
increased susceptibility to bacterial infection
|
J:236022
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:236022
|
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
|
increased susceptibility to bacterial infection
|
J:147413
|
Ccdc50em2Gpt/Ccdc50em2Gpt
(C57BL/6J-Ccdc50em2Gpt)
|
decreased susceptibility to Herpesvirales infection
|
J:345495
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:345495
|
Ccdc88bm1Pgrs/Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:230618
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:230618
|
Ccdc88bm1Pgrs/Ccdc88bm1Pgrs
(involves: 129S1/SvImJ * C57BL/6J * C57BL/10J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:230618
|
Ccl2tm1.1Pame/Ccl2tm1.1Pame Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased susceptibility to bacterial infection
|
J:171379
|
Ccl2tm1.1Pame/Ccl2tm1.1Pame Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:171379
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
increased susceptibility to infection induced morbidity/mortality
|
J:155025
|
increased susceptibility to parasitic infection
|
J:155025
|
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal susceptibility to Orthomyxoviridae infection
|
J:107677
|
decreased susceptibility to bacterial infection
|
J:107677
|
decreased susceptibility to Orthomyxoviridae infection
|
J:107677
|
decreased susceptibility to Picornaviridae infection
|
J:28704
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:107677
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
decreased susceptibility to bacterial infection
|
J:169909
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:169909
|
Ccr1tm1Cge/Ccr1tm1Cge
(C.129S4-Ccr1tm1Cge)
|
decreased susceptibility to Riboviria infection
|
J:95242
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to fungal infection
|
J:41324
|
increased susceptibility to parasitic infection
|
J:41324
|
Ccr1tm1Gao/Ccr1tm1Gao
(B6.129S4-Ccr1tm1Gao)
|
increased susceptibility to Coronaviridae infection
|
J:162707
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:162707
|
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
|
increased susceptibility to bacterial infection
|
J:111517
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
|
increased susceptibility to Coronaviridae infection
|
J:106738
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:106738
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
increased susceptibility to Coronaviridae infection
|
J:162707
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to fungal infection
|
J:120221
|
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))
|
increased susceptibility to bacterial infection
|
J:46941
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to Retroviridae infection
|
J:132342
|
increased susceptibility to fungal infection
|
J:64293
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz)
|
increased susceptibility to Coronaviridae infection
|
J:162707
|
Ccr5tm1Kuz/Ccr5tm1Kuz Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Retroviridae infection
|
J:132342
|
Ccr6tm1(EGFP)Irw/Ccr6tm1(EGFP)Irw
(B6.129S6-Ccr6tm1(EGFP)Irw)
|
decreased susceptibility to bacterial infection
|
J:132012
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:76461
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2(C)-Ccr7tm1Rfor/J)
|
decreased susceptibility to bacterial infection
|
J:210086
|
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
decreased susceptibility to infection induced morbidity/mortality
|
J:126220
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
increased susceptibility to bacterial infection
|
J:177038
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:177038
|
Cd3etm1Mal/Cd3etm1Mal Nlrp1aNeut1/Nlrp1aNeut1
(involves: C57BL/6)
|
increased susceptibility to infection induced morbidity/mortality
|
J:191055
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage)
|
abnormal response to infection
|
J:153813
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage Tg(TcrLCMV)318Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal response to infection
|
J:142387
|
Cd4tm1Knw/Cd4tm1Knw
(B6.129S-Cd4tm1Knw/J)
|
increased susceptibility to parasitic infection
|
J:87828
|
Cd4tm1Mak/Cd4tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
(PL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
(SJL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas)
|
increased susceptibility to viral infection
|
J:110749
|
Cd5ltm1Nto/Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:82352
|
Cd8am1Btlr/Cd8am1Btlr
(C57BL/6J-Cd8am1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:221492
|
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd8atm1Mak/Cd8atm1Mak
(PL.129S2(B6)-Cd8atm1Mak/Rdgz)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd8atm1Mak/Cd8atm1Mak
(SJL.129S2(B6)-Cd8atm1Mak/Rdgz)
|
increased susceptibility to Picornaviridae infection
|
J:92227
|
Cd14hdl/Cd14hdl
(C57BL/6-Cd14hdl)
|
increased susceptibility to Riboviria infection
|
J:98908
|
Cd14tm1Frm/Cd14tm1Frm
(involves: 129S4/SvJae)
|
increased susceptibility to Riboviria infection
|
J:98908
|
Cd14tm1Smg/Cd14tm1Smg
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:32729
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:32729
|
Cd14tm1Smg/Cd14tm1Smg
(C.129S1-CD14tm1Smg)
|
decreased susceptibility to bacterial infection
|
J:127072
|
Cd14tm1Smg/Cd14tm1Smg
(B6.129S1-CD14tm1Smg)
|
decreased susceptibility to bacterial infection
|
J:127072
|
Cd19tm1(cre)Cgn/Cd19+ Rbpjtm1Hon/Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:76240
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:76240
|
Cd24atm1Pjln/Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
increased susceptibility to parasitic infection
|
J:76695
|
Cd28tm1Mak/Cd28tm1Mak Stat6tm1Gru/Stat6tm1Gru
(C.129S2(B6)-Cd28tm1Mak Stat6tm1Gru)
|
increased susceptibility to parasitic infection
|
J:90987
|
Cd36obl/Cd36obl
(C57BL/6-Cd36obl)
|
increased susceptibility to bacterial infection
|
J:96018
|
Cd36tm1Frm/Cd36tm1Frm
(B6.129S4-Cd36tm1Frm)
|
abnormal response to infection
|
J:100140
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:100140
|
sepsis
|
J:100140
|
Cd40tm1Kik/Cd40tm1Kik
(B6.129P2-Cd40tm1Kik/J)
|
increased susceptibility to bacterial infection
|
J:86998
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to prion infection
|
J:115487
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal response to infection
|
J:86947
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:72658
|
Cd47tm1Fpl/Cd47+
(B6.129S7-Cd47tm1Fpl)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:36489
|
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl)
|
increased susceptibility to bacterial infection
|
J:36489
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:36489
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:134866
|
increased susceptibility to bacterial infection
|
J:134866
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
decreased susceptibility to Poxviridae infection
|
J:122201
|
increased susceptibility to Orthomyxoviridae infection
|
J:123582
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * BALB/c)
|
increased susceptibility to Orthomyxoviridae infection
|
J:123582
|
Cd70tm1.1Jda/Cd70tm1.1Jda
(B6.Cg-Cd70tm1.1Jda)
|
increased susceptibility to Riboviria infection
|
J:193042
|
Cd79atm1(cre)Reth/Cd79a+ Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
increased susceptibility to Riboviria infection
|
J:181705
|
Cd81tm1Lvy/Cd81tm1Lvy
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to parasitic infection
|
J:126000
|
Cd82tm1Kjbr/Cd82tm1Kjbr
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:326451
|
Cd200r1tm1Eakj/Cd200r1tm1Eakj
(Not Specified)
|
decreased susceptibility to Herpesvirales infection
|
J:192198
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:192198
|
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL)
|
increased susceptibility to Orthomyxoviridae infection
|
J:137452
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:288225
|
Cd209btm1Anjm/Cd209btm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:94698
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:94698
|
Cd209btm1Anjm/Cd209btm1Anjm
(B6.129P2-Cd209btm1Anjm)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:94698
|
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:153503
|
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to Riboviria infection
|
J:136330
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:136330
|
increased susceptibility to bacterial infection
|
J:162539
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:162539
|
Cd274tm2Shr/Cd274tm2Shr
(involves: 129/Sv * 129S4/SvJae)
|
decreased susceptibility to parasitic infection
|
J:113851
|
Cdh1tm1Mlec/Cdh1tm1Mlec
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:142843
|
Ceacam1Hv2-r/Ceacam1Hv2-r
(SJL/J)
|
decreased susceptibility to Coronaviridae infection
|
J:92495
|
decreased susceptibility to viral infection
|
J:25438
|
Ceacam1tm1.1Fta/Ceacam1tm1.1Fta
(C57BL/6(FVB)-Ceacam1tm1.1Fta)
|
decreased susceptibility to Coronaviridae infection
|
J:198335
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:198335
|
Ceacam1tm1Bcn/Ceacam1tm1Bcn
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:70815
|
Ceacam1tm2Bcn/Ceacam1tm2Bcn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:92376
|
Cebpatm1Dgt/Cebpatm1Dgt Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
sepsis
|
J:94682
|
Cebpbtm1.1Elgaz/Cebpbtm1.1Elgaz Lyz2em1.1(cre)Elgaz/Lyz2+
(BALB/cJ-Cebpbtm1.1Elgaz Lyz2em1.1Elgaz/Elgaz)
|
decreased susceptibility to bacterial infection
|
J:247885
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:247885
|
Cebpbtm1Aki/Cebpbtm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:153025
|
Cebpbtm1Kish/Cebpbtm1Kish
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:77003
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
increased susceptibility to fungal infection
|
J:25215
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased susceptibility to bacterial infection
|
J:76024
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
increased susceptibility to bacterial infection
|
J:76024
|
Cerktm1Fbor/Cerktm1Fbor
(involves: BALB/c)
|
increased susceptibility to bacterial infection
|
J:131522
|
Cers3tm1.1Rsnd/Cers3tm1.1Rsnd
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to fungal infection
|
J:179754
|
Cfbtm1Hrc/Cfbtm1Hrc
(involves: 129S/Sv)
|
decreased susceptibility to Coronaviridae infection
|
J:286325
|
Cfbtm1Mbo/Cfbtm1Mbo
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:83712
|
Cfdtm1Yxu/Cfdtm1Yxu
(B6.129P2-Cfdtm1Yxu)
|
increased susceptibility to bacterial infection
|
J:94855
|
Cfptm1Cmst/Cfptm1Cmst
(B6.129P2-Cfptm1Cmst)
|
sepsis
|
J:131526
|
Cftrtm1Cam/Cftrtm1Cam
(involves: 129S/SvEv)
|
increased susceptibility to infection
|
J:23850
|
Cftrtm1Hgu/Cftrtm1Hgu
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:24119
|
Cftrtm1Kth/Cftrtm1Kth
(B6.129S7-Cftrtm1Kth)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:112450
|
Cftrtm1Unc/Cftrtm1Unc
(B6.129P2-Cftrtm1Unc/J)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:112450
|
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:112450
|
Cftrtm3Mrc/Cftrtm3Mrc
(B6.129S6-Cftrtm3Mrc)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:112450
|
Cgastm1a(EUCOMM)Hmgu/Cgastm1a(EUCOMM)Hmgu
(C57BL/6N-Cgastm1a(EUCOMM)Hmgu)
|
increased susceptibility to Herpesvirales infection
|
J:201167
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:201167
|
Cgastm1a(EUCOMM)Hmgu/Cgastm1a(EUCOMM)Hmgu Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to Retroviridae infection
|
J:234263
|
Cgastm1d(EUCOMM)Hmgu/Cgastm1d(EUCOMM)Hmgu
(involves: BALB/c * C57BL/6JJcl * C57BL/6N)
|
increased susceptibility to Flaviviridae infection
|
J:207826
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:207826
|
increased susceptibility to Herpesvirales infection
|
J:207826
|
increased susceptibility to Poxviridae infection
|
J:207826
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:207826
|
Cgastm1d(EUCOMM)Hmgu/Cgastm1d(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased susceptibility to Retroviridae infection
|
J:265023
|
Char2aC3H/HeJ/Char2aC3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:117548
|
Char2bC3H/HeJ/Char2bC3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:117548
|
Char3C3H/He/Char3C57BL/6
(involves: C3H/He * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:72455
|
Char3C57BL/6/Char3C57BL/6
(involves: C3H/He * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:72455
|
Char4C57BL/6J/Char4C57BL/6J
(involves: A/J * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:71471
|
Char9A/J/Char9C57BL/6J
(involves: A/J * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:122131
|
Char9C57BL/6J/Char9C57BL/6J
(involves: A/J * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:122131
|
Char11A/J/Char11C57BL/6J
(involves: A/J * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:106220
|
Char11C57BL/6J/Char11C57BL/6J
(involves: A/J * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:106220
|
Chit1tm1Eli/Chit1tm1Eli
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:189872
|
Chit1tm1Eli/Chit1tm1Eli Tg(Scgb1a1-Il13)2Eli/0
(involves: C57BL/6 * CBA)
|
decreased susceptibility to bacterial infection
|
J:189872
|
Chit1tm1Eli/Chit1tm1Eli Tg(Scgb1a1-rtTA,tetO-CHIT1)#Eli/0
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:189872
|
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:54994
|
Chrnb2tm1Mdb/Chrnb2tm1Mdb Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:73590
|
Cigs2tm1.1Anse/Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal susceptibility to infection
|
J:181313
|
Ciitatm1Ccum/Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal susceptibility to infection
|
J:64283
|
decreased susceptibility to parasitic infection
|
J:64283
|
increased susceptibility to parasitic infection
|
J:64283
|
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:223336
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ)
|
sepsis
|
J:112692
|
Clec4b1em#Tsak/Clec4b1em#Tsak
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:258645
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:203221
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:203221
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:203159
|
Clec4etm1.1Cfg/Clec4etm1.1Cfg
(B6.Cg-Clec4etm1.1Cfg)
|
increased susceptibility to fungal infection
|
J:136334
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to fungal infection
|
J:172959
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal response to infection
|
J:203159
|
Clec4gtm1.1Fhe/Clec4gtm1.1Fhe
(B6.129-Clec4gtm1.1Fhe)
|
decreased susceptibility to Adenoviridae infection
|
J:194891
|
Clec4ntm1.2Mgne/Clec4ntm1.2Mgne
(involves: C57BL/6 * C57BL/6J)
|
abnormal susceptibility to fungal infection
|
J:209284
|
increased susceptibility to fungal infection
|
J:209284
|
Clec4ntm1Yiw/Clec4ntm1Yiw
(B6.129P2-Clec4ntm1Yiw)
|
increased susceptibility to infection induced morbidity/mortality
|
J:160680
|
Clec4ntm1Yiw/Clec4ntm1Yiw
(involves: 129P2/OlaHsd)
|
increased susceptibility to fungal infection
|
J:209284
|
Clec7atm1.1Bpip/Clec7atm1.1Bpip Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to fungal infection
|
J:203908
|
Clec7atm1Gdb/Clec7atm1Gdb
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to fungal infection
|
J:116669
|
Clec7atm1Gdb/Clec7atm1Gdb
(B6.129S6-Clec7atm1Gdb)
|
increased susceptibility to fungal infection
|
J:179011
|
Clec7atm1Yiw/Clec7atm1Yiw
(C.129P2-Clec7atm1Yiw)
|
increased susceptibility to fungal infection
|
J:116670
|
Clec12atm1Gdb/Clec12atm1Gdb
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:224869
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:224869
|
Clic4tm1.1Aidi/Clic4tm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:175404
|
Cms1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to fungal infection
|
J:55132
|
Cms2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to infection
|
J:55132
|
Cmtr1tm1b(EUCOMM)Hmgu/Cmtr1tm1b(EUCOMM)Hmgu Emx1tm1(cre)Krj/Emx1+ Tg(Thy1-YFP)HJrs/0
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * CBA)
|
abnormal susceptibility to Riboviria infection
|
J:300305
|
Col1a1tm1(tetO-Stat1)Biat/Col1a1tm1(tetO-Stat1)Biat Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:212694
|
Commd10Tg(Vav1-icre)A2Kio/? Tnfrsf14tm1.1Kro/Tnfrsf14tm1.1Kro
(involves: C57BL/6NCrl * C57BL/10 * CBA * SJL)
|
decreased susceptibility to Herpesvirales infection
|
J:243038
|
Copg1em1Geha/Copg1em1Geha
(involves: C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:345528
|
Coro1atm1Jpie/Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:133404
|
Cpsf6em1Bcgen/Cpsf6+
(Not Specified)
|
decreased susceptibility to Riboviria infection
|
J:346988
|
Cr2tm1.1Jhws/Cr2tm1.1Jhws
(Not Specified)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:205353
|
Cr2tm1Hmo/Cr2tm1Hmo
(B6.129S7-Cr2tm1Hmo)
|
increased susceptibility to bacterial infection
|
J:94855
|
Cr2tm1Tft/Cr2tm1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:95979
|
Crtamtm1Achn/Crtamtm1Achn
(involves: 129 * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:145314
|
Crtamtm1Tks/Crtamtm1Tks
(B6.Cg-Crtamtm1Tks)
|
abnormal response to infection
|
J:152770
|
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:18747,
J:53659
|
increased susceptibility to fungal infection
|
J:18747
|
increased susceptibility to parasitic infection
|
J:67766
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd)
|
increased susceptibility to infection
|
J:24122
|
Csf3tm1Ard/Csf3tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:20400
|
Csktm1Tara/Csktm2Tara Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:89716
|
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:71744
|
Ctrq1C3H/HeJ/Ctrq1C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:106111
|
Ctrq2C3H/HeJ/Ctrq2C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:106111
|
Ctrq2C3H/HeJ/Ctrq2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:106111
|
Ctrq3C3H/HeJ/Ctrq3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:106111
|
Ctrq3C3H/HeJ/Ctrq3C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:106111
|
Ctsctm1Ley/Ctsctm1Ley
(B6.129X1-Ctsctm1Ley)
|
abnormal response to infection
|
J:131520
|
sepsis
|
J:88160
|
Ctsgtm1.1Roes/Ctsgtm1.1Roes
(involves: 129P2/OlaHsd)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:77597
|
increased susceptibility to infection induced morbidity/mortality
|
J:77597
|
Ctsgtm1.1Roes/Ctsgtm1.1Roes Elanetm1(cre)Roes/Elanetm1(cre)Roes
(involves: 129P2/OlaHsd)
|
increased susceptibility to fungal infection
|
J:77597
|
Cux1tm2Ejn/Cux1tm2Ejn
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:74660
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:95694
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt H2-Ab1b-tm1Hpl/H2-Ab1+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal response to infection
|
J:95694
|
Cx3cr1tm3(Hbegf)Litt/Cx3cr1tm3(Hbegf)Litt Tg(Itgax-cre)1-1Reiz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased susceptibility to bacterial infection
|
J:210086
|
Cxcl5tm1.1Mkch/Cxcl5tm1.1Mkch
(B6.129P2-Cxcl5tm1.1Mkch)
|
decreased susceptibility to bacterial infection
|
J:208901
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:208901
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
|
decreased susceptibility to bacterial infection
|
J:162629
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:162629
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to Hepadnaviridae infection
|
J:75584
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
|
increased susceptibility to Herpesvirales infection
|
J:120743
|
Cxcl15tm1Lira/Cxcl15tm1Lira
(involves: 129 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:67605
|
Cxcl16tm1Syon/Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon)
|
decreased susceptibility to bacterial infection
|
J:155199
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
decreased susceptibility to fungal infection
|
J:73947
|
increased susceptibility to bacterial infection
|
J:65905
|
increased susceptibility to Herpesvirales infection
|
J:87365
|
increased susceptibility to parasitic infection
|
J:72824
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:208901
|
Cxcr3tm1Wwh/Cxcr3tm1Wwh
(B6.Cg-Cxcr3tm1Wwh)
|
decreased susceptibility to Riboviria infection
|
J:96905
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:96905
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Retroviridae infection
|
J:132342
|
increased susceptibility to Retroviridae infection induced morbidity/mortality
|
J:132342
|
Cxcr5tm1.1Namt/Cxcr5tm1.1Namt Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased susceptibility to prion infection
|
J:241561
|
Cxcr5tm1.1Namt/Cxcr5tm1.1Namt Tg(Itgax-cre)1-1Reiz/0 Tg(Prnp)a20Cwe/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
decreased susceptibility to prion infection
|
J:241561
|
Cybanmf333/Cybanmf333
(A.B6 Tyr+-Cybanmf333/J)
|
increased susceptibility to bacterial infection
|
J:132359
|
sepsis
|
J:132359
|
Cybbtm1Din/Y
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:22868
|
increased susceptibility to infection
|
J:22868
|
Cyldtm1Jdgl/Cyldtm1Jdgl
(involves: 129 * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:124327
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:124327
|
Cyribm1Ivdi/Cyribm1Ivdi
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282597
|
Cyribtm1c(KOMP)Wtsi/Cyribtm1d(KOMP)Wtsi Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282597
|
Dapp1Gt(OST111213)Lex/Dapp1Gt(OST111213)Lex
(B6.Cg-Dapp1Gt(OST111213)Lex)
|
increased susceptibility to bacterial infection
|
J:110009
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
abnormal response to infection
|
J:184080
|
Dclre1atm1Rleg/Dclre1atm1Rleg
(involves: 129S7/SvEvBrd)
|
increased susceptibility to bacterial infection
|
J:102381
|
Dcntm1Ioz/Dcn+
(either: C.Cg-Dcntm1Ioz or C3.Cg-Dcntm1Ioz)
|
decreased susceptibility to bacterial infection
|
J:68640
|
Dcntm1Ioz/Dcntm1Ioz
(either: C.Cg-Dcntm1Ioz or C3.Cg-Dcntm1Ioz)
|
decreased susceptibility to bacterial infection
|
J:68640
|
Ddit3tm1Dron/Ddit3tm1Dron
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased susceptibility to Retroviridae infection
|
J:112354
|
Ddx41tm1.1Arte/Ddx41tm1.1Arte Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to Retroviridae infection
|
J:265023
|
Ddx41tm1.1Arte/Ddx41tm1.1Arte Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
increased susceptibility to Retroviridae infection
|
J:265023
|
Ddx46em1Caox/Ddx46+
(involves: C57BL/6J)
|
decreased susceptibility to Riboviria infection
|
J:271836
|
Ddx60tm1b(EUCOMM)Wtsi/Ddx60tm1b(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased susceptibility to Riboviria infection
|
J:228452
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:228452
|
Ddx60tm1b(EUCOMM)Wtsi/Ddx60tm1b(EUCOMM)Wtsi Mavstm1Tsse/Mavstm1Tsse
(involves: 129 * C57BL/6N)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:228452
|
Defb1tm1Jmw/Defb1+
(B6.129S5-Defb1tm1Jmw)
|
increased susceptibility to bacterial infection
|
J:76529
|
Defb1tm1Jmw/Defb1tm1Jmw
(B6.129S5-Defb1tm1Jmw)
|
increased susceptibility to bacterial infection
|
J:76529
|
Defb3tm1Lex/Defb3tm1Lex
(B6;129S5-Defb3tm1Lex/Mmucd)
|
increased susceptibility to bacterial infection
|
J:168725
|
Defb3tm1Xen/Defb3tm1Xen
(involves: C57BL/6)
|
increased susceptibility to fungal infection
|
J:199719
|
Del(3Gbp2-ps-Gbp5)1Ktak/Del(3Gbp2-ps-Gbp5)1Ktak
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:187397
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:187397
|
Del(7Mrgpra2a-Mrgpra2b)1Xzd/Del(7Mrgpra2a-Mrgpra2b)1Xzd
(C57BL/6J-Del(7Mrgpra2a-Mrgpra2b)1Xzd)
|
increased susceptibility to bacterial infection
|
J:332494
|
Del(8Ddx19a-Ddx19b)1Chaw/+
(C57BL/6-Del(8Ddx19a-Ddx19b)1Chaw)
|
decreased susceptibility to Picornaviridae infection
|
J:289833
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:289833
|
Del(8Defa1-Def)2Xzd/Del(8Defa1-Def)2Xzd Tg(KRT14-cre)1Amc/0
(involves: C57BL/6J * CBA)
|
increased susceptibility to bacterial infection
|
J:332494
|
Del(11Nlrp1a-Nlrp1c-ps)1Smas/Del(11Nlrp1a-Nlrp1c-ps)1Smas
(Not Specified)
|
increased susceptibility to Riboviria infection
|
J:191055
|
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:194295
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:194295
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Riboviria infection
|
J:85149
|
Dhx58tm1Aki/Dhx58tm1Aki
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:156867
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:156867
|
Dhx58tm1Gnb/Dhx58tm1Gnb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal susceptibility to Riboviria infection
|
J:146113
|
decreased susceptibility to Riboviria infection
|
J:146113
|
increased susceptibility to Picornaviridae infection
|
J:146113
|
Dhx58tm1Itl/Dhx58tm1Itl
(C57BL/6-Dhx58tm1Itl)
|
increased susceptibility to Flaviviridae infection
|
J:187386
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:187386
|
Dhx58tm2.1Aki/Dhx58tm2.1Aki
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:156867
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:156867
|
Diaph1M1Btlr/Diaph1M1Btlr
(C57BL/6J-Diaph1M1Btlr)
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:254820
|
Dice1bC57BL/10Sn/Dice1bC57BL/10Sn
(involves: B10.D2-H2d/oSnJ * BALB/cAnN)
|
decreased susceptibility to parasitic infection
|
J:95337
|
Dicer1Gt(RRF266)Byg/Dicer1Gt(RRF266)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to Riboviria infection
|
J:123635
|
increased susceptibility to Herpesvirales infection
|
J:123635
|
increased susceptibility to Riboviria infection
|
J:123635
|
Dmdtm1.1Know/Dmdtm1.1Know
(involves: C3H)
|
decreased susceptibility to Picornaviridae infection
|
J:207775
|
Dmp1tm1Mis/Dmp1tm1Mis
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:241769
|
Dock2m1Hsd/Dock2m1Hsd Irf5tm1Ttg/Irf5tm1Ttg
(B6NHsd.Cg-Irf5tm1Ttg Dock2m1Hsd)
|
abnormal response to infection
|
J:182658
|
Dpp4em1Rba/Dpp4+
(C57BL/6J-Dpp4em1Rba)
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:279834
|
increased susceptibility to Coronaviridae infection
|
J:279834
|
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
|
increased susceptibility to Coronaviridae infection
|
J:279723,
J:279834
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:279834
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased susceptibility to Coronaviridae infection
|
J:223728
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased susceptibility to Coronaviridae infection
|
J:238079
|
Dpp4tm1.1(DPP4)Pbmj/Dpp4tm1.1(DPP4)Pbmj
(involves: C57BL/6 * C57BL/6NTac)
|
increased susceptibility to Coronaviridae infection
|
J:242025
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:242025
|
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
|
increased susceptibility to infection
|
J:219200
|
Dtnbp1sdy-Btlr/Dtnbp1sdy-Btlr
(C57BL/6J-Dtnbp1sdy-Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:133620
|
Dusp1tm1Brv/Dusp1tm1Brv
(C3.129S2-Dusp1tm1Brv)
|
increased susceptibility to bacterial infection
|
J:164929
|
Dusp4tm1Plev/Dusp4tm1Plev
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:170774
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
abnormal susceptibility to parasitic infection
|
J:218203
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn Rag2tm1.1Cgn/Rag2tm1.1Cgn
(involves: C57BL/6NCrl)
|
abnormal susceptibility to parasitic infection
|
J:218203
|
E2f4tm1Lees/E2f4tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:64193
|
E2f4tm1Lees/E2f4tm1Lees Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to infection
|
J:81082
|
Ebag9tm1Rehm/Ebag9tm1Rehm
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:152534
|
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to Coronaviridae infection
|
J:286951
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:286951
|
Ebi3Gt716Lex/Ebi3Gt716Lex Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:134148
|
Ebi3tm1Rsb/Ebi3tm1Rsb
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:97822
|
Efhd2tm1(KOMP)Vlcg/Efhd2tm1(KOMP)Vlcg
(C57BL/6-Efhd2tm1(KOMP)Vlcg)
|
abnormal response to infection
|
J:228565
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu Efnb2tm1.1Jwu/Efnb2tm1.1Jwu Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
increased susceptibility to Riboviria infection
|
J:178148
|
EgfrMhdadsk5/Egfr+
(involves: 129S1/SvImJ * C3HeB/FeJ)
|
increased susceptibility to Coronaviridae infection
|
J:243599
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:243599
|
Ehmt2tm1.1Cza/Ehmt2tm1.1Cza Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased susceptibility to parasitic infection
|
J:160938
|
Ehmt2tm1.1Cza/Ehmt2tm1.1Cza Tg(VAV1-cre)1Graf/0
(involves: C57BL/6 * SJL)
|
increased susceptibility to parasitic infection
|
J:160938
|
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:30617
|
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe Rnaseltm1Slvm/Rnaseltm1Slvm
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:55974
|
Eif2ak2tm1Jcbe/Eif2ak2tm1Jcbe
(involves: 129S4/SvJae)
|
increased susceptibility to Orthomyxoviridae infection
|
J:63671
|
increased susceptibility to Riboviria infection
|
J:167126,
J:63671
|
Eif2ak4m1Btlr/Eif2ak4m1Btlr
(C57BL/6J-Eif2ak4m1Btlr)
|
increased susceptibility to Adenoviridae infection
|
J:173669
|
increased susceptibility to Herpesvirales infection
|
J:173669
|
Eif4btm1.1Smoc/Eif4b+ Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:311140
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:311140
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:311140
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:311140
|
Elanetm1(cre)Roes/Elanetm1(cre)Roes
(involves: 129)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:77597
|
increased susceptibility to infection induced morbidity/mortality
|
J:77597
|
Elanetm1Sds/Elanetm1Sds
(129X1/SvJ-Elanetm1Sds)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:47420
|
increased susceptibility to bacterial infection
|
J:47420
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:47420
|
Elf4em1Hdu/Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
increased susceptibility to viral infection
|
J:328935
|
Entpd7tm1Ktak/Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak)
|
decreased susceptibility to bacterial infection
|
J:191188
|
Eomestm1Srnr/Eomestm1Srnr Tbx21tm1Srnr/Tbx21tm1Srnr Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased susceptibility to Riboviria infection
|
J:137655
|
Erap1tm1.1Gnie/Erap1tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal response to infection
|
J:143988
|
EsmrDBA/2NCrj/EsmrDBA/2NCrj
(involves: C57BL/6NCrj * DBA/2NCrj)
|
decreased susceptibility to parasitic infection
|
J:74563
|
exf/exf
(involves: C3H/HeN(MTV-))
|
increased susceptibility to bacterial infection
|
J:5649
|
Extl1em1Caox/Extl1em1Caox Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:333437
|
F2tm1Jld/F2tm1Jld Tg(Mx1-cre)1Cgn/0
(B6.Cg-F2tm1Jld Tg(Mx1-cre)1Cgn)
|
increased susceptibility to bacterial infection
|
J:144572
|
Faddtm2.1Wnt/Faddtm2.1Wnt Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
increased susceptibility to parasitic infection
|
J:162312
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
increased susceptibility to bacterial infection
|
J:136745
|
increased susceptibility to Picornaviridae infection
|
J:120427
|
Faslpr/Faslpr
(involves: MRL/Mp)
|
increased susceptibility to bacterial infection
|
J:50903
|
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:81397
|
Fastm1Osa/Fastm1Osa Gzmatm1Simn/Gzmatm1Simn Gzmbtm1Ley/Gzmbtm1Ley
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:81397
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
increased susceptibility to bacterial infection
|
J:136745
|
increased susceptibility to Picornaviridae infection
|
J:120427
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:272313
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:272313
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd)
|
increased susceptibility to parasitic infection
|
J:163761
|
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c)
|
increased susceptibility to bacterial infection
|
J:83995
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(C.129S4-Fcgr2btm1Ttk)
|
decreased susceptibility to parasitic infection
|
J:120905
|
Fcmrtm1Mak/Fcmrtm1Mak
(B6.129S2-Fcmrtm1Mak)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:194323
|
increased susceptibility to bacterial infection
|
J:194323
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:194323
|
Fcmrtm1Ohno/Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno)
|
abnormal response to infection
|
J:190117
|
Fcnatm1Tefu/Fcnatm1Tefu
(B6.129-Fcnatm1Tefu)
|
increased susceptibility to bacterial infection
|
J:190858
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:190858
|
Fcnatm1Tefu/Fcnatm1Tefu Fcnbtm1Tefu/Fcnbtm1Tefu
(B6.129-Fcnatm1Tefu Fcnbtm1Yend)
|
increased susceptibility to bacterial infection
|
J:190858
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:190858
|
Fcnbtm1Tefu/Fcnbtm1Tefu
(B6.129-Fcnbtm1Yend)
|
increased susceptibility to bacterial infection
|
J:190858
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:190858
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:64748
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
sepsis
|
J:157383
|
Fggtm2Jld/Fggtm2Jld
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:90908
|
Fgl2tm1Pam/Fgl2+
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:99453
|
Fgl2tm1Pam/Fgl2tm1Pam
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:99453
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:99453
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
decreased susceptibility to Coronaviridae infection
|
J:99453
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:99453
|
Fgrtm1Hev/Fgrtm1Hev Hcktm1Hev/Hcktm1Hev
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:16994
|
Fhittm1Hbn/Fhit+
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to infection
|
J:71303
|
Fhittm1Hbn/Fhittm1Hbn
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to infection
|
J:71303
|
Fibcd1tm1Spte/Fibcd1tm1Spte
(B6.129S1-Fibcd1tm1Spte)
|
decreased susceptibility to fungal infection
|
J:340107
|
decreased susceptibility to infection induced morbidity/mortality
|
J:340107
|
Flt3m1Btlr/Flt3m1Btlr
(C57BL/6J-Flt3m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:105543
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:159599
|
increased susceptibility to Riboviria infection
|
J:105543
|
Flt3ltm1Imx/Flt3ltm1Imx
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:189122
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:118693
|
Foxa1tm1(cre)Sew/Foxa1+ Mst1rtm1Sew/Mst1rtm1Sew
(involves: 129P2/OlaHsd * CD-1 * NIH Black Swiss)
|
decreased susceptibility to bacterial infection
|
J:105979
|
Foxn1nu/Foxn1+
(involves: BALB/c)
|
increased susceptibility to Herpesvirales infection
|
J:12543
|
Foxn1nu/Foxn1nu
(B6NTac.Cg-Foxn1nu/Tac)
|
decreased susceptibility to parasitic infection
|
J:64283
|
Foxn1nu/Foxn1nu
(involves: BALB/c)
|
decreased susceptibility to bacterial infection
|
J:50903
|
increased susceptibility to Herpesvirales infection
|
J:12543
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:12543
|
Foxn1nu/Foxn1nu Fv4r/Fv4r
(involves: BALB/c)
|
decreased susceptibility to Retroviridae infection
|
J:5714,
J:5684
|
Foxq1sa/Foxq1sa Lystbg/Lystbg
(involves: 101/Rl * C3H/Rl * C57BL/6J * C57BL10/Rl)
|
increased susceptibility to infection
|
J:5311
|
Fpr1tm1Gao/Fpr1tm1Gao
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:53354
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:53354
|
Fut2tm1Sdo/Fut2tm1Sdo
(B6.129X1-Fut2tm1Sdo)
|
increased susceptibility to fungal infection
|
J:90993
|
Fut4tm1Jbl/Fut4tm1Jbl Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl)
|
decreased susceptibility to bacterial infection
|
J:115682
|
Fv4r/Fv4+
(involves: AKR/J * BALB/c * FRG)
|
decreased susceptibility to Retroviridae infection
|
J:5714,
J:5684
|
G6pc3tm1Jyc/G6pc3tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:120741
|
Gab2tm1Gsf/Gab2tm1Gsf
(involves: BALB/c)
|
abnormal response to infection
|
J:122213
|
decreased susceptibility to Retroviridae infection
|
J:122429
|
Gata3tm1Iho/Gata3tm1Iho Il13tm1(YFP/cre)Lky/Il13+
(involves: 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:178986
|
Gata3tm1Jfz/Gata3tm1Jfz Tg(Tnfrsf4-cre)1Nik/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:93538
|
Gbp2tm1.1Kpf/Gbp2tm1.1Kpf
(involves: 129P2/OlaHsd)
|
increased susceptibility to parasitic infection
|
J:192526
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:192526
|
Gbp2btm1Tigm/Gbp2btm1Tigm
(B6.129S5-Gbp2btm1Tigm/Jdmm)
|
increased susceptibility to bacterial infection
|
J:172364
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:172364
|
Gbp5tm1Tigm/Gbp5tm1Tigm
(B6.Cg-Gbp5tm1Tigm)
|
increased susceptibility to bacterial infection
|
J:183942
|
Gbp7tm1Ddgd/Gbp7tm1Ddgd
(B6.129P2-Gbp7tm1Ddgd)
|
increased susceptibility to bacterial infection
|
J:314959
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:314959
|
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA)
|
increased susceptibility to fungal infection
|
J:112663
|
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal susceptibility to bacterial infection
|
J:234656
|
increased susceptibility to bacterial infection
|
J:234656
|
Gm36723em1Flv/Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
decreased susceptibility to bacterial infection
|
J:258967
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased susceptibility to parasitic infection
|
J:121471
|
Gpc3tm1Fil/Y
(B6.Cg-Gpc3tm1Fil)
|
increased susceptibility to bacterial infection
|
J:73877
|
Gpc3tm1Fil/Gpc3tm1Fil
(B6.Cg-Gpc3tm1Fil)
|
increased susceptibility to bacterial infection
|
J:73877
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
increased susceptibility to bacterial infection
|
J:199126
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199126
|
Gpr18tm1Lex/Gpr18tm1Lex
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:226433
|
Gpr31btm1Ktak/Gpr31btm1Ktak
(B6.Cg-Gpr31btm1Ktak)
|
increased susceptibility to bacterial infection
|
J:271242
|
Gpr34tm1.1Shbg/Gpr34tm1.1Shbg
(B6.Cg-Gpr34tm1.1Shbg)
|
increased susceptibility to fungal infection
|
J:168120
|
Gpr108tm1.1Brs/Gpr108tm1.1Brs
(involves: 129S6/SvEvTac)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:266821
|
Grass1C57BL/6J/Grass1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:134374
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:134374
|
sepsis
|
J:134374
|
Grass1C57BL/6J/Grass1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:134374
|
sepsis
|
J:134374
|
Grass1DBA/2J/Grass1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:134374
|
sepsis
|
J:134374
|
Grb2tm1Paw/Grb2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased susceptibility to Retroviridae infection
|
J:122429
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:156824
|
Gsdmaem1Cya/Gsdmaem1Cya
(C57BL/6J-Gsdmaem1Cya)
|
increased susceptibility to bacterial infection
|
J:326434
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:326434
|
Gsdmdem1Flv/Gsdmdem1Flv
(C57BL/6N-Gsdmdem1Flv)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:243487
|
Gsdmdem4Fcw/Gsdmdem4Fcw
(C57BL/6N-Gsdmdem4Fcw/J)
|
abnormal susceptibility to bacterial infection
|
J:101977
|
Gsta4tm1Pzim/Gsta4+
(involves: 129S1/Sv * 129S6/SvEvTac)
|
increased susceptibility to bacterial infection
|
J:87983
|
Gsta4tm1Pzim/Gsta4tm1Pzim
(involves: 129S1/Sv * 129S6/SvEvTac)
|
increased susceptibility to bacterial infection
|
J:87983
|
Gt(ROSA)26Sorem1(DPP4)Yowa/Gt(ROSA)26Sorem1(DPP4)Yowa
(C57BL/6-Gt(ROSA)26Sorem1(DPP4)Yowa)
|
increased susceptibility to Coronaviridae infection
|
J:279060
|
Gt(ROSA)26Sorem1(Ube2s)Chaw/?
(involves: C57BL/6)
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:306461
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+ Il13tm1(YFP/cre)Lky/Il13tm1(YFP/cre)Lky
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:178986
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sortm1(DTA)Lky Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased susceptibility to parasitic infection
|
J:133382
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Il22tm1.1(icre)Stck/Il22+
(involves: 129X1/SvJ * C57BL/6N)
|
abnormal susceptibility to bacterial infection
|
J:220074
|
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+ Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Gt(ROSA)26Sortm1(MAML1)Wsp)
|
decreased susceptibility to parasitic infection
|
J:113262
|
increased susceptibility to parasitic infection
|
J:113262
|
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+ TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J)
|
increased susceptibility to infection
|
J:153656
|
Gucy2ctm1Gar/Gucy2ctm1Gar
(either: (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6J))
|
decreased susceptibility to bacterial infection
|
J:43046
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:43046
|
Gucy2ctm1Gian/Gucy2ctm1Gian
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased susceptibility to infection
|
J:43682
|
Gzmatm1Simn/Gzmatm1Simn Gzmbtm1Ley/Gzmbtm1Ley
(B6.Cg-Gzmatm1Simn Gzmbtm1Ley)
|
increased susceptibility to Flaviviridae infection
|
J:90852
|
increased susceptibility to parasitic infection
|
J:81397
|
Gzmatm1Simn/Gzmatm1Simn Gzmbtm1Ley/Gzmbtm1Ley Prf1tm1Sdz/Prf1tm1Sdz
(B6.Cg-Gzmatm1Simn Gzmbtm1Ley Prf1tm1Sdz)
|
increased susceptibility to Flaviviridae infection
|
J:90852
|
increased susceptibility to parasitic infection
|
J:81397
|
Gzmmtm1(cre)Mjs/Gzmmtm1(cre)Mjs
(C57BL/6-Gzmmtm1(cre)Mjs)
|
increased susceptibility to Herpesvirales infection
|
J:113213
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:64283
|
increased susceptibility to parasitic infection
|
J:64283
|
H2-Ab1bm12/H2-Ab1bm12
(B6(C)-H2-Ab1bm12/KhEgJ)
|
decreased susceptibility to parasitic infection
|
J:48242
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:54709
|
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae)
|
increased susceptibility to bacterial infection
|
J:45185
|
H2-DMatm1Luc/H2-DMatm1Luc Cd74tm1Doi/Cd74tm1Doi
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:45185
|
H2-M3tm1Crw/H2-M3tm1Crw
(B6.129-H2-M3tm1Crw)
|
increased susceptibility to bacterial infection
|
J:118960
|
H2-Obem1Tvg/H2-Obem1Tvg
(C57BL/6J-H2-Obem1Tvg/Tvg)
|
decreased susceptibility to Retroviridae infection
|
J:254532
|
H2-Obvic1/H2-Obvic1
(I/LnJ)
|
decreased susceptibility to Retroviridae infection
|
J:163153
|
decreased susceptibility to viral infection
|
J:81554,
J:60602
|
H2-Obvic1/H2-Obvic1
(C3N.I-H2-Obvic1)
|
decreased susceptibility to Retroviridae infection
|
J:254532
|
H2-Obvic1/H2-Obvic1
(B6.I-H2-Obvic1)
|
decreased susceptibility to Retroviridae infection
|
J:254532
|
H2-Obvic1/H2-Obvic1
(C.I-H2-Obvic1)
|
decreased susceptibility to Retroviridae infection
|
J:254532
|
H2-T23tm1Cant/H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:89808
|
increased susceptibility to Herpesvirales infection
|
J:89808
|
H2b/H2d
((C57BL/6 x DBA/2)F1)
|
decreased susceptibility to parasitic infection
|
J:106141
|
H2d/H2d
(DBA/2)
|
decreased susceptibility to parasitic infection
|
J:106141
|
H2dlAb1-Ea/H2dlAb1-Ea
(B6.129S2-H2dlAb1-Ea/J)
|
increased susceptibility to bacterial infection
|
J:123934
|
Hamptm1Svl/Hamptm1Svl
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199427
|
Havcr2tm1Bmed/Havcr2tm1Bmed
(B6.Cg-Havcr2tm1Bmed)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:189839
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:189839
|
Hbnr1CBA/Hbnr1SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:82261,
J:85787
|
Hbnr1SWR/Hbnr1SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:82261,
J:110034,
J:85787
|
Hbnr2SWR/?
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:82261
|
Hbnr2SWR/Hbnr2SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:110034
|
Hbnr3CBA/Hbnr3SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:85787
|
increased susceptibility to parasitic infection
|
J:82261
|
Hbnr3SWR/Hbnr3SWR
(involves: CBA * SWR)
|
increased susceptibility to parasitic infection
|
J:82261,
J:85787
|
Hbnr5CBA/Hbnr5SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:85787
|
Hbnr5SWR/Hbnr5SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:85787
|
Hbnr8CBA/Hbnr8SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:85787
|
Hbnr8SWR/Hbnr8SWR
(involves: CBA * SWR)
|
decreased susceptibility to parasitic infection
|
J:85787
|
Hc0/Hc0
(involves: C57BL/10SnJ)
|
increased susceptibility to bacterial infection
|
J:44240
|
Hcfc2fkls/Hcfc2fkls
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection
|
J:251008
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:251008
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:251008
|
Hcsttm1.1Cln/Hcsttm1.1Cln Tyrobptm1Lll/Tyrobptm1Lll
(B6.Cg-Hcsttm1.1Cln Tyrobptm1Lll)
|
abnormal response to infection
|
J:147867
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
abnormal response to infection
|
J:147867
|
Hectd3tm1Lex/Hectd3tm1Lex
(FVB.129S5(B6)-Hectd3tm1Lex)
|
decreased susceptibility to bacterial infection
|
J:266602
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:266602
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:205499
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:148498
|
decreased susceptibility to Paramyxoviridae infection
|
J:148498
|
Hmox1tm1Mlee/Hmox1tm1Mlee
(involves: 129S2/SvPas * BALB/c)
|
increased susceptibility to parasitic infection
|
J:153083
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:153083
|
Hnrnpa2b1tm1.1Caox/Hnrnpa2b1tm1.1Caox Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to Herpesvirales infection
|
J:283622
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:283622
|
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:116112
|
Hps5ru2-Btlr/Hps5ru2-Btlr
(C57BL/6J-Hps5ru2-Btlr)
|
increased susceptibility to bacterial infection
|
J:133272
|
increased susceptibility to Herpesvirales infection
|
J:133272
|
Hrh1Bphs-r/Hrh1Bphs-s
((C3H/HeJ x SJL/J)F1)
|
abnormal response to infection
|
J:77938
|
increased susceptibility to bacterial infection
|
J:77938
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:77938
|
Hrh1Bphs-s/Hrh1Bphs-s
(C3.SJL-Hrh1Bphs-s)
|
abnormal response to infection
|
J:77938
|
increased susceptibility to bacterial infection
|
J:77938
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:77938
|
Hrl129S6/SvEvTac/HrlC57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to Herpesvirales infection
|
J:86189
|
HrlC57BL/6J/HrlC57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to Herpesvirales infection
|
J:86189
|
Hsf1tm1Ijb/Hsf1tm1Ijb
(either: (involves: 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S6/SvEvTac * BALB/c) or (involves: 129S6/SvEvTac * C57BL/6J) or (involves: 129S6/SvEvTac * ICR))
|
increased susceptibility to bacterial infection
|
J:58383
|
Hsp90b1tm1Zhli/Hsp90b1tm1.1Zhli Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased susceptibility to bacterial infection
|
J:118427
|
hvlk/hvlk
(C57BL/6J-hvlk)
|
increased susceptibility to Herpesvirales infection
|
J:105543
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay/J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:193592
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:18743
|
Icostm1Dgry/Icostm1Dgry
(B6.129P2-Icostm1Dgry)
|
abnormal response to infection
|
J:123477
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
abnormal response to infection
|
J:157504
|
increased susceptibility to parasitic infection
|
J:157504
|
If1l/If1l
(involves: BALB/c)
|
abnormal response to infection
|
J:38004
|
If1l/If1l
(B6.C-Ifi44lH28-c If1l/(HW81)aByJ)
|
abnormal response to infection
|
J:38004
|
Ifi35em1Hhl/Ifi35em1Hhl
(C57BL/6-Ifi35em1Hhl)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:298909
|
Ifi44tm1b(KOMP)Wtsi/Ifi44tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
increased susceptibility to Riboviria infection
|
J:297991
|
Ifi47tm1Gat/Ifi47tm1Gat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:87535
|
Ifih1tm1.1Cln/Ifih1tm1.1Cln
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:110201
|
Ifih1tm1Aki/Ifih1tm1Aki
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:137522
|
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased susceptibility to Riboviria infection
|
J:187549
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:187549
|
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
increased susceptibility to Coronaviridae infection
|
J:205203
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:205203
|
Ifit2tm1.1Ebsb/Ifit2tm1.1Ebsb
(B6NCrl.129P2(C)-Ifit2tm1.1Ebsb)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199862
|
Ifit2tm1.1Tac/Ifit2+
(involves: C57BL/6)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:195382
|
Ifit2tm1.1Tac/Ifit2tm1.1Tac
(involves: C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:195382
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:195382
|
Ifitm3tm1Masu/Ifitm3tm1Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:183865
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:183865
|
increased susceptibility to Riboviria infection
|
J:209781
|
Ifnar1m1Btlr/Ifnar1m1Btlr
(C57BL/6J-Ifnar1m1Btlr)
|
increased susceptibility to Adenoviridae infection
|
J:142790
|
increased susceptibility to Herpesvirales infection
|
J:142790
|
increased susceptibility to Orthomyxoviridae infection
|
J:142790
|
increased susceptibility to Riboviria infection
|
J:142790
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas)
|
increased susceptibility to Coronaviridae infection
|
J:144400
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:144400
|
increased susceptibility to Herpesvirales infection
|
J:197569,
J:81243
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:115139
|
increased susceptibility to Paramyxoviridae infection
|
J:160878
|
increased susceptibility to Paramyxoviridae infection induced morbidity/mortality
|
J:160878
|
increased susceptibility to Picornaviridae infection
|
J:137522
|
increased susceptibility to Poxviridae infection
|
J:101427
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal susceptibility to infection
|
J:120938
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(B6.129S2-Ifnar1tm1Agt)
|
abnormal response to infection
|
J:116703
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:199862
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
increased susceptibility to Orthomyxoviridae infection
|
J:119783
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
increased susceptibility to Riboviria infection
|
J:54482
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * BALB/c)
|
decreased susceptibility to Coronaviridae infection
|
J:291874
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:291874
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:291874
|
Ifnar1tm1Agt/Ifnar1tm1Agt Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
increased susceptibility to Herpesvirales infection
|
J:81243
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:115139
|
increased susceptibility to Poxviridae infection
|
J:101427
|
increased susceptibility to Togaviridae infection
|
J:81243
|
Ifnar1tm1Agt/Ifnar1tm1Agt Myd88tm1Aki/Myd88+
(B6.129-Myd88tm1Aki Ifnar1tm1Agt)
|
increased susceptibility to parasitic infection
|
J:140485
|
Ifnar1tm1Agt/Ifnar1tm1Agt Myd88tm1Aki/Myd88tm1Aki
(B6.129-Myd88tm1Aki Ifnar1tm1Agt)
|
increased susceptibility to parasitic infection
|
J:140485
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:140485
|
Ifnar1tm1Agt/Ifnar1tm1Agt Slamf1tm1Oono/Slamf1tm1Oono
(B6.129-Slamf1tm1Oono Ifnar1tm1Agt)
|
increased susceptibility to Paramyxoviridae infection
|
J:117810
|
Ifnar1tm1Agt/Ifnar1tm1Agt Tg(CD46)373Zbz/Tg(CD46)373Zbz
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
increased susceptibility to Paramyxoviridae infection
|
J:160878
|
increased susceptibility to Paramyxoviridae infection induced morbidity/mortality
|
J:160878
|
Ifnar1tm1Agt/Ifnar1tm1Agt Tg(Hmgcr-MX1)LStae/Tg(Hmgcr-MX1)LStae
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:119783
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:119783
|
Ifnar1tm1Pjh/Ifnar1tm1Pjh
(involves: 129S2/SvPas * BALB/c)
|
increased susceptibility to Picornaviridae infection
|
J:36004
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:36004
|
increased susceptibility to Togaviridae infection
|
J:36004
|
increased susceptibility to Togaviridae infection induced morbidity/mortality
|
J:36004
|
Ifnar2m1Btlr/Ifnar2m1Btlr
(C57BL/6J-Ifnar2m1Btlr)
|
increased susceptibility to Adenoviridae infection
|
J:147329
|
increased susceptibility to Herpesvirales infection
|
J:147329
|
increased susceptibility to Orthomyxoviridae infection
|
J:147329
|
increased susceptibility to Riboviria infection
|
J:147329
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Poxviridae infection
|
J:61048
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B6.129P2-Ifnb1tm1Tl)
|
decreased susceptibility to bacterial infection
|
J:172226
|
Ifnb1tm1Ttg/Ifnb1tm1Ttg
(involves: C57BL/6)
|
abnormal response to infection
|
J:116703
|
Ifnb1tm2.1Lien/Ifnb1tm2.1Lien Tyrc-2J/Tyrc-2J Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:172226
|
Ifnetm1.2Pjh/Ifnetm1.2Pjh
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:197569
|
increased susceptibility to Herpesvirales infection
|
J:197569
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:189794
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:189794
|
increased susceptibility to bacterial infection
|
J:66802
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd)
|
abnormal response to infection
|
J:110721,
J:29170
|
increased susceptibility to bacterial infection
|
J:110856
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:110856
|
increased susceptibility to Herpesvirales infection
|
J:29170
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:29170
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
increased susceptibility to bacterial infection
|
J:47459
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:47459
|
increased susceptibility to parasitic infection
|
J:50832
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:50832
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts)
|
abnormal response to infection
|
J:18801,
J:110826
|
increased susceptibility to Coronaviridae infection
|
J:112048
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:112048
|
increased susceptibility to parasitic infection
|
J:18801
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:18801,
J:110826
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:15723
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:15723
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts)
|
abnormal response to infection
|
J:110826
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:83180
|
increased susceptibility to parasitic infection
|
J:110826
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:110826
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * BALB/c)
|
abnormal susceptibility to infection
|
J:39478
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
decreased susceptibility to parasitic infection
|
J:50832
|
increased susceptibility to bacterial infection
|
J:47459
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:47459
|
Ifngtm1Ts/Ifngtm1Ts Tnfrsf1atm1Blt/Tnfrsf1atm1Blt Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to fungal infection
|
J:119206
|
Ifngtm1Yiw/Ifngtm1Yiw
(B6.129X1-Ifngtm1Yiw)
|
increased susceptibility to Coronaviridae infection
|
J:91691,
J:50405
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:91691,
J:50405
|
Ifngtm1Yiw/Ifngtm1Yiw
(C.129X1-Ifngtm1Yiw)
|
increased susceptibility to Coronaviridae infection
|
J:91691
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:91691
|
Ifngr1tm1.1Rds/Ifngr1tm1.1Rds Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6NTac.Cg-Ifngr1tm1.1Rds Commd10Tg(Vav1-icre)A2Kio)
|
increased susceptibility to bacterial infection
|
J:206257
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:206257
|
Ifngr1tm1.1Rds/Ifngr1tm1.1Rds Tg(Itgax-cre,-EGFP)4097Ach/0
(B6NTac.Cg-Ifngr1tm1.1Rds Tg(Itgax-cre,-EGFP)4097Ach)
|
increased susceptibility to bacterial infection
|
J:206257
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:206257
|
Ifngr1tm1.2Rds/Ifngr1tm1.2Rds
(C57BL/6NTac-Ifngr1tm1.2Rds)
|
increased susceptibility to bacterial infection
|
J:206257
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:206257
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
abnormal response to infection
|
J:115139
|
increased susceptibility to bacterial infection
|
J:314959,
J:174397
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:314959,
J:174397
|
increased susceptibility to Herpesvirales infection
|
J:81243
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:115139
|
increased susceptibility to parasitic infection
|
J:114203
|
increased susceptibility to Poxviridae infection
|
J:101427
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:63815
|
increased susceptibility to Riboviria infection
|
J:63815
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:63815
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
decreased susceptibility to bacterial infection
|
J:147443
|
Ifngr1tm1Dmer/Ifngr1tm1Dmer
(B6.Cg-Ifngr1tm1Dmer)
|
abnormal response to infection
|
J:202844
|
Ifngr1tm1Dmer/Ifngr1tm1Dmer Tg(Thy1-cre)1Vln/0
(B6.Cg-Ifngr1tm1Dmer Tg(Thy1-cre)1Vln)
|
abnormal response to infection
|
J:202844
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:48016
|
Ifnl3em1Mtba/Ifnl3em1Mtba
(involves: C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:287260
|
increased susceptibility to Riboviria infection
|
J:287260
|
increased susceptibility to viral infection
|
J:287260
|
Ifnlr1tm1b(EUCOMM)Wtsi/Ifnlr1tm1b(EUCOMM)Wtsi
(B6(Cg)-Ifnlr1tm1b(EUCOMM)Wtsi)
|
increased susceptibility to Orthomyxoviridae infection
|
J:287260
|
increased susceptibility to Riboviria infection
|
J:287260
|
increased susceptibility to viral infection
|
J:287260
|
Ifnlr1tm1Palu/Ifnlr1tm1Palu
(B6.Cg-Ifnlr1tm1Palu)
|
abnormal susceptibility to infection
|
J:131989
|
Igdcc4em1Bcgen/Igdcc4em1Bcgen
(involves: C57BL/6J)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:320015
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:320015
|
Igh-8tm1Schr/Igh-8tm1Schr
(C.129P2(BKSW)-Igh-8tm1Schr)
|
increased susceptibility to bacterial infection
|
J:75577
|
Igh-Vtm1Jjk/Igh-Vtm1Jjk
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:62284
|
Ighatm1Grh/Ighatm1Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:125472
|
Ighatm1Grh/Ighatm1Grh
(involves: 129 * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:140515,
J:74568
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal response to infection
|
J:119344
|
Ighmtm1Cgn/Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
increased susceptibility to parasitic infection
|
J:74568
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
increased susceptibility to parasitic infection
|
J:163761
|
Ighmtm1Che/Ighmtm1Che
(involves: 129 * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:74568
|
Ighmtm1Fbb/Ighmtm1Fbb
(involves: BALB/cJ)
|
increased susceptibility to Riboviria infection
|
J:57600
|
Igtpem1Myam/Igtpem1Myam Irgm1em1Myam/Irgm1em1Myam
(C57BL/6-Irgm1em1Myam Igtpem1Myam)
|
increased susceptibility to parasitic infection
|
J:308470
|
Igtpem1Myam/Igtpem1Myam Irgm1em1Myam/Irgm1em1Myam Irgm2em2Myam/Irgm2em2Myam
(C57BL/6-Irgm1em1Myam Igtpem1Myam Irgm2em2Myam)
|
increased susceptibility to parasitic infection
|
J:308470
|
Igtptm1Gvw/Igtptm1Gvw
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:99144,
J:59891
|
Iigp1tm1.1Jcho/Iigp1tm1.1Jcho
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:135070
|
Ikbipem1Bcgen/Ikbipem1Bcgen Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:282971
|
IkbkbM1Btlr/Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal response to infection
|
J:225271
|
IkbkbM1Btlr/IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
increased susceptibility to viral infection
|
J:225271
|
Ikbketm1Tman/Ikbketm1Tman
(B6.Cg-Ikbketm1Tman)
|
increased susceptibility to Orthomyxoviridae infection
|
J:119791
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
increased susceptibility to bacterial infection
|
J:20671
|
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:112400
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to Togaviridae infection
|
J:52841
|
decreased susceptibility to Togaviridae infection induced morbidity/mortality
|
J:52841
|
decreased susceptibility to viral infection
|
J:135243
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:136368
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129 * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:58851
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
increased susceptibility to bacterial infection
|
J:125570
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:125570
|
sepsis
|
J:125570
|
Il1r1tm1Imx/Il1r1tm1Imx Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:58851
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:42373
|
Il1r1tm1Roml/Il1r1tm1Roml Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:191055
|
Il1rl1tm1Brl/Il1rl1tm1Brl
(involves: 129S/SvEv * C57BL/6)
|
abnormal response to infection
|
J:63507
|
Il1rntm1Dih/Il1rn+
(involves: 129S/SvEv * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:36387
|
Il1rntm1Dih/Il1rntm1Dih
(involves: 129S/SvEv * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:36387
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to Riboviria infection
|
J:26861
|
Il2tm1Hor/Il2tm1Hor Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to Riboviria infection
|
J:26861
|
Il2rgtm1.1Flv/Y Rag2tm1.1Flv/Rag2tm1.1Flv
(involves: 129S4/SvJae * BALB/cAnNTac)
|
increased susceptibility to bacterial infection
|
J:168303
|
Il2rgtm1.1Flv/Il2rgtm1.1Flv Rag2tm1.1Flv/Rag2tm1.1Flv
(involves: 129S4/SvJae * BALB/cAnNTac)
|
increased susceptibility to bacterial infection
|
J:168303
|
Il2rgtm1Cgn/Il2rgtm1Cgn Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased susceptibility to bacterial infection
|
J:142654
|
Il2rgtm1Wjl/Il2rgtm1Wjl Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S4/SvJae)
|
increased susceptibility to bacterial infection
|
J:140483
|
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
increased susceptibility to parasitic infection
|
J:80500
|
Il3tm1Glli/Il3tm1Glli KitW/KitW-v
(involves: 129S2/SvPas * C57BL/6 * WB)
|
increased susceptibility to parasitic infection
|
J:80500
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to infection
|
J:113543
|
decreased susceptibility to parasitic infection
|
J:72587
|
increased susceptibility to parasitic infection
|
J:113543,
J:89095
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal susceptibility to infection
|
J:60609,
J:131994
|
increased susceptibility to parasitic infection
|
J:60609
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to infection
|
J:113543
|
decreased susceptibility to parasitic infection
|
J:72587
|
increased susceptibility to parasitic infection
|
J:113543,
J:89095
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal susceptibility to infection
|
J:60609,
J:131994
|
increased susceptibility to parasitic infection
|
J:60609
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il4tm1Kopf/Il4tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal response to infection
|
J:14593
|
Il4tm1Lky/Il4tm1Lky Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * BALB/c * C57BL/6J)
|
abnormal response to infection
|
J:129883
|
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt)
|
abnormal susceptibility to infection
|
J:60609
|
increased susceptibility to parasitic infection
|
J:60609
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/c)
|
abnormal susceptibility to infection
|
J:55526
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ)
|
increased susceptibility to infection
|
J:114751
|
increased susceptibility to parasitic infection
|
J:114751
|
Il4ratm1Fbb/Il4ratm2Fbb Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased susceptibility to parasitic infection
|
J:114751
|
increased susceptibility to parasitic infection
|
J:114751
|
Il4ratm1Sz/Il4ratm1Sz
(BALB/c-Il4ratm1Sz/J)
|
abnormal susceptibility to infection
|
J:131994
|
Il4ratm1Sz/Il4ratm1Sz
(BALB/c-Il4ratm1Sz)
|
increased susceptibility to parasitic infection
|
J:110429
|
Il5tm1Anjm/Il5tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to infection
|
J:113543
|
increased susceptibility to parasitic infection
|
J:113543
|
Il5tm1Anjm/Il5tm1Anjm Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to infection
|
J:113543
|
increased susceptibility to parasitic infection
|
J:113543
|
Il5tm2Anjm/Il5tm2Anjm Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to infection
|
J:113543
|
increased susceptibility to parasitic infection
|
J:113543
|
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:33140
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:17360
|
increased susceptibility to Poxviridae infection
|
J:17360
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:161073
|
Il6tm1Mur/Il6tm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:25684
|
Il6tm1Mur/Il6tm1Mur
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:40579
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
increased susceptibility to fungal infection
|
J:79314
|
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:188445
|
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased susceptibility to parasitic infection
|
J:188445
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:188445
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:188445
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:79555
|
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:82881
|
increased susceptibility to parasitic infection
|
J:82881
|
Il9tm1Flv/Il9tm1Flv
(BALB/c-Il9tm1Flv)
|
increased susceptibility to parasitic infection
|
J:208730
|
Il10tm1.1Roer/Il10tm1.1Roer
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:94537
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:15222
|
increased susceptibility to parasitic infection
|
J:123927
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
increased susceptibility to parasitic infection
|
J:157787
|
Il10tm1Roer/Il10tm1Roer Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased susceptibility to parasitic infection
|
J:94537
|
Il10ratm1.1Jack/Il10ratm1.1Jack Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:157787
|
Il10ratm1.2Jack/Il10ratm1.2Jack
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * DBA/2)
|
increased susceptibility to parasitic infection
|
J:157787
|
Il12am1Btlr/Il12am1Btlr
(C57BL/6J-Il12am1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:267667
|
Il12atm1Jm/Il12atm1Jm
(129S1/Sv-Il12atm1Jm)
|
increased susceptibility to parasitic infection
|
J:34164
|
Il12atm1Jm/Il12atm1Jm Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv * 129S6/SvEvTac)
|
decreased susceptibility to bacterial infection
|
J:140483
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
increased susceptibility to bacterial infection
|
J:120806
|
Il12btm1Jm/Il12btm1Jm
(129S1/Sv-Il12btm1Jm)
|
increased susceptibility to parasitic infection
|
J:34164
|
Il12btm1Jm/Il12btm1Jm
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:161073
|
Il12btm1Jm/Il12btm1Jm Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:140483
|
Il12rb2Ifnm-d/Il12rb2Ifnm-d Tlr4lps-del/Tlr4lps-del
(C57BL/10ScCr)
|
increased susceptibility to bacterial infection
|
J:91014,
J:70821
|
Il13tm1(YFP/cre)Lky/Il13+ Il4tm1(CD2)Mmrs/Il4+ Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:178986
|
Il13tm1Anjm/Il13tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:113543
|
Il13tm1Anjm/Il13tm1Anjm Il5tm3Anjm/Il5tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:113543
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
increased susceptibility to parasitic infection
|
J:89095
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal susceptibility to infection
|
J:131994
|
decreased susceptibility to bacterial infection
|
J:176092
|
decreased susceptibility to parasitic infection
|
J:60609
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:60609
|
Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
abnormal response to infection
|
J:130488
|
decreased susceptibility to parasitic infection
|
J:130488
|
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6)
|
abnormal susceptibility to infection
|
J:60915
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:84009
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:97038
|
increased susceptibility to parasitic infection
|
J:97620
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:60915
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:143719
|
Il17atm1Yiw/Il17atm1Yiw
(B6.129P2-Il17atm1Yiw)
|
increased susceptibility to infection induced morbidity/mortality
|
J:160680
|
Il17atm1Yiw/Il17atm1Yiw Il17ftm1Yiw/Il17ftm1Yiw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:143719
|
Il17atm1Yiw/Il17atm1Yiw Il17ftm2Yiw/Il17ftm2Yiw
(involves: 129P2/OlaHsd * BALB/c)
|
increased susceptibility to bacterial infection
|
J:143719
|
Il17atm1Yiw/Il17atm1Yiw Il17ftm2Yiw/Il17ftm2Yiw
(B6.129P2-Il17atm1Yiw Il17ftm2Yiw)
|
increased susceptibility to infection induced morbidity/mortality
|
J:160680
|
Il17bGt(371C12)Cmhd/Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd)
|
increased susceptibility to bacterial infection
|
J:229778
|
Il17ftm1Yiw/Il17ftm1Yiw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:143719
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129 * C57BL/6)
|
increased susceptibility to infection
|
J:71097
|
Il17rbtm1Anjm/Il17rbtm1Anjm
(BALB/c-Il17rbtm1Anjm)
|
increased susceptibility to parasitic infection
|
J:159464
|
Il17rbtm1Anjm/Il17rbtm1Anjm Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
increased susceptibility to parasitic infection
|
J:159464
|
Il17retm1Sdl/Il17retm1Sdl
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:178966
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:178966
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:112400
|
Il18tm1Aki/Il18tm1Aki
(B6.129P2-Il18tm1Aki)
|
increased susceptibility to bacterial infection
|
J:125285
|
Il18tm1Aki/Il18tm1Aki Il1btm1Dch/Il1btm1Dch
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:112400
|
Il18tm1Khe/Il18tm1Khe
(B6.129P2-Il18tm1Khe)
|
decreased susceptibility to bacterial infection
|
J:138759
|
Il18tm1Liew/Il18tm1Liew
(involves: 129P2/OlaHsd * CD-1)
|
increased susceptibility to bacterial infection
|
J:86621
|
increased susceptibility to parasitic infection
|
J:86621
|
sepsis
|
J:86621
|
Il21rtm1Day/Il21rtm1Day
(C57BL/6-Il21rtm1Day)
|
abnormal susceptibility to infection
|
J:111712
|
Il22tm1.1(icre)Stck/Il22tm1.1(icre)Stck
(involves: 129X1/SvJ * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:220074
|
Il22tm1.1Lex/Il22tm1.1Lex
(involves: 129S5/SvEvBrd)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:161073
|
increased susceptibility to fungal infection
|
J:179011
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:120806
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:161073
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased susceptibility to bacterial infection
|
J:229778
|
Il25tm1Anjm/Il25tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:123748
|
Il25tm1Dart/Il25tm1Dart
(C57BL/6-Il25tm1Dart)
|
abnormal response to infection
|
J:123808
|
increased susceptibility to parasitic infection
|
J:123808
|
Il27tm1Lex/Il27tm1Lex
(involves: 129S/SvEvBrd)
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:187660
|
Il27ratm1Fjs/Il27ratm1Fjs
(B6.Cg-Il27ratm1Fjs)
|
decreased susceptibility to bacterial infection
|
J:94856
|
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
|
increased susceptibility to bacterial infection
|
J:89509
|
increased susceptibility to parasitic infection
|
J:89509
|
Il31ratm1Ngh/Il31ratm1Ngh
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:123198
|
Il33tm1Aki/Il33tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:182160
|
Il33tm1Amgn/Il33tm1Amgn
(B6.129-Il33tm1Amgn)
|
increased susceptibility to parasitic infection
|
J:192531
|
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
decreased susceptibility to fungal infection
|
J:187643
|
increased susceptibility to Flaviviridae infection
|
J:187643
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:187643
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:264077
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:264077
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd)
|
increased susceptibility to Herpesvirales infection
|
J:280917
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:280917
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:296074
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:296074
|
Ilf3tm1.1Itl/Ilf3tm1.1Itl
(Not Specified)
|
increased susceptibility to Adenoviridae infection
|
J:167126
|
Inavatm1.1Itl/Inavatm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:257317
|
Inpp1tm1a(KOMP)Wtsi/Inpp1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:213427
|
Inpp5dtm1Rav/Inpp5dtm1Rav Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased susceptibility to parasitic infection
|
J:122796
|
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:76098
|
Irf1M1Btlr/Irf1+
(C57BL/6J-Irf1M1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:162995
|
Irf1M1Btlr/Irf1M1Btlr
(C57BL/6J-Irf1M1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:162995
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Poxviridae infection
|
J:101427
|
Irf1tm1Mak/Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
abnormal response to infection
|
J:64286
|
Irf2tm1Mak/Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
abnormal response to infection
|
J:64286
|
Irf3tm1Ttg/Irf3tm1Ttg
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to Picornaviridae infection
|
J:98127
|
Irf3tm1Ttg/Irf3tm1Ttg Irf7tm1Ttg/Irf7tm1Ttg
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased susceptibility to bacterial infection
|
J:158969
|
increased susceptibility to Herpesvirales infection
|
J:158969
|
increased susceptibility to Paramyxoviridae infection
|
J:158969
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
increased susceptibility to Riboviria infection
|
J:42683
|
Irf4tm1Mak/Irf4tm1Mak
(B6.129P2-Irf4tm1Mak)
|
increased susceptibility to bacterial infection
|
J:78909
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:81744
|
Irf5tm1Ttg/Irf5tm1Ttg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:97567
|
Irf5tm1Ttg/Irf5tm1Ttg
(B6.129P2-Irf5tm1Ttg)
|
abnormal response to infection
|
J:182658
|
Irf7tm1Ttg/Irf7tm1Ttg
(involves: 129P2/OlaHsd)
|
increased susceptibility to Herpesvirales infection
|
J:97662
|
increased susceptibility to Picornaviridae infection
|
J:97662
|
Irf7tm1Ttg/Irf7tm1Ttg
(B6.129P2-Irf7tm1Ttg)
|
increased susceptibility to Orthomyxoviridae infection
|
J:233979
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:233979
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(BXH2/TyJ)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(involves: BXH2/TyJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(involves: BALB/cJ * BXH2/TyJ)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1r
(involves: BXH2/TyJ * C3H/HeJ)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1s
(involves: BXH2/TyJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1r/Slc11a1s
(involves: BALB/cJ * BXH2/TyJ)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8myls/Irf8myls Slc11a1s/Slc11a1s
(involves: BALB/cJ * BXH2/TyJ)
|
increased susceptibility to bacterial infection
|
J:97931
|
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased susceptibility to Riboviria infection
|
J:36038
|
Irf9tm1Ttg/Irf9tm1Ttg
(either: (involves: C57BL/6 * CBA * ICR) or (involves: A/J * C57BL/6 * CBA))
|
increased susceptibility to viral infection
|
J:77456
|
Irgm1tm1Gat/Irgm1tm1Gat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:87535
|
increased susceptibility to parasitic infection
|
J:87535
|
Irgm2em1Myam/Irgm2em1Myam
(C57BL/6-Irgm2em1Myam)
|
increased susceptibility to parasitic infection
|
J:308470
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:308470
|
Itgadtm1.1Zimm/Itgadtm1.1Zimm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal susceptibility to infection
|
J:130908
|
decreased susceptibility to parasitic infection
|
J:130908
|
increased susceptibility to bacterial infection
|
J:130908
|
Itgamtm1Bll/Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
increased susceptibility to bacterial infection
|
J:94855
|
Itgavtm2Hyn/Itgavtm2.1Hyn Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:94376
|
Itgaxtm1.1(HBEGF)Ktak/Itgax+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal response to infection
|
J:162397
|
Itgaxtm1Bll/Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll)
|
increased susceptibility to bacterial infection
|
J:94855
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:48542
|
Itgb2tm2Bay/Itgb2tm2Bay
(B6.129S7-Itgb2tm2Bay)
|
decreased susceptibility to bacterial infection
|
J:94855
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(involves: C57BL/6)
|
abnormal response to infection
|
J:62733
|
increased susceptibility to parasitic infection
|
J:90262
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:54449
|
Itktm1Litt/Itktm1Litt Txktm1Pls/Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased susceptibility to parasitic infection
|
J:54449
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased susceptibility to parasitic infection
|
J:86257
|
Ity2C57BL/6J/Ity2MOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:45962
|
Ity2MOLF/EiJ/Ity2MOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:126552,
J:45962
|
Ity2aMOLF/EiJ/Ity2aMOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:126552
|
Ity2bMOLF/EiJ/Ity2bMOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:126552
|
Ity3C57BL/6J/Ity3C57BL/6J
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:45962
|
Ity3C57BL/6J/Ity3MOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
decreased susceptibility to bacterial infection
|
J:45962
|
Ity3MOLF/EiJ/Ity3MOLF/EiJ
(involves: C57BL/6J * MOLF/Ei)
|
increased susceptibility to bacterial infection
|
J:126552,
J:45962
|
Jagn1tm1c(EUCOMM)Hmgu/Jagn1tm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
increased susceptibility to fungal infection
|
J:214828
|
Jak3m1Btlr/Jak3m1Btlr
(C57BL/6J-Jak3m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:217795
|
Jak3M1Pgrs/Jak3+
(involves: C57BL/6J * C57BL/10J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:185217
|
Jak3M1Pgrs/Jak3M1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:185217
|
increased susceptibility to bacterial infection
|
J:185217
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:185217
|
Jak3M1Pgrs/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6J * C57BL/10J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:185217
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
abnormal response to infection
|
J:29722
|
Jam3tm1Rha/Jam3tm1Rha
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:121841
|
Jchaintm1Jse/Jchaintm1Jse
(C.129X1-Jchaintm1Jse)
|
decreased susceptibility to Herpesvirales infection
|
J:62298
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:62298
|
increased susceptibility to parasitic infection
|
J:140515
|
Jchaintm3Tl/Jchain+
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:56158
|
Jchaintm3Tl/Jchaintm3Tl
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:56158
|
Jdp2tm1Aki/Jdp2tm1Aki
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:191061
|
increased susceptibility to fungal infection
|
J:191061
|
Kat14tm1a(KOMP)Wtsi/Kat14tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:213427
|
Kcnj8gnite/Kcnj8gnite
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:126658,
J:105543
|
Kcnj8mydy/Kcnj8mydy
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection
|
J:126658
|
Kcnj8slmbr/Kcnj8slmbr
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:126658,
J:105543
|
Kcnj8sltr/Kcnj8sltr
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:126658,
J:105543
|
increased susceptibility to Riboviria infection
|
J:105543
|
Kctd9em1Beij/Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
decreased susceptibility to Coronaviridae infection
|
J:281803
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:281803
|
Kdelr1m1Btlr/Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
abnormal response to infection
|
J:224970
|
increased susceptibility to Riboviria infection
|
J:224970
|
Kdm6btm1Aki/Kdm6btm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal response to infection
|
J:164690
|
Khsrptm1.1Cyc/Khsrptm1.1Cyc
(B6.Cg-Khsrptm1.1Cyc)
|
decreased susceptibility to Herpesvirales infection
|
J:175084
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:175084
|
Kif1cLtxs1-DBA/2NCr/Kif1cLtxs1-DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Kif1cLtxs1-DBA/2NCr/Kif1cLtxs1-DBA/2NCr Ltxs2DBA/2NCr/Ltxs2DBA/2NCr Ltxs3DBA/2NCr/Ltxs3DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Kif1cLtxs1/Kif1c+
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:49726
|
Kif1cLtxs1/Kif1cLtxs1
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:49726
|
KitW-sh/KitW-sh
(involves: 101/H * C3H/HeH)
|
increased susceptibility to parasitic infection
|
J:163761
|
Klf5Gt(XB751)Byg/Klf5+
(B6.129P2-Klf5Gt(XB751)Byg)
|
abnormal response to infection
|
J:136125
|
Klra8Cmv1-del/Klra8Cmv1-r
((BXD8/TyJ x C57BL/6)F1)
|
decreased susceptibility to Herpesvirales infection
|
J:79093
|
Klra8Cmv1-del/Klra8Cmv1-s
((BXD8/TyJ x BALB/c)F1)
|
increased susceptibility to Herpesvirales infection
|
J:79093
|
Klra8Cmv1-del/Klra8Cmv1-s
((BXD8/TyJ x DBA/2)F1)
|
increased susceptibility to Herpesvirales infection
|
J:79093
|
Klra8Cmv1-r/Klra8Cmv1-r
(C.B6-Klra8Cmv1-r)
|
decreased susceptibility to Herpesvirales infection
|
J:22486,
J:79093
|
increased susceptibility to infection induced morbidity/mortality
|
J:97203
|
increased susceptibility to parasitic infection
|
J:97203
|
Klra17tm1.1Apma/Klra17tm1.1Apma
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal response to infection
|
J:152288
|
increased susceptibility to Herpesvirales infection
|
J:152288
|
Klrc1tm1Mmka/Klrc1tm1Mmka
(B6.129-Klrc1tm1Mmka)
|
increased susceptibility to Adenoviridae infection
|
J:222503
|
increased susceptibility to Orthomyxoviridae infection
|
J:222503
|
Klrk1tm1.1Bpol/Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
decreased susceptibility to Herpesvirales infection
|
J:151878
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:151878
|
Klrk1tm2.1Bpol/Klrk1tm2.1Bpol
(Not Specified)
|
decreased susceptibility to Herpesvirales infection
|
J:215590
|
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa)
|
increased susceptibility to bacterial infection
|
J:145445
|
Kpna4tm1Bdr/Kpna4tm1Bdr
(B6.Cg-Kpna4tm1Bdr)
|
increased susceptibility to Orthomyxoviridae infection
|
J:302003
|
Kptntm1a(EUCOMM)Wtsi/Kptntm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:200082
|
Krt10tm1Tmm/Krt10+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6))
|
increased susceptibility to infection
|
J:31853
|
Lancl2tm2a(KOMP)Wtsi/Lancl2tm2a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:250673
|
Lancl2tm2c(KOMP)Wtsi/Lancl2tm2c(KOMP)Wtsi Lyz2tm1(cre)Ifo/Lyz2+
(involves: C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:250673
|
Lao1tm1Oka/Lao1tm1Oka
(involves: 129S2/SvPas * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:260668
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:260668
|
Lbptm1Jack/Lbptm1Jack
(involves: 129P2/OlaHsd * BALB/c)
|
increased susceptibility to bacterial infection
|
J:43514
|
Lcn2tm1Aade/Lcn2tm1Aade
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:95107
|
sepsis
|
J:95107
|
Lcn2tm1Mak/Lcn2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:106079
|
Lcp1tm1Erjb/Lcp1tm1Erjb
(involves: 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:161042
|
Ldlrad3em1Diam/Ldlrad3em1Diam
(C57BL/6-Ldlrad3em1Diam)
|
decreased susceptibility to Togaviridae infection
|
J:300132
|
Ldlrad3em1Diam/Ldlrad3em2Diam
(C57BL/6-Ldlrad3em1Diam Ldlrad3em2Diam)
|
decreased susceptibility to Togaviridae infection
|
J:300132
|
Ldlrad3em2Diam/Ldlrad3em2Diam
(C57BL/6-Ldlrad3em2Diam)
|
decreased susceptibility to Togaviridae infection
|
J:300132
|
Leprtm1.1Rll/Lepr+
(129P3/J-Leprtm1.1Rll)
|
increased susceptibility to parasitic infection
|
J:172012
|
Leprtm1.1Rll/Leprtm1.1Rll
(129P3/J-Leprtm1.1Rll)
|
increased susceptibility to parasitic infection
|
J:172012
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
abnormal response to infection
|
J:109126
|
increased susceptibility to parasitic infection
|
J:109126
|
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL)
|
increased susceptibility to bacterial infection
|
J:131407
|
sepsis
|
J:131407
|
Lgals8tm1(KOMP)Vlcg/Lgals8tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased susceptibility to Herpesvirales infection
|
J:235778
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:136940
|
Listr1BALB/cByJ/?
(involves: BALB/cByJ * C57BL/6ByJ)
|
decreased susceptibility to bacterial infection
|
J:68879
|
Listr1BALB/cByJ/? Listr2C57BL/6ByJ/?
(involves: BALB/cByJ * C57BL/6ByJ)
|
decreased susceptibility to bacterial infection
|
J:68879
|
Listr2C57BL/6ByJ/?
(involves: BALB/cByJ * C57BL/6ByJ)
|
decreased susceptibility to bacterial infection
|
J:68879
|
Lmo4tm1Slp/Lmo4tm1Slp Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
increased susceptibility to bacterial infection
|
J:282740
|
Lmo4tm1Slp/Lmo4tm1Slp Yeats4em1Zfa/Yeats4em1Zfa Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
increased susceptibility to bacterial infection
|
J:282740
|
Lmr1BALB/c/Lmr1BALB/c
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:40874
|
Lmr1BALB/c/Lmr1BALB/c Lmr30C57BL/6/Lmr30BALB/c
(involves: BALB/c * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:57691
|
Lmr1BALB/c/Lmr1BALB/c Lmr30C57BL/6/Lmr30C57BL/6
(involves: BALB/c * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:57691
|
Lmr1BALB/c/Lmr1C57BL/6J
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:40874
|
Lmr1C57BL/6J/Lmr1C57BL/6J
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:40874
|
Lmr2BALB/c/Lmr2BALB/c
(involves: BALB/c * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:40874
|
Lmr2BALB/c/Lmr2C57BL/6J
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:40874
|
Lmr2C57BL/6J/Lmr2C57BL/6J
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to parasitic infection
|
J:40874
|
Lmrq1BALB/cAnSim/Lmrq1C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq2BALB/cAnSim/Lmrq2C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq3BALB/cAnSim/Lmrq3C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq4BALB/cAnSim/Lmrq4C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq4C57BL/10Sn/Lmrq4C57BL/10Sn
(C.B10-(D11Mit2-D11Mit29))
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq5BALB/cAnNSim/Lmrq5C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lmrq6BALB/cAnSim/Lmrq6C57BL/10Sn
(involves: BALB/cAnNSim * C57BL/10J)
|
decreased susceptibility to parasitic infection
|
J:40624
|
Lrig1tm1a(EUCOMM)Wtsi/Lrig1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:213427
|
Lrrc8eem1Bcgen/Lrrc8eem1Bcgen
(C57BL/6N-Lrrc8eem1Bcgen)
|
increased susceptibility to viral infection
|
J:288504
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:288504
|
Lrrc19tm1Ryag/Lrrc19tm1Ryag
(involves: C57BL/6J * C57BL/6NTac)
|
increased susceptibility to bacterial infection
|
J:271376
|
Lrrc55osem1Caox/Lrrc55osem1Caox
(C57BL/6-Lrrc55osem1Caox)
|
increased susceptibility to Riboviria infection
|
J:293325
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:293325
|
Lsm3em1Caox/Lsm3em1Caox
(involves: C57BL/6J)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:262834
|
decreased susceptibility to Riboviria infection
|
J:262834
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:262834
|
Lsr1A/J/?
(involves: A/J * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:7345
|
Lsr1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:7345
|
Lst1tm1(KOMP)Vlcg/Lst1tm1(KOMP)Vlcg
(C57BL/6N-Lst1tm1(KOMP)Vlcg)
|
increased susceptibility to Orthomyxoviridae infection
|
J:235700
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:235700
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
increased susceptibility to parasitic infection
|
J:31129
|
increased susceptibility to Poxviridae infection
|
J:31129
|
increased susceptibility to Riboviria infection
|
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:37696
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
increased susceptibility to bacterial infection
|
J:115034
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:115034
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
increased susceptibility to bacterial infection
|
J:31129
|
increased susceptibility to Poxviridae infection
|
J:31129
|
increased susceptibility to Riboviria infection
|
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:37696
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
increased susceptibility to bacterial infection
|
J:115034
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:115034
|
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:39519
|
Lta/Tnftm1Fda/Lta+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:39519
|
Lta/Tnftm1Fda/Lta/Tnftm1Fda
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:39519
|
Lta/Tnftm1Fda/Tnf+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:39519
|
Ltatm1.1Sned/Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:109621
|
Ltatm1Tab/Ltatm1Tab
(B6.129S2-Ltatm1Tab)
|
decreased susceptibility to parasitic infection
|
J:121070
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
increased susceptibility to bacterial infection
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
increased susceptibility to bacterial infection
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
increased susceptibility to bacterial infection
|
J:80616
|
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
increased susceptibility to bacterial infection
|
J:80616,
J:158663
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:158663
|
Ltbtm1Krn/Ltbtm1Krn
(C57BL/6-Ltbtm1Krn)
|
increased susceptibility to parasitic infection
|
J:78229
|
Ltbrtm1Avt/Ltbrtm1Avt Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:158663
|
Ltbrtm1Avt/Ltbrtm1Avt Tg(Rorc-cre)1Litt/0
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:158663
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:158663
|
Ltbrtm1Avt/Ltbrtm1Avt Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
increased susceptibility to bacterial infection
|
J:158663
|
Ltxs2BALB/cAnPt/Ltxs2DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Ltxs2DBA/2NCr/Ltxs2DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Ltxs3BALB/cAnPt/Ltxs3DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Ltxs3DBA/2NCr/Ltxs3DBA/2NCr
(involves: BALB/cAnPt * DBA/2NCr)
|
decreased susceptibility to infection
|
J:103336
|
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
increased susceptibility to Coronaviridae infection
|
J:291868
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:291868
|
Ly96tm1Kmiy/Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:92494
|
Lysetem1Janc/Lysetem1Janc
(C57BL/6J-Tmem251em1Janc)
|
decreased susceptibility to viral infection
|
J:330704
|
Lysetem1Janc/Lysetem2Janc
(C57BL/6J-Tmem251em1Janc Tmem251em2Janc)
|
decreased susceptibility to viral infection
|
J:330704
|
Lysetem2Janc/Lysetem2Janc
(C57BL/6J-Tmem251em2Janc)
|
decreased susceptibility to viral infection
|
J:330704
|
Lystbg-2Btlr/Lystbg-2Btlr
(C57BL/6J-Lystbg-2Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:133617
|
Lystbg-2J/Lystbg-2J
(C3.Cg-Lystbg-2J/J)
|
abnormal susceptibility to infection
|
J:147940
|
decreased susceptibility to fungal infection
|
J:147940
|
Lystbg-6Btlr/Lystbg-6Btlr
(C57BL/6J-Lystbg-6Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:220065
|
Lystbg-Btlr/Lystbg-Btlr
(C57BL/6J-Lystbg-Btlr)
|
increased susceptibility to bacterial infection
|
J:133616
|
increased susceptibility to Herpesvirales infection
|
J:133616
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg/J)
|
increased susceptibility to parasitic infection
|
J:6946
|
Lystbg/Lystbg Prkdcscid/Prkdcscid
(Not Specified)
|
increased susceptibility to infection
|
J:4752
|
Lyz2tm1(cre)Ifo/Lyz2+ Nsd3tm1.1Caox/Nsd3tm1.1Caox
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to Riboviria infection
|
J:251909
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:251909
|
Map2k3tm1Flv/Map2k3tm1Flv
(B6.129S1-Map2k3tm1Flv)
|
increased susceptibility to bacterial infection
|
J:124327
|
Map3k8M1Btlr/Map3k8M1Btlr
(C57BL/6J-Map3k8M1Btlr)
|
abnormal response to infection
|
J:140986
|
Map3k8m2Btlr/Map3k8m2Btlr
(C57BL/6J-Map3k8m2Btlr)
|
abnormal response to infection
|
J:212899
|
Map3k10tm1Dsd/Map3k10tm1Dsd Map3k11tm1Rjd/Map3k11tm1Rjd
(involves: 129 * 129S6/SvEvTac * C57BL/6J)
|
abnormal response to infection
|
J:177426
|
Map3k10tm1Dsd/Map3k10tm1Dsd Map3k11tm2.1Rjd/Map3k11tm2.1Rjd
(involves: 129 * C57BL/6J)
|
abnormal response to infection
|
J:177426
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:135748
|
Map3k14aly/Map3k14aly
(C57BL/6J-Map3k14aly)
|
increased susceptibility to infection
|
J:16865
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129S * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:76161
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:76161
|
Marchf2em1Cnu/Marchf2em1Cnu
(C57BL/6-Marchf2em1Cnu)
|
decreased susceptibility to bacterial infection
|
J:297482
|
decreased susceptibility to viral infection
|
J:297482
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:297482
|
Marchf3em1Hbsh/Marchf3em1Hbsh
(involves: C57BL/6J)
|
increased susceptibility to infection induced morbidity/mortality
|
J:267641
|
Marchf5tm1a(EUCOMM)Wtsi/Marchf5+
(C57BL/6-Marchf5tm1a(EUCOMM)Wtsi)
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:225000
|
Marcotm1Ktry/Marcotm1Ktry
(B6.129S6-Marcotm1Ktry)
|
increased susceptibility to bacterial infection
|
J:115081,
J:122271
|
Marcotm1Ktry/Marcotm1Ktry Msr1tm1Csk/Msr1tm1Csk
(B6.129-Marcotm1Ktry Msr1tm1Csk)
|
increased susceptibility to bacterial infection
|
J:122271
|
Mavstm1Aki/Mavstm1Aki
(Not Specified)
|
abnormal response to infection
|
J:124405
|
increased susceptibility to Picornaviridae infection
|
J:124405
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to Flaviviridae infection
|
J:162888
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:162888
|
Mavstm1Tsse/Mavstm1Tsse Tg(PVR)1Kkst/0
(involves: 129 * C57BL/6 * ICR)
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:179625
|
Mavstm1Zjc/Mavs+
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:110905
|
Mavstm1Zjc/Mavstm1Zjc
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:110905
|
Mbis1NOD/ShiLt/Mbis1NOD/ShiLt
(involves: BALB/c * NOD/Lt)
|
increased susceptibility to bacterial infection
|
J:75276
|
Mbis2BALB/c/Mbis2BALB/c
(involves: BALB/c * NOD/Lt)
|
increased susceptibility to bacterial infection
|
J:75276
|
Mbis2BALB/c/Mbis2NOD/ShiLt
(involves: BALB/c * NOD/Lt)
|
increased susceptibility to bacterial infection
|
J:75276
|
Mbis3BALB/c/?
(involves: BALB/c * NOD/Lt)
|
increased susceptibility to bacterial infection
|
J:75276
|
Mbis4NOD/ShiLt/Mbis4NOD/ShiLt
(involves: BALB/c * NOD/Lt)
|
increased susceptibility to bacterial infection
|
J:75276
|
Mbl1tm1Kata/Mbl1tm1Kata Mbl2tm1Kata/Mbl2tm1Kata
(involves: 129 * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:98124
|
Mbl1tm1Kata/Mbl1tm1Kata Mbl2tm1Kata/Mbl2tm1Kata
(involves: 129 * C57BL/6J)
|
abnormal response to infection
|
J:106352
|
increased susceptibility to bacterial infection
|
J:106353
|
Mbl1tm1Rala/Mbl1tm1Rala
(involves: 129X1/SvJ * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:145279
|
Mbpshi/Mbpshi
(C3Fe.SWV-Mbpshi/J)
|
decreased susceptibility to Picornaviridae infection
|
J:41447
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
decreased susceptibility to bacterial infection
|
J:123123
|
increased susceptibility to Herpesvirales infection
|
J:94077,
J:123123
|
Mcamtm1Lex/Mcamtm1Lex
(involves: 129S/SvEvBrd)
|
abnormal response to infection
|
J:193167
|
Mcpt1tm1Hrpm/Mcpt1tm1Hrpm
(involves: 129P2/OlaHsd * MF1)
|
increased susceptibility to parasitic infection
|
J:93616,
J:93795
|
Mcpt8tm1.1(HBEGF)Hkar/Mcpt8tm1.1(HBEGF)Hkar
(B6.Cg-Mcpt8tm1.1(HBEGF)Hkar)
|
increased susceptibility to parasitic infection
|
J:163761
|
Mgl2tm1.1(HBEGF/EGFP)Aiwsk/Mgl2+
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to parasitic infection
|
J:201044
|
Miftm1Dvd/Miftm1Dvd
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:52300
|
increased susceptibility to parasitic infection
|
J:52300
|
Mir34atm1.1Pisc/Mir34atm1.1Pisc Mirc21tm1.1Pisc/Mirc21tm1.1Pisc Mirc34tm1.1Pisc/Mirc34tm1.1Pisc
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:256929
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:173671
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:173671
|
Mir155tm1.1Brd/Mir155tm1.1Brd
(B6.Cg-Mir155tm1.1Brd Tyrc-Brd)
|
increased susceptibility to bacterial infection
|
J:121095
|
Mir378bem#Yoo/Mir378bem#Yoo
(C57BL/6J-Mir378bem#Yoo)
|
abnormal susceptibility to bacterial infection
|
J:307588
|
MlrrqDBA/2/MlrrqDBA/2
(C.D2-Mtv7DBA/2)
|
decreased susceptibility to parasitic infection
|
J:41574
|
Mmp2tm1Ito/Mmp2tm1Ito Timp1tm1Pds/Timp1tm1Pds
(either: (involves: 129S4/SvJae) or (involves: C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:94836
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(either: 129S7/SvEvBrd or (involves: 129S7/SvEvBrd * C57BL/6))
|
increased susceptibility to bacterial infection
|
J:93706
|
Mmp3tm1Mrl/Mmp3tm1Mrl Timp1tm1Pds/Timp1tm1Pds
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:94836
|
Mmp7tm1Lmm/Mmp7tm1Lmm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to bacterial infection
|
J:153651
|
Mmp7tm1Lmm/Mmp7tm1Lmm Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae)
|
decreased susceptibility to bacterial infection
|
J:94836
|
Mmp8tm1Otin/Mmp8tm1Otin
(involves: 129X1/SvJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:97118
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
increased susceptibility to Picornaviridae infection
|
J:148442
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:148442
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal response to infection
|
J:126519
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.Cg-Mmp9tm1Tvu/J)
|
decreased susceptibility to Flaviviridae infection
|
J:153406
|
decreased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:153406
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu)
|
decreased susceptibility to bacterial infection
|
J:150311
|
Mmp10tm1Jkmg/Mmp10tm1Jkmg
(B6.129X1-Mmp10tm1Jkmg)
|
increased susceptibility to bacterial infection
|
J:153651
|
Mmp12tm1Sds/Mmp12tm1Sds Timp1tm1Pds/Timp1tm1Pds
(either: (involves: 129S4/SvJae) or (involves: C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:94836
|
Mmp28tm1Mani/Mmp28tm1Mani
(B6.129X1-Mmp28tm1Mani)
|
decreased susceptibility to bacterial infection
|
J:145912
|
Morrbidem1Flv/Morrbidem1Flv
(C57BL/6N-Morrbidem1Flv)
|
increased susceptibility to bacterial infection
|
J:236609
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:236609
|
Mpeg1tm1Pod/Mpeg1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:269474
|
Mpeg1tm1Pod/Mpeg1+
(129X1/SvJ-Mpeg1tm1Pod)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:269474
|
Mpeg1tm1Pod/Mpeg1tm1Pod
(involves: 129X1/SvJ * C57BL/6)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:269474
|
Mpeg1tm1Pod/Mpeg1tm1Pod
(129X1/SvJ-Mpeg1tm1Pod)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:269474
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased susceptibility to fungal infection
|
J:67586
|
sepsis
|
J:126649
|
Mpotm1Mae/Mpotm1Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to fungal infection
|
J:53993
|
Mptx2em1Yoxi/Mptx2em1Yoxi
(C57BL/6J-Mptx2em1Yoxi)
|
increased susceptibility to bacterial infection
|
J:326562
|
Mr1tm1Gfn/Mr1tm1Gfn
(involves: 129P2/OlaHsd)
|
abnormal susceptibility to bacterial infection
|
J:276912
|
Mrc1tm1Mnz/Mrc1tm1Mnz
(B6.129P2-Mrc1tm1Mnz)
|
decreased susceptibility to parasitic infection
|
J:194065
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:194065
|
Msr1tm1Csk/Msr1tm1Csk
(involves: 129X1/SvJ * ICR)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:39079
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:39079
|
Mst1rFv2-s/Mst1rFv2-s
(B6.DDD-Mst1rFv2-s)
|
increased susceptibility to Retroviridae infection
|
J:5120
|
Mst1rFv2-s/Mst1rFv2-s
(either: A/Crgl or C57BL/Crgl)
|
decreased susceptibility to Retroviridae infection
|
J:167666
|
Mst1rFv2-s/Mst1rFv2-s
(either: BALB/cCrgl or DBA/2Crgl or Swiss)
|
increased susceptibility to Retroviridae infection
|
J:167666
|
Mst1rFv2-s/Mst1rFv2-s
(C3H/Crgl)
|
increased susceptibility to Retroviridae infection
|
J:167666
|
Mst1rtm1Ber/Mst1rtm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased susceptibility to bacterial infection
|
J:76451
|
Mst1rtm1Sjd/Mst1r+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1) or (involves: 129 * NIH Black Swiss))
|
increased susceptibility to bacterial infection
|
J:54903
|
Mst1rtm2(Mst1r*)Sew/Mst1rtm2(Mst1r*)Sew
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
increased susceptibility to Retroviridae infection
|
J:215969
|
Muc4PWK/PhJ/Muc4PWK/PhJ
(PWK/PhJ)
|
abnormal susceptibility to viral infection
|
J:287566
|
Muc4tm1Unc/Muc4tm1Unc
(B6NTac.129(FVB)-Muc4tm1Unc/Rand)
|
increased susceptibility to Coronaviridae infection
|
J:287566
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:287566
|
increased susceptibility to Togaviridae infection
|
J:287566
|
Muc5actm1.1Evns/Muc5actm1.1Evns
(B6.129S1-Muc5actm1.1Evns)
|
increased susceptibility to parasitic infection
|
J:177306
|
Muc5btm1.2Evns/Muc5btm1.2Evns
(B6.129S1-Muc5btm1.2Evns)
|
increased susceptibility to bacterial infection
|
J:207159
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:207159
|
sepsis
|
J:207159
|
Mx1r/Mx1r
(B6.A2G-Mx1r)
|
abnormal susceptibility to infection
|
J:120938
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:23752
|
Mx1r/Mx1r
(C.A2G-Mx1r)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:23752
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:23752
|
Mx1r/Mx1r
(A2G)
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:23752
|
Mx1s1/Mx1s1
(BALB/c)
|
increased susceptibility to Orthomyxoviridae infection
|
J:23752
|
Mx1s1/Mx1s1
(C57BL/6)
|
abnormal susceptibility to infection
|
J:120938
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:23752
|
Mx1s1/Mx1s1 Tg(Hmgcr-MX1)LStae/?
(involves: C57BL/6 * SJL)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:128067
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:128067
|
decreased susceptibility to Riboviria infection
|
J:128067
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:128067
|
Mx1s2/Mx1s2
(CBA/J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:23752
|
Mxra8em1Diam/Mxra8+
(C57BL/6J-Mxra8em1Diam)
|
decreased susceptibility to Togaviridae infection
|
J:280585
|
Mxra8em1Diam/Mxra8em1Diam
(C57BL/6J-Mxra8em1Diam)
|
decreased susceptibility to Togaviridae infection
|
J:280585
|
Mxra8em2Diam/Mxra8em2Diam
(C57BL/6J-Mxra8em2Diam)
|
decreased susceptibility to Togaviridae infection
|
J:280585
|
Mycltm1.1Kmm/Mycltm1.1Kmm
(B6.129S6(C)-Mycltm1.1Kmm)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:206430
|
Myd88poc/Myd88poc
(C57BL/6-Myd88poc)
|
increased susceptibility to bacterial infection
|
J:110094
|
increased susceptibility to Herpesvirales infection
|
J:110094
|
Myd88tm1.1Defr/Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
increased susceptibility to Coronaviridae infection
|
J:224849
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:224849
|
Myd88tm1Aki/Myd88tm1Aki
(Not Specified)
|
increased susceptibility to Herpesvirales infection
|
J:88906
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
abnormal response to infection
|
J:121070
|
decreased susceptibility to parasitic infection
|
J:116763
|
increased susceptibility to Coronaviridae infection
|
J:162707
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:162707
|
increased susceptibility to Picornaviridae infection
|
J:97662
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:210086
|
increased susceptibility to Picornaviridae infection
|
J:137522
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129-Myd88tm1Aki)
|
abnormal susceptibility to bacterial infection
|
J:189854
|
Myd88tm1Aki/Myd88tm1Aki Ticam1tm1Aki/Ticam1+
(B6.129P2-Myd88tm1Aki Ticam1tm1Aki)
|
increased susceptibility to parasitic infection
|
J:140485
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:140485
|
Myd88tm1Aki/Myd88tm1Aki Ticam1tm1Aki/Ticam1tm1Aki
(B6.129P2-Myd88tm1Aki Ticam1tm1Aki)
|
increased susceptibility to parasitic infection
|
J:140485
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:140485
|
mypy/mypy
(C57BL/6J-mypy)
|
increased susceptibility to Herpesvirales infection
|
J:105543
|
increased susceptibility to Riboviria infection
|
J:105543
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:297419
|
Naip5Lgn1-s/Naip5Lgn1-s
(A/J)
|
increased susceptibility to bacterial infection
|
J:20633
|
Ncf1m1J/Ncf1m1J
(B6.Cg-Dock7m +/+ Leprdb/J)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:145306
|
Ncf1tm1Shl/Ncf1tm1Shl
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal response to infection
|
J:28267
|
increased susceptibility to infection
|
J:28267
|
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi)
|
increased susceptibility to fungal infection
|
J:260777
|
Ncf4tm1Pth/Ncf4tm2Pth
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:119217
|
Ncf4tm2Pth/Ncf4tm2Pth
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:121820
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:120086
|
Ncr1m1J/Ncr1m1J Pepcb/Pepcb Ptprca/Ptprca
(B6.SJL-Ptprca Pepcb/BoyJ)
|
abnormal susceptibility to infection induced morbidity/mortality
|
J:257226
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:257226
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:257226
|
Ncr1noe/Ncr1noe
(involves: C57BL/6J)
|
decreased susceptibility to Herpesvirales infection
|
J:179728
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:179728
|
increased susceptibility to bacterial infection
|
J:179728
|
Ncr1tm1.1(icre)Viv/Ncr1tm1.1(icre)Viv
(involves: C57BL/6)
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:179728
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:179728
|
Ncr1tm1Oman/Ncr1tm1Oman
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:112394
|
Ndst2tm1Rls/Ndst2tm1Rls
(Not Specified)
|
abnormal response to infection
|
J:57120
|
Nedd9m1Btlr/Nedd9m1Btlr
(C57BL/6J-Nedd9m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:267702
|
Neurl3em1Luda/Neurl3em1Luda
(B6N.Cg-Neurl3em1Luda)
|
increased susceptibility to Riboviria infection
|
J:344721
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:344721
|
Nfatc2iptm1.1Glm/Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
increased susceptibility to parasitic infection
|
J:157559
|
Nfe2tm1Sho/Nfe2+
(C.129S4-Nfe2tm1Sho)
|
increased susceptibility to Retroviridae infection
|
J:125982
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:213427
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:37184
|
increased susceptibility to bacterial infection
|
J:37184,
J:67107
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:37184
|
Nfkb1tm1Bal/Nfkb1tm1Bal Relatm1Bal/Rela+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:67107
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:46912
|
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:45437
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:163686
|
Nfkbibtm1.2Rsch/Nfkbibtm1.2Rsch
(B6.129P2-Nfkbibtm1.2Rsch)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:176877
|
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:163302
|
Nkg7tm1.1(KOMP)Vlcg/Nkg7tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:301637
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:301637
|
Nlrc4em1Vnce/Nlrc4em1Vnce
(C57BL/6-Nlrc4em1Vnce)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:294930
|
Nlrc4tm1Gln/Nlrc4tm1Gln Slc11a1s/Slc11a1s
(B6.129S5-Nlrc4tm1Gln)
|
increased susceptibility to bacterial infection
|
J:124378
|
Nlrc4tm1Nnz/Nlrc4tm1Nnz
(involves: 129 * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:117251
|
Nlrc4tm1Vmd/Nlrc4tm1Vmd
(involves: C57BL/6N)
|
abnormal response to infection
|
J:106976
|
Nlrp3tm1Flv/Nlrp3tm1Flv Slc11a1s/Slc11a1s
(B6.129S5-Nlrp3tm1Flv)
|
increased susceptibility to bacterial infection
|
J:124378
|
Nlrp3tm1Vmd/Nlrp3tm1Vmd
(involves: C57BL/6N)
|
abnormal response to infection
|
J:106976
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:243487
|
Nlrp9bem1Flv/Nlrp9bem1Flv
(C57BL/6N-Nlrp9bem1Flv)
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:243487
|
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:173995
|
Nmiem1Hhl/Nmiem1Hhl
(C57BL/6-Nmiem1Hhl)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:298909
|
Nod1tm1Inoh/Nod1tm1Inoh Nod2tm1Flv/Nod2tm1Flv
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:132126
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal susceptibility to infection
|
J:96035
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv)
|
abnormal response to infection
|
J:147177
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:147177
|
Nod2tm1Jhgt/Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
abnormal response to infection
|
J:124575
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:100513
|
Nos2tm1Liew/Nos2tm1Liew
(involves: 129P2/Ola * MF1)
|
increased susceptibility to parasitic infection
|
J:25755
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
increased susceptibility to bacterial infection
|
J:25511
|
Nos2tm1Mrl/Nos2tm1Mrl
(B6.129S7-Nos2tm1Mrl)
|
abnormal response to infection
|
J:98070
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:105005
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:105005
|
Notch1tm1Agt/Notch1tm1Agt Notch2tm3Grid/Notch2tm3Grid Tg(TcrAND)53Hed/?
(involves: 129/Sv * 129S1/Sv * C57BL/6 * SJL)
|
abnormal response to infection
|
J:123631
|
Notch2tm1.1Hhi/Notch2tm1.1Hhi Tg(Cd8a-cre)1Itan/0
(involves: C57BL/6 * CBA)
|
increased susceptibility to parasitic infection
|
J:141009
|
Nr1h2tm1Djm/Nr1h2tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:81696
|
Nr1h2tm1Djm/Nr1h2tm1Djm Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:81696
|
Nr1h3tm1Djm/Nr1h3tm1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:81696
|
Nrrostm1Lex/Nrrostm1Lex
(B6.129S5-Nrrostm1Lex)
|
decreased susceptibility to infection
|
J:209569
|
Nsv1C57BL/6J/?
(involves: BALB/cBy * C57BL/6J)
|
increased susceptibility to viral infection
|
J:71216
|
Oas1bFlv-mr/Oas1bFlv-mr
(MOLD/RkJ)
|
decreased susceptibility to Flaviviridae infection
|
J:3674
|
Oas1bFlv-r/Oas1bFlv-r
(multiple strains)
|
decreased susceptibility to Flaviviridae infection
|
J:15009
|
Oas1bFlv-r/Oas1bFlv-r
(C3.PRI-Oas1bFlv-r)
|
decreased susceptibility to Flaviviridae infection
|
J:175365
|
Oas1bFlv-s/Oas1bFlv-s
(multiple strains)
|
increased susceptibility to Flaviviridae infection
|
J:15009
|
Oas1btm1.1Brin/Oas1btm1.1Brin
(involves: 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to Flaviviridae infection
|
J:175365
|
Oasl1tm1Yjk/Oasl1tm1Yjk
(B6.129P2-Oasl1tm1Yjk)
|
decreased susceptibility to Picornaviridae infection
|
J:194467
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:194467
|
Oca2p-3Btlr/Oca2p-3Btlr
(C57BL/6J-Oca2p-3Btlr)
|
increased susceptibility to bacterial infection
|
J:133623
|
Oca2p-4Btlr/Oca2p-4Btlr
(C57BL/6J-Oca2p-4Btlr)
|
increased susceptibility to bacterial infection
|
J:133624
|
Olahem1Kedk/Olahem1Kedk
(involves: C57BL/6)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:353571
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:353571
|
Olfm4tm1Gpro/Olfm4tm1Gpro
(involves: 129X1/SvJ * Black Swiss)
|
increased susceptibility to bacterial infection
|
J:161279
|
Otcspf-ash/Y
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:23205
|
Otud1em2Gpt/Otud1em2Gpt
(C57BL/6-Otud1em2Gpt)
|
decreased susceptibility to Herpesvirales infection
|
J:287309
|
decreased susceptibility to Riboviria infection
|
J:287309
|
Otud3em1Nju/Otud3em1Nju
(involves: C57BL/6N)
|
decreased susceptibility to Riboviria infection
|
J:294274
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:294274
|
Otud6aem1Smoc/Otud6aem1Smoc
(C57BL/6J-Otud6aem1Smoc)
|
decreased susceptibility to Herpesvirales infection
|
J:345141
|
decreased susceptibility to Riboviria infection
|
J:345141
|
Otud7btm1Dgen/Otud7btm1Dgen
(involves: 129 * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:194553
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:194553
|
Padi4tm1.1Kmow/Padi4tm1.1Kmow
(involves: BALB/cJ * C57BL/6)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:174934
|
Padi4tm1.1Ywan/Padi4tm1.1Ywan
(involves: 129S4/SvJae)
|
increased susceptibility to bacterial infection
|
J:165718
|
Parp9tm1.2Arte/Parp9tm1.2Arte
(involves: C57BL/6N * FVB/N)
|
abnormal response to infection
|
J:306337
|
Pdcd1lg2tm1Shr/Pdcd1lg2tm1Shr
(involves: 129/Sv * 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:113851
|
Pdlim2tm1Gru/Pdlim2tm1Gru
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:99108
|
Peli3tm1.1Arte/Peli3tm1.1Arte
(involves: C57BL/6NTac)
|
decreased susceptibility to Picornaviridae infection
|
J:188556
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:188556
|
Pgap4em1Osbir/Pgap4em1Osbir
(involves: C57BL/6NSlc)
|
increased susceptibility to infection induced morbidity/mortality
|
J:333707
|
increased susceptibility to prion infection
|
J:333707
|
Pglyrp1tm1.1Lky/Pglyrp1tm1.1Lky
(B6.129S4-Pglyrp1tm1.1Lky)
|
increased susceptibility to bacterial infection
|
J:171412
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(involves: 129S5/SvEvBrd)
|
increased susceptibility to bacterial infection
|
J:84680
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:84680
|
Pglyrp2tm1Lky/Pglyrp2tm1Lky
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:159600
|
Pias1tm1Kes/Pias1tm1Kes
(involves: 129S/Sv * C57BL/6)
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:92167
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:92167
|
Pigrtm1Fejo/Pigrtm1Fejo
(involves: 129 * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:140515
|
Pigrtm1Ohw/Pigrtm1Ohw
(B6.129X1-Pigrtm1Ohw)
|
increased susceptibility to bacterial infection
|
J:108538
|
Pik3cdm2Btlr/Pik3cdm2Btlr
(C57BL/6J-Pik3cdm2Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:236693
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
abnormal response to infection
|
J:131923
|
increased susceptibility to Poxviridae infection
|
J:131923
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal response to infection
|
J:131923
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(either: 129/Sv-Pik3cgtm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased susceptibility to bacterial infection
|
J:60349
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
increased susceptibility to bacterial infection
|
J:52228
|
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:191085
|
Pilrb1tm1Pgh/Pilrb1tm1Pgh
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:157763
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:157763
|
Pitm1C57BL/FaDk/Pitm1C57BL/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm1C57BL/FaDk/Pitm1RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm2C57BL/FaDk/Pitm2C57BL/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm2C57BL/FaDk/Pitm2RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm3C57BL/FaDk/Pitm3C57BL/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm3C57BL/FaDk/Pitm3RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm4C57BL/FaDk/Pitm4C57BL/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pitm4C57BL/FaDk/Pitm4RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:70033
|
Pklrchar4/Pklrchar4
(involves: A/J * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:141722,
J:86735
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:141722
|
Pklrslc/Pklrslc
(CBA/NSlc-Pklrslc)
|
decreased susceptibility to parasitic infection
|
J:141722
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:141722
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:128518
|
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
decreased susceptibility to Coronaviridae infection
|
J:229035
|
decreased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:229035
|
Pla2g7tm1.1Mcap/Pla2g7tm1.1Mcap
(B6.Cg-Pla2g7tm1.1Mcap)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:228564
|
increased susceptibility to bacterial infection
|
J:228564
|
Plac8tm1Bhk/Plac8tm1Bhk
(129S/SvEv-Plac8tm1Bhk)
|
increased susceptibility to bacterial infection
|
J:145277
|
Plattm1Mlg/Plattm1Mlg
(B6.129S2-Plattm1Mlg/J)
|
abnormal susceptibility to Coronaviridae infection
|
J:288556
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:288556
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to fungal infection
|
J:95637
|
increased susceptibility to parasitic infection
|
J:87817
|
Plaurtm1Mlg/Plaurtm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:75573
|
Plcb2tm1Dwu/Plcb2tm1Dwu
(involves: 129)
|
decreased susceptibility to bacterial infection
|
J:41948
|
decreased susceptibility to infection
|
J:41948
|
decreased susceptibility to viral infection
|
J:41948
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Herpesvirales infection
|
J:100716
|
Plekha7tm1.1Janc/Plekha7tm1.1Janc
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:227858
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:227858
|
Plekhf1tm1.1Caox/Plekhf1tm1.1Caox Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Plekhf1tm1.1Caox Lyz2tm1(cre)Ifo)
|
increased susceptibility to bacterial infection
|
J:277440
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:277440
|
Plekhm2tm1a(EUCOMM)Wtsi/Plekhm2tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:233985
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:233985
|
Plgr1BALB/cJ/Plgr1BALB/cJ
(involves: BALB/cJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:138895
|
Plgr1BALB/cJ/Plgr1BALB/cJ
(B6.C-Plgr1BALB/cJ)
|
decreased susceptibility to bacterial infection
|
J:138895
|
Plgr1BALB/cJ/Plgr1C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:138895
|
Plgr1BALB/cJ/Plgr1C57BL/6J
(B6.C-Plgr1BALB/cJ)
|
decreased susceptibility to bacterial infection
|
J:138895
|
Plp1jp-rsh/Plp1jp-rsh
(involves: 101/H * C3H)
|
decreased susceptibility to Picornaviridae infection
|
J:41447
|
Pmltm1Ppp/Pmltm1Ppp
(involves: 129S7/SvEvBrd)
|
increased susceptibility to bacterial infection
|
J:46381
|
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg)
|
increased susceptibility to bacterial infection
|
J:116935
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:123039
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:74284
|
Ppp1r14ctm1Uhl/Ppp1r14ctm1Uhl
(B6;129S6-Ppp1r14ctm1Uhl/J)
|
increased susceptibility to Coronaviridae infection
|
J:288523
|
Prdm1tm2.1Nutt/Prdm1tm2.1Nutt Tg(Lck-cre)1Cwi/?
(involves: C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:151858
|
Prdt1CAST/EiJH/Prdt1CAST/EiJH
(involves: CAST/Ei * NZW/OlaHsd)
|
decreased susceptibility to prion infection
|
J:80787
|
Prdt1NZW/OlaHsd/Prdt1NZW/OlaHsd
(involves: CAST/Ei * NZW/OlaHsd)
|
increased susceptibility to prion infection
|
J:80787
|
Prdt3CAST/EiJH/Prdt3CAST/EiJH
(involves: CAST/Ei * NZW/OlaHsd)
|
decreased susceptibility to prion infection
|
J:80787
|
Prdt3NZW/OlaHsd/Prdt3NZW/OlaHsd
(involves: CAST/Ei * NZW/OlaHsd)
|
increased susceptibility to prion infection
|
J:80787
|
Prf1m1Btlr/Prf1m1Btlr
(C57BL/6J-Prf1m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:216044
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:216044
|
Prf1tm1Clrk/Prf1tm1Clrk
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:21531
|
Prf1tm1Clrk/Prf1tm1Clrk
(C.129S7(B6)-Prf1tm1Clrk)
|
increased susceptibility to Riboviria infection
|
J:71576
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz)
|
increased susceptibility to bacterial infection
|
J:123934
|
increased susceptibility to infection
|
J:17986
|
increased susceptibility to parasitic infection
|
J:81397
|
increased susceptibility to Riboviria infection
|
J:17986
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
increased susceptibility to Picornaviridae infection
|
J:120427
|
increased susceptibility to Riboviria infection
|
J:92260,
J:193137
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:92260
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:193137
|
Prf1tm1Tsc/Prf1tm1Tsc
(involves: 129S2/SvPas)
|
decreased susceptibility to bacterial infection
|
J:50903
|
Prkcetm1Bsca/Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:103337
|
Prkcqtm1Litt/Prkcqtm1Litt
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal response to infection
|
J:141930
|
Prkdcscid/Prkdcscid Sst1C57BL/6J/Sst1C57BL/6J
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:93705
|
Prmt9em1Cya/Prmt9em1Cya Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased susceptibility to viral infection
|
J:328263
|
Prnpa/Prnpa
(NZW)
|
increased susceptibility to prion infection
|
J:8918
|
Prnpb/Prnpb
(I/LnJ)
|
decreased susceptibility to prion infection
|
J:8918
|
Prnpc/Prnpc
(MAI/Pas)
|
decreased susceptibility to prion infection
|
J:90099
|
Prnptm1(PRNP)Tkit/Prnptm1(PRNP)Tkit
(Not Specified)
|
decreased susceptibility to prion infection
|
J:86603
|
increased susceptibility to prion infection
|
J:86603
|
Prnptm1Cwe/Prnptm1Cwe Tg(Nefh-cre)22Jcol/? Tg(Prnp)37Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased susceptibility to prion infection
|
J:126424
|
Prnptm1Cwe/Prnptm1Cwe Tg(Nefh-cre)22Jcol/? Tg(Prnp)46Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
decreased susceptibility to prion infection
|
J:74652
|
Prnptm1Cwe/Prnptm1Cwe Tg(PRNP)35Jcol/Tg(PRNP)35Jcol
(involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased susceptibility to prion infection
|
J:131494
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)37Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
increased susceptibility to prion infection
|
J:74652,
J:126424
|
Prnptm1Cwe/Prnptm1Cwe Tg(PRNP)45Jcol/Tg(PRNP)45Jcol
(involves: 129 * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
increased susceptibility to prion infection
|
J:131494
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)4053Sbp/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased susceptibility to prion infection
|
J:136434
|
Prnptm1Cwe/Prnptm1Cwe Tg(PRNP)23454Sbp/0
(involves: 129S7/SvEvBrd * FVB/N)
|
increased susceptibility to prion infection
|
J:236012
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)a19Cwe/0
(Not Specified)
|
increased susceptibility to prion infection
|
J:32214
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)a20Cwe/0
(Not Specified)
|
increased susceptibility to prion infection
|
J:32214
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp)c35Cwe/0
(Not Specified)
|
increased susceptibility to prion infection
|
J:32214
|
Prnptm1Cwe/Prnptm1Cwe Tg(Prnp*S170N*N174T)1020Aag/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to prion infection
|
J:143528
|
Prnptm1Edin/Prnptm1Edin
(129P2/OlaHsd-Prnptm1Edin/EdinH)
|
abnormal susceptibility to prion infection
|
J:58820
|
Prnptm1Lnq/Prnptm1Lnq
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased susceptibility to prion infection
|
J:154937
|
Prnptm1Miy/Prnptm1Miy
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to prion infection
|
J:69186
|
Prnptm1Rcm/Prnptm1Rcm
(129P2/OlaHsd-Prnptm1Rcm)
|
abnormal susceptibility to prion infection
|
J:45908
|
Prnptm1Tuzi/Prnp+
(involves: 129P2/OlaHsd)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm1Tuzi/Prnptm2Edin
(involves: 129P2/OlaHsd)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm1Tuzi/Prnptm2Edin Tg(CMV-cre)1Cgn/?
(involves: 129P2/OlaHsd * BALB/cJ)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm2(PRNP*129M)Tkit/Prnptm2(PRNP*129M)Tkit
(Not Specified)
|
decreased susceptibility to prion infection
|
J:126777,
J:105882
|
increased susceptibility to prion infection
|
J:126777,
J:105882
|
Prnptm2(PRNP*129M)Tkit/Prnptm2(PRNP*129M)Tkit Tg(Prnp-PRNP*129M)1Tkit/?
(Not Specified)
|
decreased susceptibility to prion infection
|
J:126777
|
increased susceptibility to prion infection
|
J:126777
|
Prnptm2(PRNP*129M)Tkit/Prnptm3(PRNP*129V)Tkit
(Not Specified)
|
decreased susceptibility to prion infection
|
J:105882
|
Prnptm2Tuzi/Prnp+ Tg(CMV-cre)1Cgn/?
(involves: 129P2/OlaHsd * BALB/cJ)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm2Tuzi/Prnptm2Edin
(involves: 129P2/OlaHsd)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm2Tuzi/Prnptm2Edin Tg(CMV-cre)1Cgn/?
(involves: 129P2/OlaHsd * BALB/cJ)
|
decreased susceptibility to prion infection
|
J:92302
|
Prnptm3(PRNP*129V)Tkit/Prnptm3(PRNP*129V)Tkit
(Not Specified)
|
decreased susceptibility to prion infection
|
J:126777,
J:105882
|
increased susceptibility to prion infection
|
J:126777
|
Prnptm3(PRNP*129V)Tkit/Prnptm3(PRNP*129V)Tkit Tg(Prnp-PRNP*129V)139Tkit/?
(Not Specified)
|
abnormal susceptibility to infection
|
J:126777
|
decreased susceptibility to prion infection
|
J:105882
|
Prnptm3(PRNP*129V)Tkit/Prnptm3(PRNP*129V)Tkit Tg(Prnp-PRNP*129V)144Tkit/?
(Not Specified)
|
decreased susceptibility to prion infection
|
J:105882
|
Prnptm4(PRNP)Tkit/Prnptm4(PRNP)Tkit
(Not Specified)
|
increased susceptibility to prion infection
|
J:105882
|
Prnptm4(PRNP)Tkit/Prnptm4(PRNP)Tkit Tg(Prnp-PRNP)32Tkit/?
(Not Specified)
|
increased susceptibility to prion infection
|
J:105882
|
Prnptm5(PRNP*)TKit/Prnptm5(PRNP*)TKit Tg(Prnp-PRNP*)1Tkit/?
(Not Specified)
|
decreased susceptibility to prion infection
|
J:126777
|
increased susceptibility to prion infection
|
J:126777
|
Prnr1RIII/FaDk/Prnr1RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:89558
|
Prnr2C57BL/FaDk/Prnr2C57BL/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:89558
|
Prnr2C57BL/FaDk/Prnr2RIII/FaDk
(involves: C57BL/FaDk * RIII/FaDk)
|
decreased susceptibility to prion infection
|
J:89558
|
Pscr1DBA/2/Pscr1DBA/2
(involves: BALB/c * DBA/2)
|
decreased susceptibility to bacterial infection
|
J:8914
|
Pscr1DBA/2/Pscr1DBA/2 Pscr2DBA/2/Pscr2DBA/2 Pscr3DBA/2/Pscr3DBA/2
(involves: C57BL/6 * DBA/2)
|
decreased susceptibility to bacterial infection
|
J:8914
|
Pscr2DBA/2/Pscr2DBA/2
(involves: BALB/c * DBA/2)
|
decreased susceptibility to bacterial infection
|
J:8914
|
Pscr3DBA/2/Pscr3DBA/2
(involves: BALB/c * DBA/2)
|
decreased susceptibility to bacterial infection
|
J:8914
|
Psmb9tm1Stl/Psmb9tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Orthomyxoviridae infection
|
J:21549
|
Psmb10Tub6/Psmb10+
(C3HeB/FeJ-Psmb10Tub6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:261081
|
Psme3tm1Jjm/Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
increased susceptibility to fungal infection
|
J:88626
|
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:87866
|
Ptafrtm1Tksh/Ptafrtm1Tksh
(C57BL/6-Ptafrtm1Tksh)
|
decreased susceptibility to bacterial infection
|
J:88589
|
Ptentm1Hwu/Ptentm1Hwu Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased susceptibility to bacterial infection
|
J:148947
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:148947
|
increased susceptibility to bacterial infection
|
J:148947
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:148947
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Coronaviridae infection
|
J:243958
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:243958
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
abnormal response to infection
|
J:82750
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal response to infection
|
J:120725
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal response to infection
|
J:164638
|
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna)
|
abnormal response to infection
|
J:82750
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal response to infection
|
J:120725
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal response to infection
|
J:140698
|
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
decreased susceptibility to bacterial infection
|
J:142845
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:142845
|
Ptpn13tm1Gru/Ptpn13tm1Gru
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:118426
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
increased susceptibility to Herpesvirales infection
|
J:214487
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal response to infection
|
J:13163
|
Ptprz1tm1Mno/Ptprz1tm1Mno
(B6.129-Ptprz1tm1Mno)
|
decreased susceptibility to bacterial infection
|
J:85826
|
Ptx3tm1Mant/Ptx3tm1Mant
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased susceptibility to bacterial infection
|
J:85080
|
increased susceptibility to fungal infection
|
J:85080
|
Ptx3tm1Zuk/Ptx3tm1Zuk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to Coronaviridae infection
|
J:188421
|
Pvrtm1Gbn/Pvrtm1Gbn
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * BALB/c))
|
abnormal response to infection
|
J:123540
|
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to Herpesvirales infection
|
J:158969
|
Pycardtm1Flv/Pycardtm1Flv Slc11a1s/Slc11a1s
(B6.129S5-Pycardtm1Flv)
|
increased susceptibility to bacterial infection
|
J:124378
|
Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal response to infection
|
J:106976
|
Pymr129X1/SvJMs/PymrNC/JicJcl
(involves: 129X1/SvJMs * NC/JicJcl)
|
decreased susceptibility to parasitic infection
|
J:92924
|
PymrNC/JicJcl/PymrNC/JicJcl
(involves: 129X1/SvJMs * NC/JicJcl)
|
increased susceptibility to parasitic infection
|
J:92924
|
Rab27aash/Rab27aash
(B6.C3Sn-Rab27aash)
|
increased susceptibility to Riboviria infection
|
J:193137
|
Rab32tm1c(KOMP)Wtsi/Rab32tm1c(KOMP)Wtsi Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)
|
increased susceptibility to bacterial infection
|
J:231298,
J:267497
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:53362
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal response to infection
|
J:119344
|
Rag1tm1Mom/Rag1tm1Mom Vtcn1tm1Lpc/Vtcn1tm1Lpc
(involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:145712
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:145712
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
increased susceptibility to infection
|
J:1935
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:140483
|
increased susceptibility to bacterial infection
|
J:140483
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:64283
|
Rag2tm1Fwa/Rag2tm1Fwa Cd47tm1Fpl/Cd47tm1Fpl Il2rgtm1Cgn/Y
(involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to Retroviridae infection
|
J:203904
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraCN.B1,TcrbCN.B1)SM1Jen/0
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:162539
|
Raph1tm1.2Fbg/Raph1tm1.2Fbg
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:238262
|
Rasa4tm1Ywh/Rasa4tm1Ywh
(B6.129S6-Rasa4tm1Ywh)
|
increased susceptibility to bacterial infection
|
J:100455
|
Rbpjtm1Kyo/Rbpjtm1Kyo
(involves: 129S2/SvPas)
|
abnormal response to infection
|
J:123631
|
Rc3h1san/Rc3h1san Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
increased susceptibility to bacterial infection
|
J:196137
|
Rdh7tm1c(KOMP)Wtsi/Rdh7tm1c(KOMP)Wtsi Tg(RARE-Hspa1b/lacZ)12Jrt/0 Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * C57BL/6N * CD-1 * SJL)
|
decreased susceptibility to bacterial infection
|
J:279231
|
Rdurem1Jiche/Rdurem1Jiche
(Not Specified)
|
increased susceptibility to viral infection
|
J:340209
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:340209
|
Reg3gtm1a(KOMP)Wtsi/Reg3gtm1a(KOMP)Wtsi
(C57BL/6-Reg3gtm1a(KOMP)Wtsi)
|
increased susceptibility to Orthomyxoviridae infection
|
J:233979
|
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:46911
|
Reltm1Grd/Reltm1Grd
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:37541
|
Relatm1Rsch/Relatm1Rsch Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
increased susceptibility to bacterial infection
|
J:169863
|
Relbtm1.1Fwei/Relbtm1.1Fwei Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
increased susceptibility to bacterial infection
|
J:169863
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:40630
|
increased susceptibility to Riboviria infection
|
J:40630
|
Retnlbtm1Mer/Retnlbtm1Mer
(involves: 129S1/Sv)
|
decreased susceptibility to parasitic infection
|
J:141446
|
Rfx7tm1.1Ggaur/Rfx7tm1.1Ggaur Ncr1tm1.1(icre)Viv/Ncr1+
(involves: C57BL/6)
|
increased susceptibility to viral infection
|
J:282535
|
Rgs16tm1.1Drue/Rgs16tm1.1Drue
(involves: C57BL/6)
|
increased susceptibility to parasitic infection
|
J:188966
|
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(B6.129P2-Rhbdf2tm1Mak)
|
decreased susceptibility to infection induced morbidity/mortality
|
J:179653
|
increased susceptibility to bacterial infection
|
J:179653
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:179653
|
Rhs1C57BL/6/Rhs1C57BL/6
(involves: BALB/c * C57BL/6)
|
decreased susceptibility to Herpesvirales infection
|
J:69352
|
Rif1Gt(XT0278)Wtsi/Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
increased susceptibility to bacterial infection
|
J:195061
|
Rigitm1Aki/Rigitm1Aki
(involves: 129/Sv * C57BL/6 * ICR)
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:137522
|
Rinltm1.1Boun/Rinltm1.1Boun
(B6.Cg-Rinltm1.1Boun)
|
abnormal susceptibility to Riboviria infection
|
J:346452
|
Ripk2tm1Ghc/Ripk2tm1Ghc
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to infection
|
J:75401
|
Rmcfr/Rmcfr
(DBA/1J)
|
decreased susceptibility to Retroviridae infection
|
J:7108
|
Rmcfr/Rmcfr
(DBA/2J)
|
decreased susceptibility to Retroviridae infection
|
J:7108
|
Rmcfr/Rmcfr
(CBA/N)
|
decreased susceptibility to Retroviridae infection
|
J:7108
|
Rmcfs/Rmcfs
(CBA/J)
|
increased susceptibility to Retroviridae infection
|
J:7108
|
Rmcfs/Rmcfs
(C57L/J)
|
increased susceptibility to Retroviridae infection
|
J:7108
|
Rmcfs/Rmcfs
(C57BR/cdJ)
|
increased susceptibility to Retroviridae infection
|
J:7108
|
Rmp1DBA/2J/Rmp1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to Poxviridae infection
|
J:28150
|
Rmp2DBA/2J/Rmp2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to Poxviridae infection
|
J:11032
|
Rmp3DBA/2J/Rmp3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to Poxviridae infection
|
J:11032
|
Rmp4C57BL/6NCr/Rmp4C57BL/6NCr
(involves: C57BL/6NCr * DBA/2NCr)
|
decreased susceptibility to Poxviridae infection
|
J:29241
|
Rmp5C57BL/6NCr/Rmp5C57BL/6NCr
(involves: C57BL/6NCr * DBA/2NCr)
|
decreased susceptibility to Poxviridae infection
|
J:3240
|
Rmp6C57BL/6NCr/Rmp6C57BL/6NCr
(involves: C57BL/6NCr * DBA/2NCr)
|
decreased susceptibility to Poxviridae infection
|
J:3240
|
Rnaseh2atm1Crh/Rnaseh2atm1Crh
(Not Specified)
|
decreased susceptibility to Riboviria infection
|
J:232933
|
Rnaseltm1Slvm/Rnaseltm1Slvm
(involves: 129P2/OlaHsd)
|
increased susceptibility to Picornaviridae infection
|
J:44292
|
Rnf115em1Gpt/Rnf115em1Gpt
(C57BL/6JGpt-Rnf115em1Gpt/Gpt)
|
decreased susceptibility to viral infection
|
J:297834
|
decreased susceptibility to viral infection induced morbidity/mortality
|
J:297834
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:297834
|
Rnf122em1Caox/Rnf122em1Caox
(involves: C57BL/6J)
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:344769
|
Rnf123em1Nmea/Rnf123em1Nmea
(NC/Jic-Rnf123em1Nmea)
|
decreased susceptibility to parasitic infection
|
J:327312
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:327312
|
Rnf123em2Nmea/Rnf123em2Nmea
(NC/Jic-Rnf123em2Nmea)
|
decreased susceptibility to parasitic infection
|
J:327312
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:327312
|
Rnf144aem1Smoc/Rnf144aem1Smoc
(C57BL/6J-Rnf144aem1Smoc/Smoc)
|
increased susceptibility to Herpesvirales infection
|
J:347002
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:347002
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection
|
J:158663
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:158663
|
Rr169tm2Rao/Rr169tm2Rao
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased susceptibility to parasitic infection
|
J:94039
|
Rr253em1Kmm/Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:316113
|
Rr253em6Kmm/Rr253em6Kmm
(C57BL/6J-Rr253em6Kmm)
|
increased susceptibility to parasitic infection induced morbidity/mortality
|
J:334296
|
Rr250409tm1Lky/Rr250409tm1Lky
(involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB)
|
abnormal response to infection
|
J:125684
|
decreased susceptibility to parasitic infection
|
J:125684
|
Rtp4em#Xzs/Rtp4em#Xzs
(involves: C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:293929
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:293929
|
decreased susceptibility to viral infection
|
J:293929
|
S100a9tm1Nck/S100a9tm1Nck
(B6.129P2-S100a9tm1Nck)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:125179
|
decreased susceptibility to fungal infection
|
J:209808
|
Samd9ltm1Homy/Samd9l+
(involves: 129P2/OlaHsd)
|
increased susceptibility to Retroviridae infection
|
J:202604
|
Samd9ltm1Homy/Samd9ltm1Homy
(involves: 129P2/OlaHsd)
|
increased susceptibility to Retroviridae infection
|
J:202604
|
Samhd1tm1.2Crs/Samhd1tm1.2Crs
(involves: C57BL/6N * C57BL/6NTac)
|
increased susceptibility to Retroviridae infection
|
J:201909
|
Samhd1tm1d(EUCOMM)Wtsi/Samhd1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal response to infection
|
J:202757
|
Samhd1tm2.2Crs/Samhd1tm2.2Crs
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased susceptibility to Retroviridae infection
|
J:201909
|
Sarm1tm1.1Diam/Sarm1tm1.1Diam
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to Flaviviridae infection
|
J:200140
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:200140
|
Scd1flk/Scd1flk
(C57BL/6J-Scd1flk)
|
increased susceptibility to bacterial infection
|
J:100424
|
Scl2C57BL/6J/Scl2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to parasitic infection
|
J:12046
|
Sdc1tm1Cma/Sdc1tm1Cma
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:69845
|
Sdc1tm1Cma/Sdc1tm1Cma
(B6.Cg-Sdc1tm1Cma)
|
decreased susceptibility to bacterial infection
|
J:104294
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:104294
|
Sdc1tm1Cma/Sdc1tm1Cma
(involves: 129S4/SvJae)
|
increased susceptibility to parasitic infection
|
J:107378
|
Sec1em1Cya/Sec1em1Cya
(C57BL/6-Sec1em1Cya)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:325740
|
Seletm1Alb/Seletm1Alb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:101979
|
Seletm1Hyn/Seletm1Hyn Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
increased susceptibility to bacterial infection
|
J:31626
|
Seletm2Alb/Seletm2Alb Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:101979
|
Selenoktm1.2Itl/Selenoktm1.2Itl
(involves: BALB/cJ * C57BL/6)
|
increased susceptibility to Flaviviridae infection
|
J:169169
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:169169
|
Selenoptm1Rfb/Selenoptm1Rfb
(B6.129-Selenoptm1Rfb)
|
increased susceptibility to parasitic infection
|
J:134536
|
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:101979
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp
(involves: C57BL/6)
|
abnormal response to infection
|
J:189782
|
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben)
|
increased susceptibility to bacterial infection
|
J:125918
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:125918
|
sepsis
|
J:125918
|
Serpinb9tm1Arp/Serpinb9tm1Arp
(involves: C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:113349
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(B6.129S2-Serpine1tm1Mlg/J)
|
increased susceptibility to bacterial infection
|
J:124327
|
increased susceptibility to Coronaviridae infection
|
J:288556
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:288556
|
Sertad3em1Bcgen/Sertad3em1Bcgen
(involves: C57BL/6N)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:300469
|
Ses1aC57BL/6J/Ses1aC57BL/6J
(involves: 129 * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:81412
|
Ses1aC57BL/6J/Ses1aC57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1aC57BL/6J/Ses1aC57BL/6J
(129.B6-Ses1aC57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1aC57BL/6J/Ses1aC57BL/6J Ses4C57BL/6J/Ses4C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1aC57BL/6J/Ses1aC57BL/6J Ses5C57BL/6J/Ses5C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1aC57BL/6J/Ses1aC57BL/6J Ses6C57BL/6J/Ses6C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1bC57BL/6J/Ses1bC57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses1bC57BL/6J/Ses1bC57BL/6J
(129.B6-Ses1bC57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses2C57BL/6J/Ses2C57BL/6J
(involves: 129 * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:81412
|
Ses3C57BL/6J/Ses3C57BL/6J
(involves: 129 * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:81412
|
Ses7129S6/SvEvTac/Ses7C57BL/6J Ses8C57BL/6J/Ses8C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses7C57BL/6J/Ses7C57BL/6J Ses8C57BL/6J/Ses8C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Ses9C57BL/6J/Ses9C57BL/6J Ses10C57BL/6J/Ses10C57BL/6J
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:100367
|
Setd3tm1.1(NCOM)Mfgc/Setd3tm1.1(NCOM)Mfgc
(involves: C57BL/6NCrl)
|
decreased susceptibility to Riboviria infection
|
J:293475
|
Setdb2tm1Desr/Setdb2tm1Desr
(B6.Cg-Setdb2tm1Desr)
|
abnormal response to infection
|
J:222611
|
increased susceptibility to bacterial infection
|
J:222611
|
Sfntm1Mak/Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:168328
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:168328
|
Sftpa1tm1Haw/Sftpa1tm1Haw
(involves: 129/Sv * C57BL/6 * CD-1)
|
increased susceptibility to Orthomyxoviridae infection
|
J:86024
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd * NIH Black Swiss)
|
increased susceptibility to bacterial infection
|
J:120552,
J:110382
|
Sftpa1tm1Kor/Sftpa1tm1Kor
(involves: 129P2/OlaHsd * Black Swiss * C3H/HeN)
|
increased susceptibility to bacterial infection
|
J:130297
|
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss)
|
increased susceptibility to Orthomyxoviridae infection
|
J:72681
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:97756
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * BALB/c)
|
decreased susceptibility to parasitic infection
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to Riboviria infection
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * BALB/c)
|
decreased susceptibility to parasitic infection
|
J:97756
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
increased susceptibility to infection
|
J:70032
|
increased susceptibility to parasitic infection
|
J:70032
|
increased susceptibility to Riboviria infection
|
J:70032
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(involves: BALB/c)
|
decreased susceptibility to parasitic infection
|
J:90484
|
Sh3bp2tm1.1Ics/Sh3bp2+
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:221901
|
Sh3glb2Gt(OST224737)Lex/Sh3glb2Gt(OST224737)Lex
(B6.129S5-Sh3glb2Gt(OST224737)Lex)
|
abnormal response to infection
|
J:246421
|
Siglec1tm1Croc/Siglec1tm1Croc
(B6.129-Siglec1tm1Croc)
|
increased susceptibility to bacterial infection
|
J:189854
|
Siglec1tm2.1Croc/Siglec1tm2.1Croc
(B6.129P2(C)-Siglec1tm2.1Croc)
|
decreased susceptibility to bacterial infection
|
J:189854
|
Siglecetm1.1(SIGLEC16)Avrk/Siglecetm1.1(SIGLEC16)Avrk
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:264224
|
Siglechtm1.1Ksat/Siglechtm1.1Ksat
(B6.Cg-Siglechtm1.1Ksat)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:179283
|
decreased susceptibility to infection induced morbidity/mortality
|
J:179283
|
Slamf1tm1Cpt/Slamf1tm1Cpt
(B6.129S4-Slamf1tm1Cpt)
|
increased susceptibility to parasitic infection
|
J:90484
|
Slamf1tm1Oono/Slamf1tm1Oono
(B6.129-Slamf1tm1Oono)
|
increased susceptibility to Paramyxoviridae infection
|
J:117810
|
Slamf6tm1Dhow/Slamf6tm1Dhow
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:98995
|
increased susceptibility to bacterial infection
|
J:98995
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:98995
|
Slamf8tm1Mill/Slamf8tm1Mill
(involves: BALB/c)
|
increased susceptibility to bacterial infection
|
J:188963
|
Slc11a1r/Slc11a1r
(C3H/HeJ-Slc11a1r)
|
decreased susceptibility to bacterial infection
|
J:35004
|
Slc11a1r/Slc11a1r
(129/Sv)
|
decreased susceptibility to bacterial infection
|
J:81412
|
Slc11a1r/Slc11a1s
((129/Sv x BALB/c)F1)
|
decreased susceptibility to bacterial infection
|
J:28278
|
Slc11a1s/Slc11a1r
((129/Sv x C57BL/6J)F1)
|
abnormal susceptibility to bacterial infection
|
J:81412
|
Slc11a1s/Slc11a1s
(C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:81412
|
Slc11a1s/Slc11a1s
(BALB/c)
|
increased susceptibility to bacterial infection
|
J:28278
|
Slc11a1tm1Mcg/Slc11a1s
(involves: 129S4/SvJae * BALB/c)
|
increased susceptibility to bacterial infection
|
J:28278
|
Slc11a1tm1Mcg/Slc11a1tm1Mcg
(involves: 129S4/SvJae * BALB/c)
|
increased susceptibility to bacterial infection
|
J:28278
|
Slc12a2em1Dlp/Slc12a2+
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:285398
|
Slc12a2em1Dlp/Slc12a2em1Dlp
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to bacterial infection
|
J:285398
|
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:179286
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:179286
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to infection
|
J:211266
|
Slc38a8em1Cya/Slc38a8em1Cya
(C57BL/6J-Slc38a8em1Cya)
|
decreased susceptibility to viral infection
|
J:336781
|
decreased susceptibility to viral infection induced morbidity/mortality
|
J:336781
|
Slfn2m1Btlr/Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
increased susceptibility to bacterial infection
|
J:158985
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:158985
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:158985
|
increased susceptibility to Riboviria infection
|
J:158985
|
Slfn4tm1c(EUCOMM)Wtsi/Slfn4tm1c(EUCOMM)Wtsi Gli1tm3(cre/ERT2)Alj/Gli1+
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * Swiss Webster)
|
decreased susceptibility to bacterial infection
|
J:337060
|
Slpitm1Ktak/Slpitm1Ktak
(B6.129P2-Slpitm1Ktak)
|
increased susceptibility to bacterial infection
|
J:132933
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:81982
|
Smtntm1Gve/Smtntm1Gve
(involves: 129/Sv * C57BL/6)
|
sepsis
|
J:104648
|
Sncatm1Rosl/Sncatm1Rosl
(involves: 129X1/SvJ)
|
decreased susceptibility to bacterial infection
|
J:138194
|
Sncatm1Rosl/Sncatm1Rosl Tg(Prnp-SNCA)7Vle/Tg(Prnp-SNCA)7Vle
(involves: 129X1/SvJ * C3H * C57BL/6)
|
abnormal response to infection
|
J:138194
|
Sncatm1Rosl/Sncatm1Rosl Tg(Prnp-SNCA*A53T)83Vle/Tg(Prnp-SNCA*A53T)83Vle
(involves: 129X1/SvJ * C3H * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:138194
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
increased susceptibility to viral infection
|
J:282417
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:282417
|
Snx8tm1Hbsh/Snx8tm1Hbsh
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:254306
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:254306
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to Togaviridae infection induced morbidity/mortality
|
J:57474
|
Socs4m1Nch/Socs4m1Nch
(C.C3Fe-Socs4m1Nch)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:241977
|
Socs4m1Nch/Socs4m1Nch
(C3H/He-Socs4m1Nch)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:241977
|
Socs4m1Nch/Socs4m1Nch
(C6.C3Fe-Socs4m1Nch)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:241977
|
Sp140em1Vnce/Sp140em1Vnce
(C57BL/6J-Sp140em1Vnce)
|
increased susceptibility to bacterial infection
|
J:313901
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:313901
|
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
sepsis
|
J:36473
|
Spibtm1Ksho/Spibtm1Ksho
(involves: C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:187649
|
Spir1BALB/cOlaHsd/Spir1BALB/cOlaHsd
(involves: BALB/cOlaHsd * CBA/CaOlaHsd)
|
decreased susceptibility to bacterial infection
|
J:84089
|
Spir1BALB/cOlaHsd/Spir1CBA/CaOlaHsd
(involves: BALB/cOlaHsd * CBA/CaOlaHsd)
|
decreased susceptibility to bacterial infection
|
J:84089
|
Spir1CBA/CaOlaHsd/Spir1CBA/CaOlaHsd
(involves: BALB/cOlaHsd * CBA/CaOlaHsd)
|
increased susceptibility to bacterial infection
|
J:84089
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:213427
|
Spon2tm1Mjb/Spon2tm1Mjb
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal susceptibility to infection
|
J:87393
|
Spp1Ric-r/Spp1+
(AKR/J)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(A/J)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(BALB/cJ)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(C57L/J)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(SWR/J)
|
decreased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-r/Spp1+
(C3H/Rv)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:7240
|
Spp1Ric-s/Spp1+
(A/HeJ)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(C3H/HeJ)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(C3H/HeN)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(C3H/St)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(CBA/J)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(DBA/1J)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(DBA/2J)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1Ric-s/Spp1+
(SJL/J)
|
increased susceptibility to bacterial infection
|
J:5949
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal response to infection
|
J:103013
|
abnormal susceptibility to infection
|
J:140014
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal response to infection
|
J:60284
|
decreased susceptibility to Herpesvirales infection
|
J:60284
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased susceptibility to bacterial infection
|
J:12830
|
Spta1sph/Spta1sph
(either: (B6.C3-Spta1sph x WB.C3-Spta1sph)F1 or (WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
decreased susceptibility to parasitic infection
|
J:111131
|
Sros1em1Caox/Sros1em1Caox
(involves: C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:306407
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:306407
|
Sst1C3HeB/FeJ/Sst1C3HeB/FeJ
(involves: C3HeB/FeJ * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:63410
|
Sst1C3HeB/FeJ/Sst1C3HeB/FeJ
(B6.C3-Sst1C3HeB/FejKrmn/Mmnc)
|
increased susceptibility to bacterial infection
|
J:313901
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:313901
|
Sst1C3HeB/FeJ/Sst1C57BL/6J
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:63410
|
Sst1C57BL/6J/Sst1C57BL/6J
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:63410,
J:93705
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm)
|
abnormal response to infection
|
J:136946
|
St6gal1tm1Jlau/St6gal1tm1Jlau
(129S4/SvJae-St6gal1tm1Jlau)
|
increased susceptibility to bacterial infection
|
J:140702
|
Stard13tm1a(KOMP)Wtsi/Stard13tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:213427
|
Stat1m1Anu/Stat1m1Anu
(C57BL/6JSfdAnu-Stat1m1Anu)
|
abnormal response to infection
|
J:104190
|
Stat1m1Btlr/Stat1m1Btlr
(C57BL/6J-Stat1m1Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:105543
|
increased susceptibility to Riboviria infection
|
J:105543
|
Stat1m2Btlr/Stat1m2Btlr
(C57BL/6J-Stat1m2Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:134096
|
Stat1tm1Dlv/Stat1tm1Dlv
(either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1))
|
increased susceptibility to Coronaviridae infection
|
J:31325
|
increased susceptibility to Riboviria infection
|
J:31325
|
Stat1tm1Dlv/Stat1tm1Dlv
(B6.129-Stat1tm1Dlv)
|
increased susceptibility to Herpesvirales infection
|
J:81243
|
increased susceptibility to Togaviridae infection
|
J:81243
|
Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv)
|
increased susceptibility to bacterial infection
|
J:130622
|
increased susceptibility to Riboviria infection
|
J:130622
|
Stat1tm1Dlv/Stat1tm1Dlv Tg(ANPEP)270Mmul/Tg(ANPEP)270Mmul
(involves: 129S/SvEv * ICR)
|
increased susceptibility to Coronaviridae infection
|
J:99728
|
Stat1tm1Dlv/Stat1tm1Dlv Tg(ANPEP)861Mmul/Tg(ANPEP)861Mmul
(involves: 129S/SvEv * ICR)
|
increased susceptibility to Coronaviridae infection
|
J:99728
|
Stat1tm1Rds/Stat1tm1Rds
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
increased susceptibility to bacterial infection
|
J:31326
|
increased susceptibility to Riboviria infection
|
J:31326
|
Stat1tm1Rds/Stat1tm1Rds
(involves: 129)
|
increased susceptibility to Herpesvirales infection
|
J:81243
|
increased susceptibility to Riboviria infection
|
J:66564
|
increased susceptibility to Togaviridae infection
|
J:81243
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
increased susceptibility to Coronaviridae infection
|
J:286237
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:286237
|
Stat1tm1Rds/Stat1tm1Rds Stat2tm1Shnd/Stat2tm1Shnd
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to Riboviria infection
|
J:66564
|
Stat1tm1Tdec/Stat1tm1Tdec
(involves: 129P2/OlaHsd * BALB/c)
|
increased susceptibility to bacterial infection
|
J:130622
|
increased susceptibility to Riboviria infection
|
J:130622
|
Stat1tm2.1Uvin/Stat1tm2.1Uvin
(B6.129P2-Stat1tm2.1Uvin)
|
increased susceptibility to bacterial infection
|
J:209388
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:209388
|
Stat2p117/Stat2p117
(C57BL/6J-Stat2P117)
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:164049
|
Stat2tm1.1(STAT2)Diam/Stat2tm1.1(STAT2)Diam
(C57BL/6-Stat2tm1.1(STAT2)Diam)
|
increased susceptibility to Flaviviridae infection
|
J:261503
|
increased susceptibility to Flaviviridae infection induced morbidity/mortality
|
J:261503
|
Stat2tm1Shnd/Stat2tm1Shnd
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to Riboviria infection
|
J:66564
|
Stat3tm2Aki/Stat3tm2Aki
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal response to infection
|
J:122213
|
Stat4ity14/Stat4ity14
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to bacterial infection
|
J:207092
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:207092
|
Stat4ity14/Stat4tm1Gru
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:207092
|
Stat4tm1Gru/Stat4tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
increased susceptibility to bacterial infection
|
J:163843
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:163843
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
decreased susceptibility to Herpesvirales infection
|
J:107370
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:110429
|
Sting1gt/Sting1gt
(C57BL/6-Sting1gt)
|
abnormal response to infection
|
J:168746
|
increased susceptibility to Herpesvirales infection
|
J:201167
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:201167
|
Sting1gt/Sting1gt
(involves: C57BL/6)
|
increased susceptibility to Retroviridae infection
|
J:265023
|
Sting1tm1Gnb/Sting1tm1Gnb
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to Herpesvirales infection
|
J:141011
|
increased susceptibility to Riboviria infection
|
J:141011
|
Sting1tm1Gnb/Sting1tm1Gnb
(involves: 129P2/OlaHsd)
|
abnormal response to infection
|
J:168746
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N)
|
sepsis
|
J:158190
|
Stk38tm1Xen/Stk38tm1Xen
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:224932
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:224932
|
Stx11tm1.2Ics/Stx11tm1.2Ics
(involves: C57BL/6NTac)
|
increased susceptibility to Riboviria infection
|
J:193137
|
Sulf1Gt(OST352220)Lex/Sulf1Gt(OST352220)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:171883
|
tAE5/tAE5
(Not Specified)
|
increased susceptibility to infection
|
J:83862
|
Tap1m2Btlr/Tap1m2Btlr
(C57BL/6J-Tap1m2Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:236697
|
Tap1tm1Arp/Tap1tm1Arp
(B6.129S2-Tap1tm1Arp/J)
|
decreased susceptibility to bacterial infection
|
J:123934
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:123934
|
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal response to infection
|
J:211913
|
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:166476
|
Tbrs1C57BL/6J/Tbrs1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:67658
|
Tbrs2C57BL/6J/Tbrs2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:67658
|
Tbrs2C57BL/6J/Tbrs2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:67658
|
Tbrs3C57BL/6J/Tbrs3C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:67658
|
Tbrs3C57BL/6J/Tbrs3C57BL/6J Tbrs4C57BL/6J/Tbrs4C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:83619
|
Tbrs3C57BL/6J/Tbrs3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:67658
|
Tbrs4C57BL/6J/Tbrs4C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased susceptibility to bacterial infection
|
J:83619
|
Tbs1I/StSnEgYCit/Tbs1A/SnYCit
(involves: A/SnYCit * I/StSnEgYCit)
|
decreased susceptibility to bacterial infection
|
J:80972
|
Tbs2I/StSnEgYCit/Tbs2A/SnYCit
(involves: A/SnYCit * I/StSnEgYCit)
|
decreased susceptibility to bacterial infection
|
J:80972
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:73833
|
Tbx21tm2Srnr/Tbx21+ Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
increased susceptibility to Riboviria infection
|
J:174315
|
Tbx21tm2Srnr/Tbx21tm2Srnr Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
increased susceptibility to Riboviria infection
|
J:174315
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to bacterial infection
|
J:155199
|
Tcratm1Mom/Tcratm1Mom
(B6.129S2-Tcratm1Mom)
|
increased susceptibility to bacterial infection
|
J:106241
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
abnormal response to infection
|
J:119344
|
Tcrbtm1Mom/Tcrbtm1Mom Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:119344
|
Tecpr1tm1Chsa/Tecpr1tm1Chsa
(involves: 129S4/SvJae)
|
abnormal susceptibility to infection
|
J:198333
|
Terf2ipGt(XD108)Byg/Terf2ip+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:163158
|
Tfebem1Xinli/Tfebem1Xinli
(involves: C57BL/6J)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:342735
|
Tfpi2tm1Dgen/Tfpi2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:301794
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:301794
|
Tg(Ace2-ACE2)1Cqin/0
(involves: ICR)
|
increased susceptibility to Coronaviridae infection
|
J:141460,
J:287631,
J:288244
|
Tg(Alb-PLG)1Dgi/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to bacterial infection
|
J:120780
|
Tg(CAG-ACE2)AC63Ctkt/0
(either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))
|
increased susceptibility to Coronaviridae infection
|
J:117824
|
Tg(CAG-ACE2)AC70Ctkt/0
(either: (involves: BALB/c * C3H/HeJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6 * C57BL/6J))
|
increased susceptibility to Coronaviridae infection
|
J:117824
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:117824
|
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh)
|
increased susceptibility to Coronaviridae infection
|
J:286175
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:286175
|
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J)
|
increased susceptibility to Coronaviridae infection
|
J:227925,
J:258199
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:227925,
J:258199
|
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
increased susceptibility to parasitic infection
|
J:134448
|
Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
increased susceptibility to parasitic infection
|
J:134448
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
abnormal susceptibility to Picornaviridae infection
|
J:236222
|
Tg(CD46)2Gsv/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to Paramyxoviridae infection
|
J:109895
|
Tg(CLEC4C-HBEGF)956Cln/0
(C57BL/6-Tg(CLEC4C-HBEGF)956Cln)
|
increased susceptibility to Herpesvirales infection
|
J:166504
|
Tg(DPP4)2Nnag/0
(B6.Cg-Tg(DPP4)2Nnag)
|
increased susceptibility to Coronaviridae infection
|
J:286321
|
Tg(DPP4)2Nnag/0 Tmprss2tm1(KOMP)Vlcg/Tmprss2tm1(KOMP)Vlcg
(involves: C57BL/6NCr * C57BL/6NTac * DBA)
|
decreased susceptibility to Coronaviridae infection
|
J:283077
|
Tg(FOXJ1-ACE2)1Rba/0
(involves: C3H * C57BL/6)
|
increased susceptibility to Coronaviridae infection
|
J:287092,
J:288386
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:287092,
J:288386
|
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to Riboviria infection
|
J:68811
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:68811
|
Tg(H2-Db)2Bujf/0
(FVB/NPas-Tg(H2-Db)2Bujf)
|
decreased susceptibility to Picornaviridae infection
|
J:18556
|
Tg(H2-Ea-LACK)1Ngkh/0
(C.Cg-Tg(H2-Ea-LACK)1Ngkh)
|
decreased susceptibility to parasitic infection
|
J:181384
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:181384
|
Tg(H2-Ld)LoxNibl/0
(C57BL/6-Tg(H2-Ld)LoxNibl)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:284394
|
Tg(Hmgcr-MX1)LStae/Tg(Hmgcr-MX1)LStae
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:119783
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:119783
|
Tg(ICAM1)4Grom/?
(involves: BALB/cAnNTac)
|
increased susceptibility to Picornaviridae infection
|
J:92607
|
Tg(Il1rn)1Dih/0
(involves: C57BL/6 * CBA)
|
decreased susceptibility to Herpesvirales infection
|
J:88605
|
increased susceptibility to bacterial infection
|
J:36387
|
Tg(Il1rn)1Dih/Tg(Il1rn)1Dih
(involves: C57BL/6 * CBA)
|
increased susceptibility to bacterial infection
|
J:36387
|
Tg(IL2-Il10)1Kro/0
(involves: C3H * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:41588
|
increased susceptibility to bacterial infection
|
J:80569
|
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0
(C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)
|
abnormal susceptibility to infection
|
J:194800
|
Tg(Itgax-HBEGF/OVA/EGFP)1Garbi/0
(C57BL/6-Tg(Itgax-HBEGF/OVA/EGFP)1Garbi)
|
abnormal susceptibility to infection
|
J:194800
|
Tg(Itgax-TGFBR2)1Flv/0
(C.Cg-Tg(Itgax-TGFBR2)1Flv)
|
decreased susceptibility to parasitic infection
|
J:98953
|
Tg(K18-ACE2)2Prlmn/0
(involves: C57BL/6J * SJL/J)
|
increased susceptibility to Coronaviridae infection
|
J:283648
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:283648
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
increased susceptibility to Coronaviridae infection
|
J:294084,
J:300960,
J:302313,
J:296067
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:294084,
J:300960
|
increased susceptibility to Orthomyxoviridae infection
|
J:296067
|
increased susceptibility to viral infection
|
J:296067
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:296067
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:79706
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:79706
|
Tg(KRT14-Il4)#Lsch/0
(involves: BALB/cBy * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:126285
|
Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
increased susceptibility to Coronaviridae infection
|
J:286231,
J:285467
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:286231,
J:285467
|
Tg(Lck-Tax)53Hall/0
(involves: C57BL/6)
|
increased susceptibility to fungal infection
|
J:129531
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
increased susceptibility to parasitic infection
|
J:92453
|
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
increased susceptibility to bacterial infection
|
J:95913
|
Tg(PRG1)18Wlad/0
(involves: C57BL/6J * CBA/J)
|
decreased susceptibility to Picornaviridae infection
|
J:127826
|
increased susceptibility to Picornaviridae infection
|
J:92990
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:92990
|
Tg(PRG3)9Wlad/0
(involves: C57BL/6J * CBA/J)
|
increased susceptibility to Picornaviridae infection
|
J:92990,
J:127826
|
Tg(Prnp)4053Sbp/0
(involves: FVB/N)
|
increased susceptibility to prion infection
|
J:136434
|
Tg(Prnp)a20Cwe/0
(Not Specified)
|
increased susceptibility to prion infection
|
J:130657,
J:143528
|
Tg(PVR)1Kkst/0
(involves: ICR)
|
increased susceptibility to Picornaviridae infection
|
J:153943
|
Tg(Scgb1a1-Muc5b,-AcGFP)#Evns/0
(involves: C57BL/6J * C57BL/6N)
|
decreased susceptibility to bacterial infection
|
J:207159
|
Tg(Scgb1a1-PLUNC)#Chuh/0
(involves: FVB/N)
|
decreased susceptibility to bacterial infection
|
J:171589
|
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/?
(involves: C3H * C57BL/6)
|
abnormal response to infection
|
J:63507
|
Tg(SFTPC-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
abnormal susceptibility to Coronaviridae infection
|
J:285467
|
Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:210877
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:210877
|
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to Coronaviridae infection
|
J:290259
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:290259
|
Tgm6em1Bge/Tgm6em1Bge
(C57BL/6N-Tgm6em1Bge)
|
increased susceptibility to bacterial infection
|
J:268324
|
Thbdtm1.1Hlwu/Thbdtm1.1Hlwu Lyz2tm1(cre)Ifo/Lyz2+
(B6.129-Thbdtm1.1Hlwu Lyz2tm1(cre)Ifo)
|
decreased susceptibility to bacterial infection
|
J:188879
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:188879
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
decreased susceptibility to infection
|
J:290567
|
decreased susceptibility to infection induced morbidity/mortality
|
J:290567
|
Ticam1Lps2/Ticam1Lps2
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:86521,
J:92674
|
increased susceptibility to Herpesvirales infection
|
J:84896
|
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2/J)
|
increased susceptibility to Coronaviridae infection
|
J:288471
|
increased susceptibility to Coronaviridae infection induced morbidity/mortality
|
J:288471
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:145306
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal susceptibility to Poxviridae infection
|
J:162716
|
increased susceptibility to Picornaviridae infection
|
J:169158
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:169158
|
Ticam1tm1Aki/Ticam1tm1Aki
(B6.129P2-Ticam1tm1Aki)
|
abnormal response to infection
|
J:144301
|
increased susceptibility to bacterial infection
|
J:144301
|
Ticam1tm1Tsse/Ticam1tm1Tsse Tg(PVR)1Kkst/0
(involves: 129 * C57BL/6 * ICR)
|
increased susceptibility to Picornaviridae infection
|
J:179625
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:179625
|
Ticam2tm1Aki/Ticam2tm1Aki
(involves: C57BL/6)
|
increased susceptibility to Coronaviridae infection
|
J:270045
|
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae)
|
decreased susceptibility to bacterial infection
|
J:94836
|
Timp1tm1Pds/Timp1tm1Pds
(involves: C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:94836
|
Tir2C57BL/6JOlaHsd/Tir2C57BL/6JOlaHsd
(involves: A/JOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir2C57BL/6JOlaHsd/Tir2C57BL/6JOlaHsd
(involves: BALB/cOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir2C57BL/6JOlaHsd/Tir2C57BL/6JOlaHsd
(A.B6-Tir2)
|
decreased susceptibility to parasitic infection
|
J:97672
|
Tir2C57BL/6JOlaHsd/Tir2C57BL/6JOlaHsd
(A.B6-(D5Mit200-D5Mit10))
|
decreased susceptibility to parasitic infection
|
J:135428
|
Tir3BALB/cOlaHsd/Tir3C57BL/6JOlaHsd
(involves: BALB/cOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir3C57BL/6JOlaHsd/Tir3C57BL/6JOlaHsd
(involves: BALB/cOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir3C57BL/6JOlaHsd/Tir3C57BL/6JOlaHsd
(A.B6-Tir3)
|
decreased susceptibility to parasitic infection
|
J:97672
|
Tir3C57BL/6JOlaHsd/Tir3C57BL/6JOlaHsd
(A.B6-(D1Mit60-D1Mit217))
|
decreased susceptibility to parasitic infection
|
J:135428
|
Tir4C57BL/6JOlaHsd/?
(involves: BALB/cOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir4C57BL/6JOlaHsd/Tir4C57BL/6JOlaHsd
(involves: A/JOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir4C57BL/6JOlaHsd/Tir4C57BL/6JOlaHsd
(involves: BALB/cOlaHsd * C57BL/6JOlaHsd)
|
decreased susceptibility to parasitic infection
|
J:40771
|
Tir4C57BL/6JOlaHsd/Tir4C57BL/6JOlaHsd
(A.B6-Tir1)
|
decreased susceptibility to parasitic infection
|
J:97672
|
Tir4C57BL/6JOlaHsd/Tir4C57BL/6JOlaHsd
(A.B6-(D17Mit29-D17Mit11))
|
decreased susceptibility to parasitic infection
|
J:135428
|
Tir9C57BL/6/Tir9C57BL/6
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to parasitic infection
|
J:84716
|
Tir10C57BL/6/Tir10C57BL/6
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to parasitic infection
|
J:84716
|
Tiraptm1Medz/Tiraptm1Medz
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:96018
|
Tlr1tm1Flv/Tlr1tm1Flv
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:95726
|
Tlr2lngd/Tlr2lngd
(C57BL/6J-Tlr2lngd)
|
increased susceptibility to bacterial infection
|
J:94077
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to Herpesvirales infection
|
J:88174
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:88174
|
increased susceptibility to bacterial infection
|
J:95726
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
decreased susceptibility to parasitic infection
|
J:116763
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:146111
|
Tlr2tm1Kir/Tlr2tm1Kir
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J))
|
increased susceptibility to bacterial infection
|
J:85323
|
Tlr2tm1Kir/Tlr2tm1Kir
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:96018
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:121930
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:147177
|
Tlr3tm1Flv/Tlr3tm1Flv
(Not Specified)
|
increased susceptibility to Herpesvirales infection
|
J:88906
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
decreased susceptibility to Riboviria infection
|
J:136330
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:136330
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:119967
|
Tlr3tm1Flv/Tlr3tm1Flv
(B6N.129S1-Tlr3tm1Flv/J)
|
increased susceptibility to Coronaviridae infection
|
J:288471
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
increased susceptibility to bacterial infection
|
J:5721,
J:51522,
J:87807
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal susceptibility to infection
|
J:162716
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:162716
|
Tlr4lps-del/Tlr4lps-del
(C57BL/10ScCr)
|
increased susceptibility to bacterial infection
|
J:51522,
J:88996
|
Tlr4lps-hypo/Tlr4lps-hypo
(B6.Cg-Tlr4lps-hypo Cln8mnd)
|
decreased susceptibility to bacterial infection
|
J:103167
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:145306
|
increased susceptibility to bacterial infection
|
J:53519
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:98224
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:111778
|
Tlr4tm1Aki/Tlr4tm1Aki Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:111778
|
Tlr5tm1Aki/Tlr5tm1Aki
(B6.129P2-Tlr5tm1Aki)
|
decreased susceptibility to bacterial infection
|
J:112391
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:111778
|
Tlr9M1Btlr/Tlr9M1Btlr
(involves: C57BL/6)
|
increased susceptibility to Herpesvirales infection
|
J:88906
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:88906
|
Tlr9M2Btlr/Tlr9M2Btlr
(C57BL/6J-Tlr9M2Btlr)
|
increased susceptibility to Herpesvirales infection
|
J:128405
|
Tlr9tm1Aki/Tlr9tm1Aki
(B6.129P2-Tlr9tm1Aki)
|
abnormal response to infection
|
J:121070
|
decreased susceptibility to parasitic infection
|
J:116763
|
Tlr12tm1Gho/Tlr12tm1Gho
(Not Specified)
|
increased susceptibility to bacterial infection
|
J:89754
|
Tmem41bem1Cya/Tmem41b+
(involves: C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:316472
|
Tmem268em1Cheyy/Tmem268em1Cheyy
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:350812
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:350812
|
Tmevp2C57BL/10SnSg/Tmevp2C57BL/10SnSg
(involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)
|
decreased susceptibility to Picornaviridae infection
|
J:54593
|
Tmevp3C57BL/10SnSg/Tmevp3C57BL/10SnSg
(involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)
|
decreased susceptibility to Picornaviridae infection
|
J:54593
|
Tmevp3C57BL/10SnSg/Tmevp3SJL/J
(involves: A/WySn * C57BL/10SnSg * SJL/J * Swiss)
|
decreased susceptibility to Picornaviridae infection
|
J:54593
|
Tmprss2tm1(KOMP)Vlcg/Tmprss2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased susceptibility to Coronaviridae infection
|
J:283077
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:214427
|
Tmprss2tm1Psn/Tmprss2tm1Psn
(B6JRj.129S1-Tmprss2tm1Psn)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:287633
|
decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:287633
|
Tmprss2tm1Psn/Tmprss2tm1Psn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:244166
|
TnfM1Btlr/TnfM1Btlr
(C57BL/6J-TnfM1Btlr)
|
increased susceptibility to bacterial infection
|
J:124642
|
TnfR8H/TnfR8H
(involves: I/St)
|
increased susceptibility to bacterial infection
|
J:114302
|
Tnftm1.1Sned/Tnftm1.1Sned Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:95684
|
Tnftm1.1Sned/Tnftm1.1Sned Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
increased susceptibility to bacterial infection
|
J:95684
|
Tnftm1.2Sned/Tnftm1.2Sned
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:97783
|
increased susceptibility to parasitic infection
|
J:97783
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:47673,
J:114740
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv)
|
increased susceptibility to bacterial infection
|
J:95684
|
Tnftm1Gkl/Tnftm1Gkl
(either: B6.129-Tnftm1Gkl or (involves: 129 * C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:97783
|
increased susceptibility to parasitic infection
|
J:97783
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:124642
|
Tnftm1Jods/Tnftm1Jods
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:115034,
J:98170
|
Tnftm1Ljo/Tnf+
(involves: 129S1/Sv)
|
increased susceptibility to bacterial infection
|
J:41992
|
increased susceptibility to fungal infection
|
J:41992
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv)
|
abnormal susceptibility to infection
|
J:41992
|
increased susceptibility to bacterial infection
|
J:80616,
J:95684,
J:41992
|
increased susceptibility to fungal infection
|
J:41992
|
Tnftm1Ljo/Tnftm1Ljo
(either: B6.129-Tnftm1Ljo or (involves: 129 * C57BL/6))
|
decreased susceptibility to bacterial infection
|
J:97783
|
increased susceptibility to parasitic infection
|
J:97783
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:127028
|
Tnftm2Jods/Tnftm2Jods
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:98170
|
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:114740
|
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:92470
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:14424
|
increased susceptibility to parasitic infection
|
J:114203
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:50903
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:210950
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
increased susceptibility to parasitic infection
|
J:114203
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
increased susceptibility to bacterial infection
|
J:45147
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: C57BL/6)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:210950
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:58851
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(B6.129S-Tnfrsf1btm1Imx Tnfrsf1atm1Imx/J)
|
decreased susceptibility to Coronaviridae infection
|
J:288523
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas)
|
decreased susceptibility to bacterial infection
|
J:4753,
J:121930
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:4753,
J:139030,
J:210950
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:21815
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to bacterial infection
|
J:50903
|
increased susceptibility to parasitic infection
|
J:114203
|
Tnfrsf10btm1Wnt/Tnfrsf10btm1Wnt
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased susceptibility to Herpesvirales infection
|
J:94681
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:94681
|
Tnfrsf14tm1Kro/Tnfrsf14tm1Kro
(C57BL/6-Tnfrsf14tm1Kro)
|
decreased susceptibility to Herpesvirales infection
|
J:243038
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
decreased susceptibility to bacterial infection
|
J:87620
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:87620
|
Tnfsf12tm1Ash/Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash)
|
increased susceptibility to bacterial infection
|
J:104801
|
Tom1l2Gt(XG909)Byg/Tom1l2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to infection
|
J:133892
|
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to bacterial infection
|
J:133892
|
increased susceptibility to infection
|
J:133892
|
Tpsb2tm1(cre)Adch/Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch)
|
increased susceptibility to bacterial infection
|
J:124554
|
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg)
|
increased susceptibility to parasitic infection
|
J:133373
|
Traddtm1.1Mpa/Traddtm1.1Mpa
(involves: BALB/cJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:139030
|
Trafd1tm1Ayos/Trafd1tm1Ayos
(involves: 129 * C57BL/6J)
|
decreased susceptibility to Riboviria infection
|
J:144594
|
Trim6em1Raj/Trim6em1Raj
(C57BL/6J-Trim6em1Raj)
|
abnormal response to infection
|
J:326927
|
Trim7em1Jiew/Trim7em1Jiew
(C57BL/6-Trim7em1Jiew)
|
decreased susceptibility to Herpesvirales infection
|
J:292408
|
decreased susceptibility to viral infection
|
J:292408
|
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac)
|
increased susceptibility to bacterial infection
|
J:251270
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:251270
|
Trim13tm1.1Jskg/Trim13tm1.1Jskg
(B6.129S7(Cg)-Trim13tm1.1Jskg)
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:243916
|
Trim14em1Rfw/Trim14em1Rfw
(involves: C57BL/6J)
|
increased susceptibility to Herpesvirales infection
|
J:249057
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:249057
|
Trim25tm1Mura/Trim25+ Usp15L749R/Usp15+
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Trim25tm1Mura/Trim25tm1Mura
(involves: 129S4/SvJae)
|
decreased susceptibility to parasitic infection
|
J:259382
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Trim29tm1a(EUCOMM)Wtsi/Trim29tm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
decreased susceptibility to Picornaviridae infection
|
J:349246
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:349246
|
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
decreased susceptibility to Picornaviridae infection
|
J:349246
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:349246
|
Trim35em1Smoc/Trim35em1Smoc
(C57BL/6J-Trim35em1Smoc)
|
increased susceptibility to Orthomyxoviridae infection
|
J:303214
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:303214
|
Trim38tm1(KOMP)Vlcg/Trim38tm1(KOMP)Vlcg
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:239773
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:239773
|
increased susceptibility to infection induced morbidity/mortality
|
J:239773
|
Trim40em1Caox/Trim40em1Caox
(involves: C57BL/6J)
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:255265
|
Trim41tm1Caox/Trim41tm1Caox
(B6.Cg-Trim41tm1Caox)
|
increased susceptibility to bacterial infection
|
J:340065
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:340065
|
increased susceptibility to Herpesvirales infection
|
J:340065
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:340065
|
increased susceptibility to Riboviria infection
|
J:340065
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:340065
|
Trim55tm1Slbt/Trim55tm1Slbt
(involves: 129 * C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:268979
|
Trim65em1Cya/Trim65em1Cya
(involves: C57BL/6)
|
increased susceptibility to Picornaviridae infection
|
J:240099
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:240099
|
Trp63tm2Brd/Trp63+
(involves: 129S7/SvEvBrd)
|
increased susceptibility to infection
|
J:100483
|
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae)
|
increased susceptibility to bacterial infection
|
J:60896
|
Trpm2tm1.1Alp/Trpm2tm1.1Alp
(B6.129P2-Trpm2tm1.1Alp)
|
increased susceptibility to bacterial infection
|
J:174397
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:174397
|
Trpv2tm1Mijc/Trpv2tm1Mijc
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:158505
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:158505
|
Trpv3Nh/Trpv3+
(involves: DS)
|
increased susceptibility to bacterial infection
|
J:42153
|
Txktm1Pls/Txktm1Pls
(involves: 129S6/SvEvTac)
|
increased susceptibility to parasitic infection
|
J:54449
|
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ)
|
increased susceptibility to parasitic infection
|
J:120304
|
Tyk2tm1Biat/Tyk2tm1Biat
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal response to infection
|
J:116703
|
increased susceptibility to Herpesvirales infection
|
J:116703
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:116703
|
increased susceptibility to Riboviria infection
|
J:65408
|
increased susceptibility to viral infection induced morbidity/mortality
|
J:65408
|
Tyk2tm1Biat/Tyk2tm1Biat
(B6NCrl.129P2-Tyk2tm1Biat)
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:187818
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:187818
|
Tyk2tm3.1Biat/Tyk2tm3.1Biat
(B6NCrl.129P2(C)-Tyk2tm3.1Biat)
|
increased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:187818
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:187818
|
Tyrobptm1Viv/Tyrobptm1Viv
(B6.129P2-Tyrobptm1Viv)
|
increased susceptibility to Herpesvirales infection
|
J:124749
|
U90926em1Dnkv/U90926em1Dnkv
(C57BL6/J-U90926em1Dnkv)
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:340649
|
Ubdtm1Smwe/Ubdtm1Smwe
(B6.129S6-Ubdtm1Smwe)
|
increased susceptibility to bacterial infection
|
J:110321
|
Ube2stm1.1Smoc/Ube2stm1.1Smoc
(involves: C57BL/6)
|
decreased susceptibility to Herpesvirales infection
|
J:306461
|
decreased susceptibility to Picornaviridae infection
|
J:306461
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:306461
|
decreased susceptibility to Riboviria infection
|
J:306461
|
Ubl7em1Fanm/Ubl7em1Fanm
(involves: C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection
|
J:349835
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:349835
|
increased susceptibility to Riboviria infection
|
J:349835
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:349835
|
Ucp2tm1Rcq/Ucp2tm1Rcq
(involves: 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:66262
|
decreased susceptibility to infection induced morbidity/mortality
|
J:66262
|
decreased susceptibility to parasitic infection
|
J:66262
|
Uggt1tm1a(KOMP)Wtsi/Uggt1+
(involves: C57BL/6N)
|
abnormal susceptibility to Picornaviridae infection
|
J:244058
|
decreased susceptibility to Picornaviridae infection
|
J:244058
|
decreased susceptibility to Picornaviridae infection induced morbidity/mortality
|
J:244058
|
Umodtm1Xrw/Umodtm1Xrw
(involves: 129S6/SvEvTac)
|
increased susceptibility to bacterial infection
|
J:95431
|
Unc13dJinx/Unc13dJinx
(C57BL/6J-Unc13dJinx/Mmucd)
|
increased susceptibility to Herpesvirales infection
|
J:105543,
J:119974
|
increased susceptibility to Riboviria infection
|
J:105543,
J:119974
|
Unc93b13d/Unc93b13d
(C57BL/6J-Unc93b13d)
|
increased susceptibility to bacterial infection
|
J:105484
|
increased susceptibility to Herpesvirales infection
|
J:105484
|
Usp13em1Nmw/Usp13em1Nmw
(B6.Cg-Usp13em1Nmw)
|
increased susceptibility to bacterial infection
|
J:285981
|
Usp15L749R/Usp15+
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Usp15L749R/Usp15L749R
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:259382
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:259382
|
decreased susceptibility to parasitic infection
|
J:259382
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Usp15L749R/Usp15tm1Pgrs
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Usp15tm1Pgrs/Usp15tm1Pgrs
(Not Specified)
|
decreased susceptibility to parasitic infection induced morbidity/mortality
|
J:259382
|
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
increased susceptibility to bacterial infection
|
J:163843
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:163843
|
Usp18ity9/Usp18tm1Dez
(involves: 129 * C57BL/6 * FVB/N)
|
increased susceptibility to bacterial infection
|
J:163843
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:163843
|
Usp18tm1Dez/Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to Coronaviridae infection
|
J:214425
|
Usp20em1Dalin/Usp20em1Dalin
(involves: C57BL/6)
|
increased susceptibility to Herpesvirales infection
|
J:274572
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:274572
|
Usp21tm1.1Jhy/Usp21tm1.1Jhy
(B6.129S7(Cg)-Usp21tm1.1Jhy)
|
decreased susceptibility to Riboviria infection
|
J:208320
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:208320
|
Usp49em1Gpt/Usp49em1Gpt
(involves: C57BL/6NGpt)
|
decreased susceptibility to Herpesvirales infection
|
J:285681
|
decreased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:285681
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal response to infection
|
J:55647
|
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to parasitic infection
|
J:134827
|
Vsig4tm1Gne/Vsig4tm1Gne
(involves: C57BL/6N)
|
increased susceptibility to bacterial infection
|
J:138691
|
Vtcn1tm1Lpc/Vtcn1tm1Lpc
(B6.129S-Vtcn1tm1Lpc)
|
decreased susceptibility to bacterial infection
|
J:145712
|
decreased susceptibility to bacterial infection induced morbidity/mortality
|
J:145712
|
Vtcn1tm1Mak/Vtcn1tm1Mak
(C.Cg-Vtcn1tm1Mak)
|
decreased susceptibility to parasitic infection
|
J:112130
|
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr)
|
increased susceptibility to bacterial infection
|
J:140334
|
Wasltm1.1Ttha/Wasltm1.1Ttha Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
increased susceptibility to bacterial infection
|
J:271857
|
Wfdc1tm1Bcm/Wfdc1tm1Bcm
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to Orthomyxoviridae infection
|
J:216357
|
Wrntm1Led/Wrntm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
increased susceptibility to infection
|
J:106446
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased susceptibility to prion infection
|
J:131028
|
Xbp1tm2Glm/Xbp1tm2Glm Tg(Vil1-cre)997Gum/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N * SJL)
|
increased susceptibility to bacterial infection
|
J:188627
|
Xcr1tm2(HBEGF/Venus)Ksho/Xcr1+
(involves: C57BL/6 * C57BL/6J)
|
decreased susceptibility to bacterial infection
|
J:204851
|
Xpr1Sxv/Xpr1Sxv
(M. spretus)
|
increased susceptibility to Retroviridae infection
|
J:7951
|
Yeats4em1Zfa/Yeats4em1Zfa Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased susceptibility to bacterial infection
|
J:282740
|
Yod1em1Smoc/Yod1em1Smoc
(C57BL/6JSmoc-Yod1em1Smoc/Smoc)
|
increased susceptibility to bacterial infection
|
J:350806
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:350806
|
Ythdf3em1Caox/Ythdf3em1Caox
(involves: C57BL/6J)
|
decreased susceptibility to Riboviria infection
|
J:276397
|
decreased susceptibility to Riboviria infection induced morbidity/mortality
|
J:276397
|
Zbp1tm1.1Jreh/Zbp1tm1.1Jreh
(involves: C57BL/6 * C57BL/6N)
|
increased susceptibility to Herpesvirales infection
|
J:252669
|
Zbtb46tm1(HBEGF)Mnz/Zbtb46+
(C57BL/6-Zbtb46tm1(HBEGF)Mnz)
|
abnormal response to infection
|
J:189122
|
increased susceptibility to parasitic infection
|
J:189122
|
Zc3h7aitem1Caox/Zc3h7aitem1Caox
(C57BL/6J-Zc3h7aitem1Caox)
|
increased susceptibility to Riboviria infection
|
J:282488
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:282488
|
Zcchc3em1Hbsh/Zcchc3em1Hbsh
(involves: C57BL/6)
|
increased susceptibility to Herpesvirales infection
|
J:271802
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:271802
|
increased susceptibility to Poxviridae infection induced morbidity/mortality
|
J:271802
|
Zdhhc1tm1Yyiw/Zdhhc1tm1Yyiw
(involves: 129S6/SvEvTac)
|
increased susceptibility to Herpesvirales infection
|
J:284987
|
increased susceptibility to Herpesvirales infection induced morbidity/mortality
|
J:284987
|
Zdhhc11tm1.1(KOMP)Vlcg/Zdhhc11tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased susceptibility to viral infection
|
J:310891
|
Zfp148tm1.1Jmer/Zfp148tm1.1Jmer Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to bacterial infection
|
J:198847
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:198847
|
Zfp292em1Zfa/Zfp292em1Zfa
(involves: C57BL/6)
|
increased susceptibility to bacterial infection
|
J:259392
|
increased susceptibility to bacterial infection induced morbidity/mortality
|
J:259392
|
Zfp639tm1.2Jaty/Zfp639tm1.2Jaty
(involves: 129 * BALB/cJ * C57BL/6 * SJL)
|
decreased susceptibility to Retroviridae infection
|
J:305874
|
Zfp683Gt(OST314703)Lex/Zfp683Gt(OST314703)Lex
(B6.129S5-Zfp683Gt(OST314703)Lex)
|
abnormal susceptibility to infection
|
J:187727
|
Zfyve1em1Hbsh/Zfyve1em1Hbsh
(C57BL/6J-Zfyve1em1Hbsh)
|
decreased susceptibility to viral infection
|
J:292942
|
decreased susceptibility to viral infection induced morbidity/mortality
|
J:292942
|
Zg16tm1Lex/Zg16tm1Lex
(B6.129S-Zg16tm1Lex)
|
increased susceptibility to bacterial infection
|
J:239095
|
Zkscan3tm1.2Itl/Zkscan3tm1.2Itl
(B6.Cg-Zkscan3tm1.2Itl)
|
abnormal response to infection
|
J:318724
|
Zup1em1Lisi/Zup1em1Lisi
(involves: C57BL/6J)
|
increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
|
J:350802
|
increased susceptibility to Riboviria infection induced morbidity/mortality
|
J:350802
|